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Thesis Abstract
In cases of compromised bone remodeling like osteoporosis, insufficient osseointegration
occurs and results in implant failure. Implant retention relies on proper secondary fixation, which
is developed during bone remodeling. This process is disrupted in metastatic bone diseases like
osteoporosis. Osteoporosis is characterized low bone mass and bone strength resulting from
either accelerated osteoclast-mediated bone resorption or impaired osteoblast-mediated bone
formation. These two processes are not independent phenomena. In fact, osteoporosis can be
viewed as a breakdown of the cellular communication connecting bone resorption to bone
formation. Because bone remodeling occurs at temporally generated specific anatomical sites
and at different times, local regulators that control cross-talk among the cells of the BRU are
important. Previous studies show Ti implant surface characteristics like roughness,
hydrophilicity, and chemistry influence the osteoblastic differentiation of human MSCs and
maturation of OBs. Furthermore, microstructured Ti surfaces modulate the production of factors
shown to be important in the reciprocal communication necessary for the maintenance of healthy
bone remodeling. Semaphorin signaling proteins are known to couple the communication of
osteoblasts to osteoclasts and are capable of stimulating bone formation or bone resorption
depending on certain cues. Implant surface properties can be optimized to exploit these effects
to favor rapid osseointegration in patients with osteoporosis.
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Chapter 1. Introduction
Specific Aims
Successful osseointegration of dental and orthopaedic implants is determined by the degree
of bone apposition to the surface of the implant material. This complex cascade of biological
events involves primary bone formation, ultimately leading to the development of mature lamellar
bone via bone remodeling. In cases of compromised bone remodeling, like osteoporosis,
insufficient osseointegration occurs, which can result in implant failure.
In addition to its role in osseointegration, bone remodeling provides the mechanism for
adaptation to mechanical stress and repair of micro-damage. The versatility of bone remodeling
implies its ubiquity within the skeleton and its initiation highlights the importance of locally
generated and regulated factors ensuring appropriate coupling mechanisms among bone
forming osteoblasts (OBs), bone resorbing osteoclasts (OCs), and their respective
mesenchymal (MSC) or hematopoietic (HSC) stem cell lineage precursors. These cells comprise
the bone remodeling unit (BRU), and their contemporaneous and multidirectional communication
balances bone formation with bone resorption. Any defects in this coupling process may lead to
the dysregulation of bone homeostasis leading to low bone mass and strength resulting in
osteoporosis. Thus, the continuous loss of bone that occurs in osteoporosis implies a defect in
the coupling process. Although age-related mechanisms contributing to osteoporosis may
originate from accelerated bone resorption or impaired bone formation, these processes are not
independent phenomena. Therapeutic interventions targeting either half of this process will
inevitably affect its counterpart.
Implant surfaces made from titanium (Ti) or its alloys, including commercially pure Ti (cpTi),
titanium – aluminum – vanadium (Ti6Al4V), and titanium – zirconium (TiZr), can be modified to
stimulate osteogenesis, resulting in enhanced osseointegration, eliminating the need for
exogenous biologics such as bone morphogenetic proteins (BMPs). Surface microroughness,
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 11
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hydrophilicity, and chemistry influence the osteoblastic differentiation of human mesenchymal
stem cells (MSCs). When grown on Ti surfaces that are microstructured and hydrophilic, these
cells produce factors that create an osteogenic environment by: stimulating osteoblastic
differentiation in progenitor cells distal to the implant; promoting vasculogenesis; reducing
inflammation; and regulating osteoclastic resorption to achieve net new bone formation. These
in vitro findings are correlated with preclinical studies in animal models and with human clinical
studies. However, this research was limited to healthy animals and did not focus on
compromised conditions.
The overall goal of this research project addresses the clinical need for materials that enable
rapid and sufficient implant osseointegration for patients with osteoporosis. The central
hypothesis is that microstructured Ti and TiZr surfaces regulate the remodeling phase of
osseointegration through direct actions on the coupling of cells in the BRU. Furthermore, we can
tailor Ti implant design to exploit these effects to favor rapid osseointegration in patients with
osteoporosis. However, to optimize osteoporotic osseointegration, we need a more complete
understanding of cellular and molecular coupling events within the BRU and how modified Ti
implants exert their regulatory control on bone remodeling. The objectives of this research
project were completed by pursuing the following three specific aims.
Aim 1: Determine the effects of microstructured titanium and titanium-zirconium
surfaces on production of factors that regulate OC activity by cells of the osteoblast
lineage. We will investigate how Ti and TiZr surface properties control local factor production
responsible for the communication occurring within the BRU. The working hypothesis is that
the microtopography and hydrophilicity of Ti and TiZr surfaces regulate production of factors
associated with the reciprocal communication between MSCs, OBs, and OCs, specifically
factors associated with Eph/Ephrin and semaphorin signaling. Smooth, rough, and hydrophilicrough Ti and TiZr disks will be used to assess changes in MSC and OB gene expression and
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protein production of this signaling pathway.
Aim 2: Determine the mechanisms through which implant surface properties influence
cellular communication in bone remodeling. We have established that MSC differentiation
and OB maturation are very different when cultured on microstructured surfaces vs. TCPS.
MSCs and OBs primarily express the α5β1 integrin complex when grown on TCPS but shift to
α1β1 and α2β1 when grown on microstructured substrates. Furthermore, microstructured
implant surfaces facilitate osteogenesis through the non-canonical Wnt5a pathway, in contrast
to the canonical Wnt3a pathway seen on TCPS. Semaphorins not only mediate BRU crosstalk
but also stimulate osteoblastic differentiation and bone growth through β-catenin, bypassing
canonical Wnt3a signaling, suggesting they are involved. The working hypothesis is that
microstructured, hydrophilic surfaces regulate the BRU through semaphorin signaling inducing
OB differentiation. We have developed a system that allows us to focus on surface-dependent
mechanisms that control BRU reciprocal communication.
Aim 3: Examine whether Ti implant surface properties can impact osseointegration in
an in vivo model of compromised bone remodeling. Using an osteoporotic aged rat model,
the in vivo effectiveness of surface modified Ti implants to influence bone formation will be
examined as a function of surface-dependent regulation of OB/OC coupling mechanisms. The
working hypothesis is that modified Ti implants can reinvigorate locally compromised bone
remodeling without use of additional therapeutics. Osseointegration of modified Ti implants will
be compared between aged osteoporotic rats with or without medications commonly used to
combat osteoporosis. MSCs and OBs isolated from these rats will be used to correlate in vitro
and in vivo results.

Significance
Aging of the population is currently a topic of public health concern. The number of people
aged 60 or older is projected to grow to nearly 2 billion by 2050, with most of the increase seen
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in developing countries.1 Consequently, the increasing occurrence of disorders and morbidities
associated with aging is driving the necessity to develop technologies addressing the needs of
this demographic.
Currently, 18.1% of American adults over the age of 65 are completely edentulous and an
estimated 37.9 million adults in the United States will have no natural teeth by 2020.2 Historically,
edentulous patients have been treated with removable dentures. However, decreased dietary
adequacy has been observed in these patients compared to dentate patients. Implant-supported
dentures significantly improve quality of life in comparison to removable dentures, but many
prosthetic and surgical problems and complications are still present. In a systematic review of
data pooled from maxillary and mandibular fixed implant prostheses, only 29% of prostheses
remained complication free after 5 years, which decreased to 9% after 10 years. 3 These
complications were attributed to the effects of aging on metabolic and endocrine processes,
making implant osseointegration difficult to predict accurately.
Sufficient bone volume (BV) and bone mineral density (BMD) are two of the most important
patient factors for predicting implant success. These factors significantly diminish with age and
their reduction is exacerbated by menopause. Patients experiencing excessive decreases in
BMD are at risk of developing osteoporosis. Osteoporosis is a metabolic bone disease
characterized by low BMD and BV, impairing bone strength and healing. An estimated 53.6
million U.S. adults over the age of 50 were affected by osteoporosis or osteopenia in 2010. 4 By
2030, its prevalence is projected to increase to 71.4 million people. 4 Furthermore, 80% of those
affected by osteoporosis were postmenopausal women.4
Countless research efforts have focused on developing new methods of altering biomaterial
surfaces and characterizing their effects on early stage osteogenesis. No efforts, however, have
sought to investigate how implant surfaces modulate the bone remodeling phase of
osseointegration. By investigating the extent to which microstructured surfaces orchestrate the
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dynamic cellular interplay of the BRU, this research shifts the paradigm of contemporary
biomaterial surface research. An understanding of bone remodeling regulation will allow us to
address the clinical need for implants capable of osseointegration in patients with a multitude of
disorders compromising bone remodeling. The aim is not to cure these disorders, but rather
determine whether microstructured implant surfaces can locally mitigate their effects and
reinvigorate bone remodeling to promote rapid and sufficient osseointegration.
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Chapter 2. Background
Implants are used in orthopaedics and dentistry to improve the quality of life for patients who
suffer from chronic back pain, degenerative joints, or edentulism. Titanium (Ti) and its alloys,
including commercially pure Ti (cpTi), titanium–aluminum–vanadium (Ti6Al4V), and titanium–
zirconium (TiZr), are commonly used to restore structure and function of musculoskeletal tissues
because of their high biocompatibility, corrosion resistance, and favorable weight-to-strength
ratio. These attributes of Ti are due to its ability to form a passive oxide layer making it stable in
biological systems. Since bone has a high composition of inorganic calcium phosphates, many
have speculated that the passive oxide layer of Ti mimics the ceramic nature of bone. Ti and Ti
alloy implants support stable osseointegration, the biological phenomenon providing a direct
structural and functional connection between surfaces of load-bearing implant and living bone.
The modern use of metallic implants for orthopaedic and dental applications has been
evolving over the last 60 years.5–7 Early efforts in biomaterial design were primarily concerned
with the biocompatibility of the material with the host tissue. Materials that limited the
development of foreign body giant cells, provided no evidence of local toxicity, and mitigated
fibrous encapsulation were deemed acceptable. Implants made from these materials were
viewed as biologically inert fixtures, anchored in place either using cement or via mechanical
interlocking between the implant and the surrounding bone tissue. However, failure to achieve
mechanical stability led to micromotion of the implant and localized inflammation, and frequently
ending with osteolysis and implant failure.
Over the last few decades, research has made it clear that implant materials should go
beyond compatibility and actively promote bone formation. One approach has been to induce
peri-implant bone formation through the use of osteoinductive agents like demineralized bone
matrix (DBM)8,9 and bone morphogenetic protein-2 (BMP2).10,11 Alternative approaches have
included the use of bone graft substitutes that are designed to be osteogenic via the use of a
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 16
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variety of factors, including platelet rich plasma (PRP), 12–14 platelet derived growth factor
(PDGF),15,16 and insulin-like growth factor-1 (IGF1),17,18 as well as vasculogenic factors like
vascular endothelial growth factor (VEGF),17,19 and fibroblast growth factor-2 (FGF2).20,21
However, many of these biologics are temporary solutions designed to stimulate initial bone
formation. Long-term stability of an implant requires solutions that not only result in net bone
formation but also provide continued osteogenic signals throughout the entire process of
osseointegration. Physical modifications to the implant material surface, which will be present
long after the exogenous bioactive agents are gone, provide the best options to achieve this.

Stages of Osseointegration
Bone is a dynamic tissue making it obvious that coordinated and sequentially organized
cellular communication and biomechanical cues are needed to initiate and maintain the events
responsible for osseointegration (Fig.1). Osseointegration begins with surgical trauma followed
by the insertion of an implant. After implant insertion, blood vessels rupture and release proteins,
ions, sugars, and lipids, important for blood clot formation (Fig.1A). Following formation of the
blood clot, initial inflammatory response is controlled via immunomodulatory cells such as
neutrophils, dendritic cells, and macrophages (Fig.1B). These immune cells produce
chemokines that clean and disinfect the microenvironment, guide MSC recruitment or additional
immune cells, and initiate tissue repair.
The blood clot spans the gap between the injured bone and the implant. Formation of the
blood clot is an important step in implant osseointegration, as it serves as a provisional matrix
and scaffold for the migration of MSCs to the implant surface (Fig.1B). Surface design that
facilitates this contact osteogenesis has been shown to control the fundamental processes that
drive the osteoblastic differentiation of MSCs.22,23 Differentiating MSCs and mature OBs produce
factors that create an osteogenic microenvironment, promote angiogenesis, reduce
inflammation, and regulate osteoclast-mediated bone resorption. A cell-rich, immature bone
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Figure 1. Schematic illustrating the steps of implant osteointegration. Osteointegration involves formation
of a fibrin clot (A), recruitment of monocytes, macrophages and MSCs (B); osteoblastic differentiation of MSCs
and primary bone formation as well as vasculogenesis (C); and ultimately osteoclast-mediated bone remodeling
(D); leading to mature bone (E).

(primary bone) forms in direct contact with the surface of the Ti implant (Fig.1C). Following the
formation of the primary bone, OCs begin to form (Fig.1D). Their formation marks the beginning
of the bone remodeling phase of osseointegration and with it comes the progressive removal of
the primary bone, creating space for new lamellar bone formation and replacing passive primary
stability with active secondary fixation through biological bonding (Fig.1E).
In vivo, bone is formed by OBs on areas of the bone surfaces that have been prepared by
OCs. It is unclear as to how resorption sites are selected, but the process is initiated by the
retraction of bone-lining cells to uncover osteoid. After removal of the osteoid, the OC attaches
to the mineralized surface and forms a sealing zone. Beneath the OC, the formation of a closed
compartment called the resorption lacunae occurs where the OC membrane is folded forming
the ruffled border. The OC is able to release hydrogen ions through the ruffled border via activity
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 18
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of carbonic anhydrase, thereby reducing the pH and dissolving the mineralized portion of the
extracellular matrix.24,25 Other enzymes like lysosomal cysteine proteinases and matrix
metalloproteinases are then secreted to degrade the organic matrix.26,27
The resorption pit created by the osteoclast has been shown to be chemotactic for
osteoprogenitor cells,28 which migrate onto the surface and differentiate into mature osteoblasts.
These cells produce growth factors like BMPs together with their regulatory apparatus, which
induce osteoblast differentiation of MSCs and osteoprogenitor cells. The secretory osteoblasts
produce osteoid consisting of extracellular matrix proteins such as type I collagen as well as
osteocalcin and osteonectin. Mineralization of the osteoid is then promoted through the
regulation of local concentrations of calcium and phosphate and tailoring of the extracellular
matrix components.

Biomimetic Implant Surfaces: Lessons from Bone Remodeling
Based on the research from our group and others, 29 biologically inspired dental and
orthopaedic implant surfaces are now being produced that mimic the features of an OC
resorption pit. Studies using model Ti surfaces fabricated using photolithography and
micromachining show that 30 – 100μm diameter craters are preferentially colonized by
osteoblasts,30,31 which are similar in size to OC resorption pits.32,33 Moreover, OCs do not
uniformly degrade the mineralized portion of bone and are unable to completely degrade all the
extracellular matrix components leaving debris such as collagen and hydroxyapatite fragments
in the wake of their resorption. Hydroxyl ions also remain in the resorption pit as a result of the
dissolution of hydroxyapatite crystals.34 Once the OC detaches from the bone, a resorption pit
remains that has a unique surface with a particular chemistry and complex hierarchical structure
that contains micro-, meso-, and nano features. Thus, native bone has physical features capable
of altering the mechanical environment experienced by osteoblast lineage cells, and the inherent
chemistry, roughness, and hydrophilicity of the bone surface can influence cell attachment and
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cell shape, which can dictate cell proliferation and differentiation in vitro as well as
osseointegration in vivo.
Surface Chemistry
Surface chemistry of an implant is determined by the properties of the bulk material as well
as its method of fabrication. As stated previously, Ti is the choice material for both dental and
orthopedic implant materials because of favorable bulk properties its high biocompatibility,
increased resistance to corrosion, and favorable weight-to-strength ratio. Ti-based alloys, like
Ti-6Al-4V and TiZr, are also used because of their improved material properties, particularly
mechanical strength. Because of the altered bone turnover, many osteoporotic/osteopenic
patients have severely limited bucco-lingual and/or mesiodistal dimensions, which further
complicate dental implant interventions. Reduced diameter implants (1.8 – 3.0mm) have become
a common alternative for these patients. 35 Although Ti is the dominant material for dental implant
applications, its mechanical properties can be inadequate following reductions in its diameter,
increasing incidences of fatigue fracture and deformation from masticatory forces. Research
investigating TiZr and Ti-6Al-4V substrates has shown increasing support for their use as an
alternative biomaterial.
Traditionally, Ti implants are produced by machining Ti or alloyed rods. The machining
process results in a smooth surface with some microscopic irregularities; 36–38 however, these
irregularities have not been shown to be clinically significant.37 Using this machined surface as
a base, additive or subtractive post-processing methods are employed to further alter the surface
of the implant to generate a surface topography with features similar to OC resorption pits.
Additive layering of Ti particles onto existing machined surfaces is frequently used to create
bulk structures from computer aided designs. 39 Ti plasma spraying applies layers of Ti particles
onto the surface of machined rod implants using a plasma torch. Local melting typically occurs
during this process, which can generate a patchwork surface containing irregular regions of
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depressions and protrusions as well as relatively smooth areas. Bulk structures can also be
produced by additive manufacturing reducing cost, time, and material waste. Metallic implants
fabricated bottom-up can possess irregular geometries. Selective laser melting and electron
beam melting are two methods in which powder layers of micron sized metallic particles are
fused using a high energy beam, in a layer-by-layer fashion following a computer aided design.
Surface Topography
The positive influence of surface topography on osseointegration, achieved through
subtractive methods like grit-blasting and acid-etching, has been a topic of investigation for
several decades. It has been understood for some time that macro- and micro-rough implants
outperform their smooth counterparts. 40–44 Today, microrough surfaces dominate the market as
they have been shown to achieve faster bone integration, a higher percentage of bone to implant
contact (BIC), and a higher resistance to shear, as determined by removal torque values (RTVs),
when compared to smooth implant surfaces.35
Recently, studies have suggested features at the submicron and nanoscale have a direct
effect on the biological response of bone. 45–48 Type I collagen, the primary organic component
of bone, consists of fibers ~300nm in length and ~0.5nm in width while the hydroxyapatite
crystals in bone are generally ~50nm in length and ~5nm in diameter. 49 In order to mimic these
features, nanomodifications have been developed to directly restructure the oxide layer formed
on the implant surface using coatings,50 hydrothermal reactions treatments,51 and surface
oxidation.52,53 Reorganization of the oxide layer leads to a disordered nanostructure orientation,
which has been shown to be more favorable compared to a highly ordered pattern. 54
Hydrophilicity
Hydrophilicity is related to the wettability of the implant surface and is generally regarded as
a result of the surface chemistry.55 The hydrophilicity of an osteoclast resorption pit surface is
not known, making it difficult to mimic this property, but hydrophilic surfaces are known to
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promote an environment conducive for bone formation.56,57 This has been attributed to rapid
spreading of serum on the surface providing an overall coating of bioactive factors58 that can
influence early cell adhesion,59 proliferation,60 and differentiation23,61 by modulating the bonding
strength, total amount, and conformation of adsorbed proteins. 62 One method commonly used
to retain surface hydrophilicity of a biomaterial is to reduce atmospheric hydrocarbon
contamination.63 Post-processing saline storage or plasma cleaning before implantation are two
commonly used methods to either prevent the deposition of hydrocarbons or rid the surface of
deposited hydrocarbons. Both processes indirectly increase the presence of hydroxyl ions on
the implant surface, which could be the reason for the increased performance of hydrophilic
compared to hydrophobic implants.

Coupling of Bone Resorption to Formation: Implications for Osteoporosis
In a healthy adult skeleton, the amount of resorbed bone is generally equal to the amount of
new bone formation, thus maintaining skeletal integrity. This coordination, referred to as
coupling, could play a significant role in the pathophysiology of osteoporosis. If the acceleration
of bone resorption were matched by an equal or greater increase in bone formation there might
be transient bone loss, but ultimately the removed bone would be replaced by new bone. Hence,
the continuous loss of bone that occurs in osteoporosis implies a defect in the coupling process.
Thus, it is of great importance to determine which factors regulate coupling and the influence
implant surfaces have on these mechanisms.
Regulation of Estrogen
The rate at which bone remodeling occurs varies when an implant is present and depends
on the type of implant used and its surface properties.64–66 Cells on microstructured surfaces
exhibit and osteoblastic phenotype within the first 4 days of culture and produce factors that act
via autocrine/paracrine signaling to regulate peri-implant bone remodeling.61 On TCPS, MSC
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catenin in the cytoplasm and its translocation into the nucleus to serve as a transcriptional
activator.67–69 Previous studies have demonstrated surface mediated MSC differentiation
downregulates genes associated with the Wnt3A pathway while upregulating genes of the
Wnt11 and non-canonical calcium-dependent Wnt5a pathway.70–72 Expression of Wnt5a and
Wnt11 signaling pathway components are also induced in mature female OBs when treated with
17β-estradiol (E2),73,74 the primary sex hormone responsible for the development of postmenopausal osteoporosis. Moreover, sensitivity to E2 treatment is increased when these cells
are cultured on microrough and/or hydrophilic Ti implant surfaces compared to smooth Ti or
TCPS.74–76 Estrogen deficiency may play a role in the impaired formation response during
remodeling, because animals lacking ERα showed decreased formation responses to
mechanical loading by a mechanisms that involves the Wnt signaling pathway.
Estrogen is an osteoprotective hormone, and its deficiency leads to an elevated rate of bone
turnover culminating in osteoporosis in females and, in some cases, older males. A hallmark of
E2 deficiency is an elevated rate of bone turnover in which the rate of OC-mediated bone
resorption increases and, secondarily, OB-mediated bone formation decreases. In osteoporotic
patients, MSCs and OBs produce factors favoring osteoclastogenesis unfettered by any
regulatory feedback mechanisms. Increased levels of pro-inflammatory IL-6 and decreased
levels of TGFβ1 are produced by bone cells isolated from osteoporotic patients compared to
healthy patients.77–79 Interestingly, both E2 treatment and microstructured Ti substrates are
known to inhibit IL-6 production while enhancing production of TGFβ1 and OPG.75,80,81
Communication from Osteoblasts
Many of the factors produced by osteoblasts cultured on microrough Ti surfaces regulate
bone remodeling by favoring osteogenesis over osteoclastic resorption, promoting net new bone
formation (Fig.2). TGFβ1-dependent regulation of OPG production is one of the classic
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Figure 2. Cell signaling mechanisms among osteoblast lineage cells and osteoclasts involved in osseointegration,
lead to release of local regulatory factors in the peri-implant space. Abbreviations: Transforming growth factor
beta-1 (TGFβ1); receptor activator of NFκB ligand (RANKL); osteoprotegerin (OPG); 1α,25-Dihydroxy vitamin D3
(1,25(OH)2D3).

mechanisms controlling localized bone remodeling. 80 TGFβ1 enhances the proliferation of MSCs
and OBs and stimulates extracellular matrix production of proteins like type I collagen. Latent
TGFβ1 and latent TGFβ binding protein are synthesized and stored in the extracellular matrix.
Most of the TGFβ1 produced by OBs cultured on Ti is in latent form, 82 and the amount
incorporated into the matrix is increased on rougher surfaces. Once the bone remodeling phase
of osseointegration begins, the OCs degrade the newly synthesized matrix releasing the stored,
latent TGFβ1 and convert it into active TGFβ1. Once activated, TGFβ1 acts on osteoclasts and
downregulate their activity, in part by regulating production of OPG.80
OPG serves as a decoy receptor for receptor activator of NFκB ligand (RANKL). 83 By binding
to RANKL, it prevents osteoclast differentiation by preventing its interaction with receptor
activator of NFκB (RANK) on the OCP surface, an interaction required for the fusion and
subsequent maturation of differentiated OCs. A feedback mechanism is in place that allows
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osteoblasts to produce soluble RANKL in order to deplete excess OPG if the regulatory stimulus
favors new osteoclast formation. Microrough Ti substrates facilitate increased production of OPG
by osteoblasts; however, levels of RANKL do not change. 84 Thus, the net effect is bone formation
without bone resorption.
Local regulatory factor production has also been shown to be sensitive to microstructured Ti
implants. In addition to the high production of negative regulators of osteoclast activity, cells
produce high levels of osteocalcin and osteopontin. 22,53,85 Osteocalcin has been shown to
promote the chemotaxis, adhesion, and spreading of osteoclasts 86,87 while osteopontin plays a
role in anchoring osteoclasts to the mineralized bone matrix. 88 The sequential production of
these factors suggests microstructured Ti facilitates the production of a cascade of factors by
MSCs and osteoblasts to mediate osteoclast recruitment while preventing their premature fusion
and activity. Although PGE2 stimulates osteoclastic activity at high levels, it is required at low
levels for osteoblast activity.89,90 Osteoblast production of PGE1 and PGE2 is markedly increased
when cells are cultured on microrough surfaces.82 Blocking the production of prostaglandins by
the cyclooxygenase (Cox) inhibitor, indomethacin, also blocks the increase in other osteoblastic
markers when cells are cultured on these surfaces, suggesting that they are necessary for
enhanced osteogenesis.91,92
BMP signaling is also tightly regulated during surface mediated osteogenesis, and that
modulation of these signals can enhance or inhibit bone remodeling.93 Autocrine and paracrine
actions of BMPs are known to be involved in cell proliferation, differentiation, and apoptosis. 94
Among these proteins, BMPs 2, 4, and 7 have shown to be the most important in bone formation
and healing.95,96 Modulation of these osteogenic factors by implant surfaces provide molecular
evidence of the increased osteoblastogenesis seen in vitro and increased healing times seen
clinically. MSCs cultured on microstructured Ti substrates, display temporal upregulation of
BMPs with increases of BMP2 and BMP4 occurring as early as 4 days, suggesting that they are
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early regulators of surface-mediated osteogenesis.93 Their presence could also serve as the
impetus for the commitment of MSCs to the osteoblast lineage when cultured on microstructured
Ti, as they are known to regulate embryonic skeletal development.11 Furthermore, they also
provide a mechanism for the differentiation of MSCs distal to the implant surface, as they are
capable of multidirectional signaling. When MSCs were silenced for BMP2, production of OPG
decreased suggesting that BMP2 effects impacts bone remodeling.93
Axon Guidance Molecules
Axon guidance molecules were originally identified as instructive cues for the navigation of
axons, allowing axons to migrate to their targets during nervous system development. These
molecules that guide growing axons towards and away from specific brain regions have been
classified as attractive and repulsive, respectively. 97 Besides their roles in neural circuit
formation, axon guidance molecules have been implicated in various other biological processes,
including cell motility, proliferation, differentiation, angiogenesis, cardiogenesis, tumor growth,
tissue development, immune response, and, more recently, the coupling of osteoblasts and
osteoclasts during bone remodeling.98–104
Interactions of Eph family proteins with membrane bound Ephrin ligands on adjacent cells
activate Eph receptor kinase-dependent pathways. Interestingly, the ephrins can also trigger
tyrosine phosphorylation-dependent and independent signals, making bidirectional cell contactdependent communications possible. 100 Loss- and gain-of-function experiments showed that
osteoclast-derived EphrinB2 can act through a contact-dependent mechanism through its
receptor, EphB4, expressed on the surface of osteoblasts. 105,106 Forward signaling of EphrinB2
through EphB4 has been shown to enhance osteogenic differentiation, while reverse signaling
of EphB4 through EphrinB2 into OCPs can inhibit osteoclastogenesis by suppressing the c-FosNFATc1 cascade.105,106 Overexpression of EphB4 in osteoblasts increases bone mass in
transgenic mice, while high levels of EphrinB2 over-expression induce the committal of MSCs
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to an osteoblastic lineage.106–108 Another possible ephrin/Eph mechanism within the osteoblast
lineage arises from the finding that PTH and PTHrP promote production by osteoblasts of
ephrinB2, and that blockade of the interaction between EphrinB2 and receptor EphB4 impairs
late-stage differentiation of osteoblasts, indicating a role for this pathway in promoting osteoblast
differentiation and bone formation.109
Control of bone remodeling can also occur through the semaphorin signaling system,
including their receptors, PLXNs and NRPs. Of the eight classes of semaphorin family proteins
categorized by structure and sequence similarities, SEMA4D and SEMA3A have shown
particularly convincing and intriguing control over bone remodeling.110 Sema4D is a
transmembrane protein that is highly expressed at the cell membrane of both OCPs and mature
OCs, whereas its expression in OBs is undetectable. 111,112 Of the three receptors to which
SEMA4D can bind, its highest affinity is for the PLXNB1 receptor, which is strongly increased
during OB differentiation but not osteoclastogenesis.113 The binding of SEMA4D to PLXNB1
impairs bone formation by inhibiting IGF-1 signals.112 Treatment of OBs with recombinant
SEMA4D enhances motility and impairs cell – cell interaction, suggesting that OC-derived
SEMA4D is required for the proper positioning of OBs within the bone microenvironment. 112
Genetic deletion of SEMA4D or PLXNB1 or blocking SEMA4D signaling with neutralizing
antibodies in mice causes increased trabecular bone volume.112 Moreover, when SEMA4D was
neutralized in OVX mice, bone formation was promoted without affecting bone resorption.
Similar results were observed in a preclinical osteoporotic model when SEMA4D-targeting
siRNA interfering molecules were specifically delivered to the bone using polymeric
nanoparticles.114 Potent increases in trabecular bone volume are seen with SEMA4D silencing
by enhancing OB number and activity, as indicated by the elevated mineral apposition rate.114
Interestingly, the number of OCs are unchanged suggesting SEMA4D regulates the activity of
mature OCs rather than their maturation. 114
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The class III semaphorin, SEMA3A, is a secreted protein which exerts its biological activity
through interactions with NRP1 and its subsequent complex formation with PLXNA1.115,116 NRP1
deficient mice display features of osteoporosis, which was reflected by both an increase in OC
number and decrease in OB number. 116 Interestingly, SEMA3A binding to NRP1 also disrupts
the interaction between PLXNA1 and TREM2-DAP12, which is responsible for RANKL-induced
osteoclastogenesis.116 Therefore, NRP1 is thought to compete with TREM2 for the PLXNA1
complex formation. When NRP1 expression is low, binding of PLXNA1 to TREM2 is favored,
stimulating osteoclastogenesis; however, in the presence of SEMA3A, generation of the
SEMA3A-NRP1-PLXNA1 complex is favored, inhibiting osteoclastogenesis. These findings
suggested that SEM3A secreted by osteoblast lineage cells synchronously affects both
osteoclasts and osteoblasts in paracrine and autocrine manners, respectively.
Like the effects of estrogen, SEMA3A is osteoprotective. The osteoprotective potential of
SEMA3A is supported by some in vitro and preclinical studies. Treatment of OBs with
recombinant SEMA3A activates Rac1 through FARP2, which facilitates the translocation of βcatenin into the nucleus bypassing the need for any canonical Wnt3A initiating signals.116–118
SEMA3A was also able to enhance bone regeneration in a cortical defect mouse model.
Moreover, in a postmenopausal osteoporosis mouse model, SEMA3A treatment decreases
bone loss after ovariectomy. These observations demonstrate that SEMA3A plays a crucial role
in bone protection, yet no clear evidence that SEMA3A has similar bone protective effects in
humans exists. To date, one cross-sectional study among postmenopausal women indicates
that serum SEMA3A levels are positively with bone turnover as determined by serum osteocalcin
levels. However, this association did not exist with BMD.119
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Chapter 3. Comparable Responses of Osteoblast
Lineage Cells to Microstructured Hydrophilic
Titanium-Zirconium and Microstructured Hydrophilic
Titanium
Abstract
Although titanium (Ti) is commonly used for dental implants, Ti alloy materials are being
developed in order to improve their physical material properties. Studies indicate that osteoblast
differentiation and maturation of human mesenchymal stem cells (MSCs) and normal human
osteoblasts (NHOsts) respond to microstructured Ti and titanium-aluminum-vanadium (Ti6Al4V)
surfaces in a similar manner. The goal of this study was to determine whether this is the case
for osteoblast lineage cells grown on microstructured TiZr surfaces and whether their response
is affected by surface nanotexture and hydrophilicity. Grade 4 Ti and TiZr (13-17% Zr) discs
were modified by large grit sand-blasting and acid-etching with storage in saline solution,
resulting in a complex microstructured and hydrophilic surface corresponding to the
commercially available implants SLActive® and Roxolid® SLActive® (Institut Straumann AG,
Basel, Switzerland). The subsequent Ti modSLA and TiZr modSLA surfaces were characterized
and osteogenic markers were measured. Evaluation of physical parameters revealed that the
fabrication method was capable of inducing a microstructured and hydrophilic surface on both
the Ti and TiZr discs. Overall the surfaces were similar, but differences in nanostructure
morphology/density and surface chemistry were detected. On Ti modSLA and TiZr modSLA,
osteoblastic differentiation and maturation markers were enhanced in both MSCs and NHOsts
while inflammatory markers decreased compared to TCPS. These results indicate a similar
positive cell response of MSCs and NHOsts when cultured on Ti modSLA and TiZr modSLA.
Both surfaces were hydrophilic, indicating the importance of this property to osteoblast lineage
cells.
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Introduction
For the past two decades, titanium (Ti) has been the dominant material for dental implant
applications due to its ability to form a passive oxide layer that makes it stable in biological
systems.120 Ti exhibits superior biocompatibility and corrosion resistance as a result of this
passive layer when compared to other implant materials and contributes to its functional
osseointegration with the surrounding bone tissue.121
Despite their high success rate, significant bone resorption in patients with Ti implants placed
in close proximity to adjacent teeth as well as insufficient formation of peri-implant bone have
been observed, particularly in patients with reduced or limited bucco-lingual and/or mesiodistal
dimensions.122 Implants with reduced diameter (1.8 – 3.0 mm) have been used to prevent bone
loss in these patients.122 While reduced diameter implants have reported retention rates of up to
100%, reducing the diameter of grade 4, commercially pure Ti (cpTi) implants compromises their
mechanical properties, thereby increasing incidences of fatigue fracture and deformation from
masticatory forces.123–128
Alloying titanium is a common method used to increase the inherent strength of the implant
material; however, the corrosion characteristics and toxicity of certain alloying components must
be considered when selecting the appropriate material for surgical applications. Titaniumaluminum-vanadium alloy (Ti6Al4V) is frequently used for dental and orthopaedic implants and
has shown good biocompatibility, stability, corrosion resistance, and mechanical properties.
Recent studies have reported that components of Ti6Al4V may be gradually released over
time.129–131 These ions, particularly vanadium, have been shown to cause adverse cells
responses in vitro,131–137 although it is unclear whether a sufficient quantity of these ions will
leach from an implant and cause a similar adverse reaction in vivo.
Using other alloying components that have elicited no adverse reactions in vitro, like
zirconium (Zr), would avoid this outcome entirely.138 An implant consisting of Ti alloyed with 13
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to 17% Zr was developed by Institut Straumann AG (Basel, Switzerland). An analysis of the
material properties of the TiZr alloy demonstrated a 40% increase in tensile strength and a 60%
greater yield strength compared to the lower limit of the standard for cold worked grade 4 Ti, and
13 to 42% higher endurance levels when compared to cpTi of similar dimensions, while retaining
superior corrosion resistance.35,139 The enhanced mechanical properties of the TiZr alloy make
it an excellent candidate for small diameter implants.
Surface modifications that produce a complex micro-topography and increase hydrophilicity
of dental implants have been shown to increase osteoblast differentiation, suggesting that they
might also improve osseointegration, stability and retention of TiZr dental implants. 23,29,55,61,140–
145

One such surface modification involves sand-blasting and acid-etching cpTi with immediate

storage in saline solution, used by Straumann for fabrication of their commercially available Ti
SLActive® and Roxolid® (13 – 17% TiZr alloy) SLActive implants. Clinical studies have shown
that the Roxolid® implant meets established dental implant survival criteria and has a high
success rate in patients (ranging from 95.2 to 100%), acceptable bone-level changes, probing
pocket depth, plaque and sulcus bleeding. 146–148 Although both preclinical in vivo and clinical
studies have concluded that cpTi and TiZr dental implants behave similarly,146,149–151 there are
few in vitro data supporting these findings. Additionally, the available in vitro studies have been
limited to characterizing the molecular level cellular response of the osteoblast-like MG63 cell
line.35 No study has directly compared the biological response of two key cell types important for
osseointegration (progenitor cells and cells committed to an osteoblast phenotype) to cpTi and
TiZr.
The method used to modify the surface of the SLActive® and Roxolid® implants is the same,
but the differences in chemical composition result in varying surface characteristics, potentially
influencing cell response in different ways. 52 Therefore, the purpose of this study was to assess
the osteoblastic differentiation and maturation of human mesenchymal stem cells (MSCs) and
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normal human osteoblast (NHOst) cells in response to grit-blasted, acid-etched and hydrophilic
titanium-zirconium (TiZr modSLA) surfaces, and determine the similarity of these responses to
those seen on grit-blasted, acid-etched, hydrophilic Ti (Ti modSLA).

Materials and Methods
Surfaces and Modifications
Grade 4 Ti and TiZr (13 – 17wt% Zr) discs, 5mm in diameter and 1mm in thickness, were
provided by Institut Straumann AG (Basel, Switzerland). Discs were modified by the same
protocol used to produce commercially available Ti SLActive® and Roxolid® SLActive®
implants. Disc surfaces were first treated by large grit sand-blasting (250 – 500µm) followed by
acid-etching in a boiling mixture of HCl and H2SO4 with immediate storage in 0.9% NaCl solution.
The subsequent Ti modSLA and TiZr modSLA discs were sterilized using γ-irradiation.
Surface Characterization
Scanning Electron Microscopy (SEM)
Qualitative and quantitative characterization of the disc surface topography was evaluated
using SEM (Ultra 60 FEG-SEM, Carl Zeiss SMT Ltd., Cambridge, UK). Secondary electron
images were recorded at varying magnifications using an acceleration voltage of 5kV for three
different samples (n=3). Morphometric quantification of nanostructure size and peak-to-peak
distance was measured using ImageJ software (National Institutes of Health, USA). A grid
composed of 20 evenly spaced squares arranged into a 4x5 matrix was superimposed onto the
highest magnification SEM images. The diameter and peak distance to its closest neighbor were
obtained for the centermost nanostructure within each square for a total of 60 measurements
per material.
X-Ray Photoelectron Spectroscopy (XPS)
Chemical composition of the surface of the samples (n=3) was obtained by XPS (Thermo KAlpha XPS, Thermo Fisher Scientific, Waltham, Massachusetts). Spectra were collected using
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a 400µm X-ray spot size at three different locations on each individual sample.
Contact Angle Measurement
Measurements were obtained using a goniometer (CAM 250, Ramé-Hart, Mountain Lakes,
NJ). Samples (n=3) were measured in three different locations and dried with nitrogen between
each measurement. A drop size of 2µL was used per individual measurement and a contact
angle was calculated every 5s for 20s. The four measurements were then averaged to obtain
one of the three measurements per disc.
Confocal Laser Microscopy
Surface roughness of the samples (n=3) was evaluated using a confocal laser microscope
(Lext, Olympus, Shinjuku, Tokyo, Japan). Three measurements per sample were taken over an
area of 644µm x 644µm with a 20x objective and a scanning pitch of 50nm. A cutoff wavelength
of 100µm was used when calculating surface roughness (Sa) and peak-to-valley height (Sz).
Cell Culture
We used two different cell cultured models to examine cell response. Normal human
osteoblasts (NHOst cells) (Lonza Biosciences, Walkersville, MD), a non-transformed cell line
obtained from normal human bone, were cultured using Dulbecco’s modified Eagle medium
(DMEM CellGro®, Mediatech, Inc., VA) supplemented with 10% fetal bovine serum (FBS, Life
Technologies, Carlsbad, CA) and 1% penicillin-streptomycin (Life Technologies). Human MSCs
(Lonza Biosciences), originally isolated from normal human bone marrow and demonstrated to
be multipotent, were cultured in MSC growth medium (Lonza Biosciences). All cells were
cultured at 37°C in 5% CO2 and 100% humidity. NHOst cells and MSCs were cultured on tissue
culture polystyrene (TCPS) to facilitate determination of confluence. Test surfaces were Ti
modSLA or TiZr modSLA. Cells were seeded on all groups at a density of 10,000 cells/cm2 in a
96-well plate. After 24h, discs were transferred to a new 96-well plate with fresh medium and
subsequently fed every 48h until confluence.
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Cell Morphology
MSCs or NHOst cells were plated on Ti modSLA or TiZr modSLA at a density of 5,000
cells/cm2 in a 96-well plate and media were changed after 24h. Cells were cultured for 72h,
washed in PBS, and then fixed in 3.7% paraformaldehyde. After a 10min fixation, surfaces were
washed with PBS, and permeabilized with 0.05% Triton X-100 for 10min. Surfaces were washed
again with PBS, and incubated in a staining solution consisting of 0.165 µM AlexaFluor 488
phalloidin (Life Technologies) and 2 µg/mL Hoechst 33342 (Life Technologies) to visualize actin
filaments and nucleic acids respectively. After staining, surfaces were mounted on glass cover
slips using SlowFade (Life Technologies) and images were captured with a laser scanning
microscope (Zeiss LSM 710, Carl Zeiss SMT Ltd., Cambridge, UK) at an excitation of 488nm for
actin filaments and an excitation of 405nm for nucleic acids using a 40x objective.
Biological Response
At confluence, cells were incubated with fresh media for 24h. Media were collected and
ELISAs used to measure levels of osteocalcin (Biomedical Technologies Inc., Stoughton, MA)
osteoprotegerin (OPG, R&D Systems, Minneapolis, MN), vascular endothelial growth factor
(VEGF, R&D Systems), bone morphogenetic protein-2 (BMP2, PeproTech, Rocky Hill, NJ),
interleukin-6 (IL6, R&D Systems), and interleukin-10 (IL10, R&D Systems) following
manufacturer’s instructions. Cells attached to surfaces were washed twice with 0.2ml PBS.
Three discs were combined in 0.5ml of 0.05% TritonX-100 for each individual sample in a total
sample size of six (n=6). Cells were lysed by sonication at amplitude 40 using an ultrasonicator
(Vibra-Cell, Sonics, Newtown, CT).
DNA content in the cell lysate was measured (QuantiFluor™ dsDNA system, Promega,
Madison, WI) using a fluorescence detector (Synergy H1 Hybrid Reader, BioTek, Winooski, VT)
at an excitation of 485nm and emission of 538nm. Immunoassay levels were normalized to DNA
content. Cell lysate was also analyzed for alkaline phosphatase specific activity as the release
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of p-nitrophenol from p-nitrophenylphosphate (Sigma-Aldrich, St. Louis, MO) at a pH of 10.25
and a temperature of 37°C. Absorbance was measured at 405nm and alkaline phosphatase
activity was quantified using a standard curve. Activity was normalized to total protein content in
the cell lysates, as determined by bicinchoninic acid protein assay kit (Thermo Fisher Scientific).
To quantify mRNA, cells were plated as described above. At confluence on TCPS, cells on
all surfaces were incubated with fresh media for 12h. Samples were harvested using a TRIzol ®
(Invitrogen, Carlsbad, CA) extraction method. Six 5mm discs were combined in TRIzol ® for each
individual sample in a total sample size of six (n=6). RNA was quantified using a NanoDrop
spectrophotometer (Thermo Fisher Scientific) and then reverse transcribed into 250 ng/µL
cDNA. Real-time PCR was performed using a fluorescent dye (Power SYBR Green, Applied
Biosystems, Foster City, CA) to quantify starting mRNA levels for integrin subunits alpha-1,
alpha-2, alpha-5 and beta-1 (ITGA1, ITGA2, ITGA5, and ITGB1) and members of the bone
morphogenetic protein (BMP) family: BMP4 and BMP7, BMP receptor-2 (BMPR2) and the BMP
inhibitor Noggin (Nog). Levels of mRNA are normalized to glyceraldehyde phosphate
dehydrogenase (GAPDH). Primer sequences are listed in Table 1.
Statistical Analysis
Surface

characterization

experiments and assessments
of cell morphology were done
using 3 discs per material. Data
for surface analysis represent 3
measurements

per

disc,

resulting in an n=9 per variable.
Data are presented as the
mean ± standard error (SE).
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For cell morphology, no quantitative analyses were performed. In vitro assays (n=6 cultures per
variable) are presented as the mean ± SE. All cell culture experiments were repeated at least
three times to ensure validity of the results. Data shown in the figures are from representative
experiments. Expression of mRNAs for BMPs, receptors, inhibitors and integrins are
represented as treatment over control using the fold increase of Ti modSLA and TiZr modSLA
compared to TCPS as an internal control for the experiment. QQ-plots (not reported) showed
the data were normally distributed, and the Brown-Forsythe test indicated the data were
homoscedastic. A parametric one–way analysis of variance was performed with a Bonferroni
post-hoc correction and α = 0.05 for the analysis of protein production. A Student’s t-test was
used to compare gene expression on the two test surfaces using an alpha of 0.05. All statistical
analyses were performed using JMP statistical software (SAS, Cary, NC).

Results
Material Characterization
At low magnification, SEM images showed that the macroscale and microscale topography
were similar for both surfaces (data not shown). However, SEM imaging at high magnification
(Fig.3A, B, C) revealed larger and more exaggerated micro-scale surface features on Ti
modSLA compared to TiZr modSLA (Fig.3D, E, F). Small, high density nanostructures were
detected on Ti modSLA while large nanostructures at a lower density were observed on TiZr
modSLA. Mean surface roughness (Sa) was greater on Ti modSLA compared to TiZr modSLA
with no significant differences detected in mean peak-to-valley height (Sz) (Fig.3G).
Morphometric analysis of the surface nanostructures (Fig.3H) reinforced the qualitative
observations indicated by the SEM images. The mean nanostructure separation distance and
nanostructure diameter were greater on TiZr modSLA when compared to Ti modSLA.
XPS (Table 2) indicated similar oxygen and carbon levels between Ti modSLA and TiZr
modSLA. Unalloyed Ti modSLA had only Ti while TiZr modSLA displayed appreciable
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percentages of Ti and Zr. Contact angle measured 0° for both surfaces.

Figure 3. Qualitative and quantitative characterization of the micro- and nano-scale parameters of the Ti modSLA
and TiZr modSLA surfaces. SEM images of the Ti modSLA surface at 20Kx (A), 100Kx (B), and 200Kx (C). SEM
images of the TiZr modSLA surface at 20Kx (D), 100Kx (E), and 200Kx (F). (G) Mean ± standard error (SE) of
surface roughness (Sa) and peak-to-valley height (Sz). For each parameter, mean values of three measurements
per three samples per modification are presented. (H) Mean ± standard error (SE) of nanostructure separation
(peak-to-peak distance) and diameter associated with Ti modSLA and TiZr modSLA. For each parameter, 20
measurements for three SEM images samples per modification are presented.
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Cell Morphology
Figure 4 shows MSCs and NHOst cells superimposed on the rough metallic surfaces of Ti
modSLA or TiZr modSLA (actin – green, DNA – blue). Parallel striations of the actin filaments
could be seen surrounding the nucleus of each cell. The nuclei and actin filaments around the
nucleus were localized to area of the cell that did not overlay the valleys (dark regions) of the
substrate. In contrast, distal actin filaments spanned valleys, and many appeared to associate
with rough peaks (light areas) of the surface.

Figure 4. Cell staining of MSCs (left) and NHOst cells (right) on Ti modSLA or TiZr modSLA 72h after
cell seeding. Actin filaments are stained green and nucleic acids are stained blue. Each image was taken
using a 40x objective.
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Biological Response
Cells grown on TiZr modSLA exhibited similar responses to those grown on Ti modSLA when
compared to behavior on TCPS. DNA content was significantly lower on Ti modSLA and TiZr
modSLA compared to TCPS for both MSCs (Fig.5A) and NHOst cells (Fig.5B), but DNA content
of both MSC and NHOst cultures was greater on TiZr modSLA compared to Ti modSLA. Alkaline
phosphatase specific activity was significantly higher on Ti modSLA and TiZr modSLA when
compared to TCPS for both MSCs (Fig.5C) and NHOst cells (Fig.5D) (MSCs: Ti modSLA < TiZr
modSLA; NHOst cells: Ti modSLA = TiZr modSLA). Production of osteocalcin (Fig.5E, F),
osteoprotegerin (Fig.5G, H), VEGF (Fig.6A, B), and BMP2 (Fig.6C, D) was comparable in MSC
and NHOst cultures grown on both Ti modSLA and TiZr modSLA and was greater than
production on TCPS. IL6 production by MSCs (Fig.6E) and NHOst cells (Fig.6F) was
significantly lower on Ti modSLA and TiZr modSLA compared to TCPS. No significant difference
in MSC production of IL6 was detected between Ti modSLA and TiZr modSLA; however, IL6
production by NHOst cells was significantly lower on TiZr modSLA compared to Ti modSLA.
IL10 was produced in greater amounts by both MSCs (Fig.6G) and NHOst cells (Fig.6H) on Ti
modSLA and TiZr modSLA compared to TCPS. MSCs produced less IL10 on TiZr modSLA
compared to Ti modSLA, but no significant difference was detected in NHOst cell IL10 production
on these surfaces.
Compared to TCPS, significantly higher mRNA for BMP4, BMP7, BMPR2, and NOG were
detected for MSCs and NHOst cells on Ti modSLA and TiZr modSLA (data not shown). There
were some differences noted in gene expression in MSCs (Fig.7A) and NHOst cells (Fig.7B)
grown on the test surfaces. BMP4 mRNA levels were higher for MSCs on TiZr modSLA
compared to Ti modSLA; however, BMP4 mRNA levels were significantly lower for NHOSt cells
on TiZr modSLA compared to Ti modSLA. No significant differences were detected in MSC or
NHOst cell BMP7, BMPR2, and NOG expression for cells cultured on either Ti modSLA or TiZr
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Figure 5. Effects of Ti modSLA and TiZr modSLA on the maturation of MSCs (left) and NHOst cells (right). MSCs
and NHOst cells were plated separately on TCPS, Ti modSLA, or TiZr modSLA. At confluence on TCPS, cells
were incubated in fresh media for 24h, collected, and measured for (A, B) DNA content, (C, D) alkaline
phosphatase specific activity, (E, F) osteocalcin, and (G, H) osteoprotegerin. Data shown are the mean ± standard
error (SE) of six independent samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. Ti modSLA.
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modSLA. mRNA levels of ITGα1, ITGα2, and ITGβ1 were significantly higher on Ti modSLA and
TiZr modSLA compared to TCPS, while mRNA levels of ITGα5 were significantly lower for both
MSCs and NHOst cells (data not shown). No significant differences in integrin expression were
detected between MSCs plated on Ti modSLA or TiZr modSLA (Fig.8A); however, NHOst cell
expression of ITGα2 was significantly lower on TiZr modSLA compared to Ti modSLA (Fig.8B).

Discussion
This study examined the response of cells involved in implant osseointegration of clinically
available TiZr implant surfaces in order to assess whether there are differences with their
response to commercially pure Ti surfaces processed in an identical manner. This is important
because TiZr alloy provides the mechanical strength needed for small diameter implants that
are designed for patients with limited mandibular bone dimensions, 35 but less is known
concerning the biological responses of osteoblast lineage cells to TiZr modSLA surfaces than is
known concerning cell responses to Ti modSLA. Our results show that the surfaces are similar
at the microscale but differ at the nanoscale. Cell number was higher on the hydrophilic TiZr
surface than on hydrophilic cpTi, but osteoblastic differentiation of MSCs and osteoblastic
maturation of NHOst cells were comparable. Moreover, production of factors that promote
osteogenesis and vasculogenesis were comparable. MSCs and NHOst cells on both surfaces
produced increased levels of the anti-inflammatory cytokine IL10 and reduced levels of the proinflammatory cytokine IL6. While responses to both surfaces were similar, the expression of
mRNAs for BMP4, BMP7, and the BMP-inhibitor Noggin differed between the two cell types.
MSCs expressed higher levels of BMP4 whereas NHOst cells expressed higher BMP7.
The morphology of the Ti modSLA and TiZr modSLA surfaces was not identical. Average
roughness (Sa) of Ti modSLA was greater than was achieved on TiZr modSLA, although peakto-valley height (Sz) was identical. SEM revealed the formation of nanostructures on the Ti
modSLA and TiZr modSLA surfaces similar to those described in previous studies. 52,63 There
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Figure 6. Effects of Ti modSLA and TiZr modSLA on the soluble factor production of MSCs (left) and NHOst cells
(right). MSCs and NHOst cells were plated separately on TCPS, Ti modSLA, or TiZr modSLA. At confluence on
TCPS, cells were incubated in fresh media for 24h, collected, and measured for (A, B) VEGF, (C, D) BMP2, (E,
F) interleukin 6, and (G, H) interleukin 10. Data shown are the mean ± standard error (SE) of six independent
samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. Ti modSLA.
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were distinct differences in the size and distribution of the nanostructures, with diameters and
distances between nanostructures being greater on TiZr modSLA.
The exact mechanism by which these nanostructures spontaneously generate is not known.
Differences in the micro and nanoscale features of the Ti modSLA and TiZr modSLA surfaces
following grit-blasting, acid-etching and storage in saline solution probably reflect differences in
the Ti oxidation layer due to the underlying bulk material. The nanostructure is part of the oxide
layer and grows as a result of the storage in saline solution (aqueous solution). The underlying
bulk directly influences the oxide layer and thus the nanostructures depend on the bulk material.
Wennerberg et al. speculated that the different corrosion properties and thus different diffusion
energies/behavior are responsible for the
differences in nanostructures.52 Furthermore,
they suggest that the hydride layer resulting
from acid-etching might act as nucleation
centers. We did not examine the underlying
mechanisms that resulted in the differences in
nanostructures, but our data indicate that they
contributed to the overall biological response of
the MSCs and NHOst cells. That nanoscale
features can impact cell response has been
noted by us as well as others.51,142,152–154
The surface energy of the two metals used
in this study was indirectly measured using
contact angle measurements to assess the
surface hydrophilicity and XPS to determine the
amount of surface carbon contamination.

Figure 7. Effects of Ti modSLA and TiZr modSLA on
BMP mRNA levels of (A) MSCs and (B) NHOst cells.
MSCs and NHOst cells were plated separately on
TCPS, Ti modSLA, or TiZr modSLA. At confluence on
TCPS, cells were incubated in fresh media for 12h,
collected, and measured mRNA levels of BMP4,
BMP7, BMPR2, and NOG. Data is represented as fold
change compared to TCPS. *p < 0.05 vs. Ti modSLA.
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These measurements confirmed that the sand-blasting/acid-etching procedure with subsequent
storage in saline solution induced a comparable surface energy between the two metals. In
addition to detecting differences in bulk material using the presence or absence of zirconium,
XPS showed increased oxygen and decreased carbon content and thus low level of carbon
contamination. Contact angles measured 0°, demonstrating the surfaces of Ti modSLA and TiZr
modSLA to be super-hydrophilic, consistent with the results of XPS and previous studies.52,71,155
These results also suggest that the retention of a clean surface via prevention of hydrocarbon
adsorption was a critical processing step. Variations in surface topography at the microscale and
nanoscale can cause patterning of hydrophobic and hydrophilic regions, 156 which can impact
protein adsorption and ultimately integrin signaling. We did not compare dry microstructured Ti
and TiZr to determine if such patterning had occurred, but our results indicate that the aqueous
storage mitigated this occurring. Moreover, there were no visible differences in cell morphology
or actin filament alignment to indicate a difference in attachment by either cell type on either
surface. Our results indicate that both surfaces supported osteoblast differentiation of MSCs.
The cells adopted a branched and elongated phenotype on the surface consistent with
commitment to an osteogenic lineage rather than to adipogenic differentiation. As noted
previously the cells tended to attach to the peaks via filopodia and suspend the cell body over
valleys.157
The qualitative capacity for Ti modSLA and TiZr modSLA to support a healthy osteoblastic
phenotype is supported quantitatively using measurements of osteoblastic markers of
differentiation and maturation. For both cell types, DNA content was decreased on both surfaces
compared to TCPS, a trend described previously in studies comparing TCPS to Ti
modSLA61,144,158 and TiZr modSLA. 35 DNA content was greater on TiZr modSLA compared to Ti
modSLA supporting the report that MC3T3-E1 osteoblasts exhibited greater attachment to a
smooth TiZr (50% Zr) alloy compared to smooth cpTi.145 Together, these results suggest the
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possibility that cells can attach or proliferate
more readily on the surface of a TiZr alloy
compared to cpTi. Overall, however, osteoblast
differentiation

on

comparable

with

the

two

surfaces

respect

to

was

alkaline

phosphatase specific activity and production of
osteocalcin,

osteoprotegerin,

VEGF,

and

BMP2. Moreover, MSCs and NHOst cells
exhibited comparable production of immune
mediators

on

both

surfaces.

As

noted

previously for cells grown on Ti modSLA,158
production of the pro-inflammatory cytokine IL6
was reduced and production of the antiFigure 8. Effects of Ti modSLA and TiZr modSLA on
integrin mRNA levels of (A) MSCs and (B) NHOst
cells. MSCs and NHOst cells were plated separately
on TCPS, Ti modSLA, or TiZr modSLA. At confluence
on TCPS, cells were incubated in fresh media for 12h,
collected, and measured mRNA levels of ITGα1,
ITGα2, ITGα5, and ITGβ1. Data is represented as fold
change compared to TCPS. *p < 0.05 vs. Ti modSLA.

inflammatory cytokine IL10 was increased by
cells grown on TiZr modSLA.
Expression of genes encoding for additional
osteoblastic proteins by MSCs and NHOst cells

were similarly enhanced on Ti modSLA and TiZr modSLA. mRNA levels of BMPs (BMP4,
BMP7), BMPR2 receptor, and NOG antagonist were increased to comparable levels by both cell
types on modified surfaces compared to TCPS. Studies have demonstrated that BMPs are
important factors for stimulating an osteogenic environment, which facilitates osteoblastic
differentiation and maturation,159,160 and the signaling of BMPs is mediated by activation of their
receptors and modulated by their antagonists. Promotion of the optimal osteogenic environment
requires a delicate balance among these factors. As seen previously, the expression of BMP
complexes was sensitive to microrough, nanostructured, and hydrophilic Ti;71,158 a result that
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was not altered on TiZr modSLA. The small differences detected in BMP4 production were
attributed to the intricate nature of the BMP system and do not reflect a preference toward either
surface material.
A similar result was also observed for the expression of integrin subunits. The α and β integrin
subunit combinations determine which extracellular matrix proteins will be recognized by a cell,
thus dictating cellular interactions with implanted materials by sending important information to
the cell in order to maintain a healthy osteoblastic phenotype. 161 Ti modSLA and TiZr modSLA
were able to similarly enhance the expression of osteoblastic integrin subunits ITGα1, ITGα2,
and ITGβ1 while decreasing the expression of ITGα5 by both MSCs and NHOst cells when
compared to TCPS. Osteoblasts primarily express α5β1 when grown on TCPS but shift to the
production of α1β1 and α2β1 when grown on rough Ti substrates. 161 α2β1 is further increased
on surfaces exhibiting high surface energy in the presence of nanostructures, 155,161–163 a trend
that remains consistent when the bulk material of the surface is altered.
It is evident that MSC and NHOst osteoblastic differentiation and maturation have no
significant preference to either Ti modSLA or TiZr modSLA, confirming the results observed both
in vivo and clinically.146,149–151 Interestingly, this result was achieved despite differences in bulk
material composition and surface roughnesses at both the micro- and nanoscale. This alludes
to the possibility that a super-hydrophilic surface can conceal any modulatory effects the surface
nanostructures may have had on the osteoblastic differentiation and maturation of MSCs and
NHOst cells. Previous studies have reported the positive effects nanostructures have on
osteoblastic differentiation and maturation over a range of varying morphologies.51,142,164
However, these surfaces were not considered to be super-hydrophilic leaving unanswered
questions regarding the degree to which a super-hydrophilic surface is able to overpower the
effects of nanostructures. Because of the similar cellular response between the two materials it
can be assumed that implants composed of either cpTi or 13 – 17% TiZr subjected to a similar
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sandblasting and acid-etching procedure will achieve similar levels of osseointegration when
used clinically.
Overall, these results indicate that the in vitro outcomes observed with Ti modSLA, which
have been shown to have a positive correlation with clinical outcomes, 165 are also demonstrated
in MSC and NHOst cells grown on TiZr modSLA. Many other cell types are involved in
osseointegration and subsequent remodeling of the peri-implant bone, which were not examined
in this study. Moreover, we used commercially available MSCs and NHOst cells, which were
from single donors. Thus, our results do not consider variability inherent to the human population,
or the health status of the donors themselves. Despite these caveats, our data support the
hypothesis that osteoblastic differentiation and maturation in response to the modSLA surface
contribute to the clinical performance of TiZr implants.146,148,166

Conclusions
Ti and TiZr were successfully modified to enhance surface hydrophilicity, create microroughness, and induce nanostructure formation. The surfaces at the micron scale achieved by
grit-blasting and acid-etching were similar and similar degrees of surface energy were obtained
for both materials. Differences in bulk material led to variations in surface nanostructure
morphology and density, osteoblastic differentiation and maturation of MSCs and NHOst cells
were enhanced on both Ti modSLA and TiZr modSLA to a comparable extent. It can be indirectly
concluded that the clinical use of 13 – 17% TiZr alloyed metals for dental implants will lead to a
successful outcome comparable to those observed with cpTi.

Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 47

Osseointegration in Metabolically Compromised Conditions • Spring 2019

Chapter 4. Osteogenic Response of Human MSCs and
Osteoblasts to Hydrophilic and Hydrophobic
Nanostructured Titanium Implant Surfaces
Abstract
Microstructured implant surfaces created by grit blasting and acid etching titanium (Ti)
support osseointegration. This effect is further enhanced by storing in aqueous solution to retain
hydrophilicity, but this also leads to surface nanostructure formation. The purpose of this study
was to assess the contributions of nanostructures on the improved osteogenic response of
osteoblast lineage cells to hydrophilic microstructured Ti. Human mesenchymal stem cells
(MSCs) and normal human osteoblasts (NHOsts) were cultured separately on nonnanostructured/hydrophobic

(SLA),

nanostructured/hydrophilic

(modSLA),

or

nanostructured/hydrophobic (SLAnano) Ti surfaces. XPS showed elevated carbon levels on SLA
and SLAnano compared to modSLA. Contact angle measurements indicated only modSLA was
hydrophilic. Confocal laser microscopy revealed minor differences in mean surface roughness.
SEM showed the presence of nanostructures on modSLA and SLAnano. MSCs and NHOst cells
exhibited similar morphology on the substrates and osteoblastic differentiation and maturation
were greatest on modSLA. These results suggest that when the appropriate microstructure is
present, hydrophilicity may play a greater role in stimulating MSC and NHOst osteoblastic
differentiation and maturation than the presence of nanostructures generated during storage in
an aqueous environment.

Introduction
Successful dental implantation is measured by the degree of osseointegration between the
surface of the implant material and bone tissue. 167,168 Surface modifications altering implant
topography140,169 and energy23,144 on titanium (Ti) and Ti-based alloys141,145 have been heavily
emphasized in current research efforts in order to overcome problems associated with
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osseointegration. Surface roughness at the micro-level enhances osteoblast differentiation and
local factor production30,31,61,142,170,171 by mimicking resorption pit structural features 172.
Microscale and submicroscale features are sensed by osteoblast lineage cells via integrin alpha1,beta-1 (α1β1) and alpha-2,beta-1 (α2β1) signaling,155,157,161,173 leading to osteoblast
differentiation of mesenchymal stem cells (MSCs) and maturation of committed osteoblasts
(NHOst cells)173 and osteoblast-like MG63 cells.161
Recent studies have suggested that nanostructured topography provides a surface structure
much more analogous to that of natural bone. 142,164,174–177 Nanoscale surface features mimic the
extracellular matrix with which cells normally interact, thereby influencing the type, quantity, and
adsorbed protein conformation, integrin signaling, and signaling pathways that work together to
control cellular adhesion, proliferation, and differentiation. 178 However, many studies examining
the role of nanotopography have used patterned tissue culture polystyrene (TCPS) as the
substrate,154,179,180 which is very different from materials used clinically such as Ti. Thus, it is
difficult to extrapolate the reported findings to implant surface effects.
Hydrophilic (high energy) implant surfaces have also been shown to improve clinical
outcomes,23,144 particularly when the surface is microtextured. 155 Recently it was shown that
when grit blasted/acid etched Ti implants were stored in water or saline to retain their hydrophilic
surface post-processing, nanostructures formed on the surface due to reorganization of the
outermost oxide layer.52 It is not clear what contribution the nanostructures make to the improved
osseointegration seen with hydrophilic, microtextured Ti implants. 181 Nonetheless, many studies
have suggested the importance of a nanostructured surface for facilitating osteoblast
differentiation and maturation in vitro.51,61,182 Furthermore, an in vivo rabbit study by Wennerberg
et al., which used disc implants, suggests that the presence of nanostructures is beneficial for
new bone formation.183
The hypothesis of the present study is that nanostructures generated by storage in saline will
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impact the overall biological response to hydrophilic, microstructured Ti. To do this, we cultured
human MSCs and NHOst cells on Ti surfaces that were fabricated using the same methods
employed for production of commercially available implants. Ti discs were grit blasted and acid
etched, then stored in air (SLA); grit blasted, acid etched, and stored in saline (modSLA); or grit
blasted, acid etched, stored in saline to generate nanostructures, then dried and stored in air
(SLAnano). This experimental design enabled comparison of hydrophilicity + nanostructures;
hydrophobicity + nanostructures; and hydrophobicity without nanostructures.

Materials and Methods
Ti Disc Preparation
5 mm diameter and 1 mm thick discs were fabricated from Grade 4 Ti and subjected to one
of the following modifications.
SLA
Sand-blasted with large grit particulate (250 – 500 µm corundum) followed by acid etching in
a boiling mixture of HCl and H2SO4. Discs were cleaned in HNO3, rinsed in ultrapure water,
packed in aluminum foil, and γ-irradiated before use.
modSLA
Same initial sandblasting and acid etching procedure as used for SLA samples, but
subsequent steps took place under nitrogen to prevent exposure to air. The discs were rinsed,
stored in 0.9% NaCl solution, and γ-irradiated before use.
SLAnano
modSLA samples that were removed from 0.9% NaCl solution after aging 5 weeks, a
procedure outlined by Wennerberg et al. Once removed from solution, samples were rinsed in
ultrapure water, packed in aluminum foil, and γ-irradiated before use.
Surface Characterization
Scanning Electron Microscopy (SEM)
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Surface topography was qualitatively evaluated using SEM (Ultra60 FE-SEM, Zeiss). Six
images at varying magnifications were captured on each of n=3 discs per surface modification
using 5 kV accelerating voltage for a total of 18 images per modification.
X-ray Photoelectron Spectroscopy (XPS)
Chemical composition of the samples (n=3) was obtained from the sample surfaces by XPS
(Thermo K-Alpha XPS, Thermo Fisher Scientific). Spectra were collected using a 400 µm X-ray
spot size at three different locations on each individual sample.
Contact Angle Measurement
Measurements were obtained using a goniometer (CAM 250, Ramé-Hart). Samples (n=3)
were measured in three different locations and dried with nitrogen between each measurement.
A drop volume of 2 µL was used per individual measurement and a contact angle was calculated
every 5 seconds for 20 seconds. The four measurements were then averaged together to obtain
one of the three measurements per disc.
Confocal Laser Microscopy (CLM)
Surface roughness of the samples (n=3) was evaluated using a confocal laser microscope
(Lext, Olympus). Three measurements per sample were taken over an area of 644 µm x 644 µm
with a 20x objective and a scanning pitch of 50 nm. A cutoff wavelength of 100 µm was used
when calculating surface roughness (Sa) and peak-to-valley height (Sz).
Cell Culture
Human MSCs (Lonza Biosciences, Walkersville, MD) were cultured in MSC growth medium
(MSCGM; Lonza Biosciences). NHOst cells (Lonza Biosciences) were cultured using Dulbecco’s
modified Eagle medium (DMEM CellGro ®; Mediatech, Inc., VA) supplemented with 10% fetal
bovine serum (FBS, Life Technologies, Carlsbad, CA) and 1% penicillin-streptomycin (Life
Technologies). All cells were 4th passage and cultured at 37°C in 5% CO2 and 100% humidity.
MSCs and NHOsts were cultured on unmodified/non-patterned tissue culture polystyrene
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(TCPS), SLA, SLAnano, or modSLA at a density of 10,000 cells/cm2 in a 96-well plate. After 24
h, discs were transferred to a new 96-well plate with fresh medium and subsequently fed every
48 h until confluence.
Cell Morphology
MSCs and NHOst cells were plated on SLA, SLAnano, or modSLA at a density of 5,000
cells/cm2 in a 96-well plate and media were changed after 24 h. Cells were cultured for 72 h,
washed in PBS, and then fixed in 3.7% paraformaldehyde. After a 10 min fixation, surfaces were
washed with PBS, and permeabilized with 0.05% Triton X-100 for 10 min. Surfaces were washed
again with PBS, and incubated in a staining solution consisting of 0.165 µM AlexaFluor 488
phalloidin (Life Technologies) and 2 µg/mL Hoechst 33342 (Life Technologies) to visualize actin
filaments and nucleic acids respectively. After staining, surfaces were mounted on glass cover
slips using SlowFade (Life Technologies) and images were captured with a Laser Scanning
Microscope (Zeiss LSM 710, Carl Zeiss SMT Ltd., Cambridge, UK) at an excitation of 488 nm
for actin filaments and an excitation of 405 nm for nucleic acids using a 40x objective.
Biological Response
At confluence, cells were incubated with fresh media for 24 h. Media were collected and
ELISAs were used to measure levels of osteocalcin (Biomedical Technologies Inc., Stoughton,
MA), osteoprotegerin (R&D Systems, Minneapolis, MN), vascular endothelial growth factor-A
(VEGF, R&D Systems), bone morphogenetic protein-2 (BMP2, PeproTech, Rocky Hill, NJ),
interleukin 6 (IL6, R&D Systems), and interleukin 10 (IL10, R&D Systems) following
manufacturer’s instructions. Cells attached to surfaces were washed twice with 0.2 ml PBS.
Three 5 mm discs were combined in 0.5 ml of 0.05% TritonX-100 for each individual sample in
a total sample size of six (n=6). Cells were lysed by sonication at amplitude 40 using an
ultrasonicator (Vibra-Cell, Sonics, Newtown, CT).
DNA content in the cell lysate was measured (QuantiFluor™ dsDNA system, Promega,
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Madison, WI) using a fluorescence detector (Synergy H1 Hybrid Reader, BioTek, Winooski, VT)
at an excitation of 485 nm and emission of 538 nm. Immunoassay levels were normalized to
DNA content. Cell lysate was also analyzed for alkaline phosphatase specific activity as the
release of p-nitrophenol from p-nitrophenylphosphate (Sigma-Aldrich, St. Louis, MO) at a pH of
10.25 and a temperature of 37°C. Absorbance was measured at 405 nm and alkaline
phosphatase activity was quantified using a standard curve. Activity was normalized to total
protein content in the cell lysates, as determined by bicinchoninic acid protein assay kit (Thermo
Fisher Scientific).
To quantify mRNA, cells were plated as described above. At confluence on TCPS, cells were
incubated with fresh media for 12 h. Samples were harvested using a TRIzol ® (Invitrogen,
Carlsbad, California) extraction method. Six 5 mm discs were combined in TRIzol ® for each
individual sample in a total sample size of six (n=6). RNA was quantified using a NanoDrop
spectrophotometer (Thermo Fisher Scientific) and then reverse transcribed into 250 ng/µL
cDNA. Real-time PCR was performed using a fluorescent dye (Power SYBR Green, Applied
Biosystems, Foster City, CA) and StepOnePlus™ Real-Time PCR system (Applied Biosystems)
to quantify starting mRNA levels using gene specific primers (Table 1). Specific genes were
amplified for 40 cycles and levels of mRNA were normalized to GAPDH.
Statistical Analysis
Data from surface characterization experiments are presented as the mean ± standard error
(SE). Data for surface analyses represent 3 measurements per disc, resulting in an n=9 per
variable. For cell morphology, no quantitative analyses were performed. All cell culture
experiments had an N=6 independent cultures for each variable. Experiments were repeated at
least three times to ensure validity of the results. Data from individual experiments were not
combined and data shown in the figures are from representative experiments. A one–way
analysis of variance was performed followed by a Bonferroni correction to maintain an
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experiment-wise error rate (α) of 0.05. All statistical analyses were performed using JMP
statistical software.

Results
Material Characterization
Low magnification SEM imaging (Fig.9A – C) revealed a similar topography among SLA,
SLAnano, and modSLA. Confocal microscopy confirmed these qualitative observations (Fig.9G
– I), resulting in no significant differences among the mean surface roughness’s (S a) or the mean
peak-to-valley height (Sz) of the SLA (Sa = 1.65 ± 0.01 µm; Sz = 23.17 ± 0.82 µm), SLAnano (S a
= 1.79 ± 0.03 µm; Sz = 25.55 1 ± 0.80 µm), and modSLA (S a = 1.74 ± 0.01 µm; Sz = 21.88 ± 0.51
µm). At a higher SEM magnification, no nanostructures were observed on SLA (Fig.9D) while
similar needle-like nanostructures were observed on SLAnano (Fig.9E) and modSLA (Fig.9F).
Using ImageJ software (National Institutes of Health, USA), a morphometric analysis was
conducted by superimposing a grid composed of 20 evenly spaced squares arranged into a 4x5
matrix onto the highest magnification SEM images. The diameter and peak distance to its closest
neighbor were obtained for the centermost nanostructure within each square for a total of 60
measurements per material. Differences between SLAnano and modSLA mean nanostructure
diameter (11.44 ± 0.38 nm; 10.21 ± 0.34 nm, respectively) and mean nanostructure separation
(18.87 ± 0.7 nm; 12.95 ± 0.5 nm, respectively) were observed.
XPS survey spectra displayed titanium (Ti), oxygen (O), and carbon (C) as the main atomic
components of the SLA, SLAnano, and modSLA surfaces (Fig.9J – L). The chemical
composition was almost identical between SLA and SLAnano with spectral analyses indicating
a high presence of Ti, O, and C. The spectral analysis for modSLA revealed a lower quantity of
C compared to that detected on SLA and SLAnano. Measured contact angles are also shown in
Figure 9. SLA (Fig.9M) and SLAnano (Fig.9N) had hydrophobic surfaces with contact angles
of 126 ± 4° and 132 ± 4° respectively while modSLA (Fig.9O) had a hydrophilic surface with 0°
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contact angle.

Figure 9. Material characterization of the non-nanostructured/hydrophobic SLA,
nanostructured/hydrophobic SLAnano, and nanostructured/hydrophilic modSLA surface
modifications. Substrates were examined by scanning electron microscopy at 20Kx (A – C) and
200Kx (D – F). Surface roughness and morphology were assessed using laser confocal microscopy
measured using a 644 µm x 644 µm scan size. Topographical images shown were taken with a 60
µm x 60 µm to exaggerate surface features (G – I). Surface chemical composition was assessed
using XPS with spectra of O, Ti, and C shown (J – L). Surface energy was assessed using contact
angle measurements (M – O).
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Cell Morphology
Figure 10 shows both the stained components of the MSCs and NHOst cells superimposed
with the rough metallic surfaces of the SLA, SLAnano, and modSLA (actin – green; DNA – blue).
Striations of the actin filaments and the nucleus can be visualized in each of the images. The
actin filaments in both cell types adopted a parallel orientation that did not exhibit a preference
for any particular structure. Nuclei and the immediate surrounding actin filaments mostly avoid
the valleys (dark areas) of the rough surfaces; however, the more distal actin filaments can be
seen spanning valleys. MSCs and NHOst cells cultured on TCPS exhibited morphologies
comparable to those reported in the literature for non-patterned TCPS.

Figure 10. Cell staining of MSCs (A – C) and NHOst cells (D – F) on SLA, SLAnano, or modSLA 72 h after cell
seeding. Actin filaments are stained green and nucleic acids are stained blue. Each image was taken using a 40x
objective.

Biological Response
DNA content was significantly lower on SLA, SLAnano, and modSLA compared to TCPS for
both MSCs (Fig.11A) and NHOst cells (Fig.11E) with modSLA exhibiting significantly lower DNA
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compared to SLA and SLAnano. Compared to TCPS, MSCs and NHOst cells cultured on SLA,
SLAnano, and modSLA had significantly higher alkaline phosphatase specific activities
(Fig.11B, F) and production of osteocalcin (Fig.11C, G) and osteoprotegerin (Fig.11D, H).
Alkaline phosphatase specific activity in the MSC cultures was comparable on the modified
surfaces. MSCs cultured on modSLA produced significantly higher osteocalcin and
osteoprotegerin compared to SLA and SLAnano with SLAnano producing significantly lower
osteocalcin compared to SLA. Alkaline phosphatase specific activity and osteocalcin production
by NHOst cells were significantly higher compared to SLA and SLAnano with significantly lower
alkaline phosphatase specific activity detected on SLAnano compared to SLA. No significant
differences in NHOst osteoprotegerin production were detected between modSLA and SLA;
however, production on both was significantly greater compared to SLAnano.
MSCs and NHOst cells cultured on modified surfaces produced significantly higher quantities
of VEGF (Fig.12A, E), BMP2 (Fig.12B, F), and the anti-inflammatory cytokine IL10 (Fig.12C,
G) compared to those cultured on TCPS. The opposite effect was observed for the production
of the pro-inflammatory cytokine IL6 (Fig.12D, H) where significantly lower quantities were
detected on modified surfaces compared to TCPS. VEGF, BMP2, and IL10 production by MSCs
was significantly greater on modSLA compared to SLA and SLAnano with a significantly lower
production detected on SLAnano compared to SLA. No significant differences were detected in
NHOst VEGF production among modified surface. NHOst cells cultured on SLAnano produced
significantly lower quantities of BMP2 compared to SLA and modSLA which were not
significantly different from each other. IL10 production by NHOst cells was significantly higher
on modSLA compared to SLA and SLAnano with a significantly lower production detected on
SLAnano compared to SLA. Both MSCs and NHOst cells cultured on modSLA exhibited
significantly lower productions of IL6 compared to SLA and SLAnano. No significant differences
were detected between MSC IL6 production between SLA and SLAnano while NHOsts produced
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a significantly lower amount of IL6 on SLAnano compared to SLA.

Figure 11. Effects of surface nanoscale features and energy on the maturation of MSCs (A – D)
and NHOst cells (E – H). MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano,
or modSLA grown to confluence. At confluence, cells were incubated in fresh media for 24 h,
collected, and measured for (A, E) DNA content, (B, F) alkaline phosphatase specific activity, (C,
G) osteocalcin, and (D, H) osteoprotegerin. Data shown are the mean ± standard error (SE) of six
independent samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano.
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BMPs, receptor, and antagonist expression are shown in Figure 13. Compared to TCPS,
significantly higher mRNA expressions of BMP4, BMP7, BMPR1A, and NOG were detected for
MSCs (Fig.13A – D) and NHOst cells (Fig.13E – H) on SLA, SLAnano, and modSLA. MSCs
cultured on modSLA had significantly higher expressions of each gene with significantly lower
BMP4 and NOG expressions detected on SLAnano compared to SLA. NHOst cells cultured on
modSLA exhibited significantly higher expressions of BMP4, BMP7, and NOG compared to SLA
and SLAnano. SLAnano significantly upregulated NHOst BMPR1A expression compared to SLA
and modSLA. NHOst NOG expression was significantly greater on SLAnano compared to SLA.
mRNA levels of ITGα1 (Fig.14A, E), ITGα2 (Fig.14B, F) and ITGβ1 (Fig.14D, H) were
significantly higher on modified surfaces compared to TCPS for both cell types. Additionally,
MSC and NHOst ITGα5 (Fig.14C, G) expression was significantly lower on modified surfaces
compared to TCPS except for MSCs cultured on SLAnano which was significantly greater. MSCs
cultured on modSLA exhibited significantly higher mRNA levels of ITGα1, ITGα2, and ITGβ1
compared to SLA and SLAnano with significantly lower mRNA levels of ITGα1 and ITGβ1 on
SLAnano compared to SLA. No significant difference was detected in MSC ITGα2 mRNA levels
between SLA and SLAnano. Among modified surfaces, NHOst expression of ITGα1 was not
significantly different. NHOst cells cultured on modSLA had significantly higher ITGα2 and ITGβ1
mRNA levels compared to SLA and SLAnano. MSCs and NHOst cells cultured on SLAnano
exhibited significantly higher ITGα5 expression compared to SLA and modSLA. No significant
differences were detected between SLA and modSLA MSC ITGα5 expression while NHOst
ITGα5 expression was significantly lower on modSLA compared to SLA.

Discussion
Implant surface properties dictate the resulting molecular events that take place at the cellmaterial interface. Studies have highlighted the importance of surface properties such as
roughness, topography, chemistry, and energy in the modulation of cell proliferation and
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Figure 12. Effects of surface nanoscale features and energy on the soluble factor production of MSCs (A – D)
and NHOst cells (E – H). MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, or modSLA
grown to confluence. At confluence, cells were incubated in fresh media for 24 h, collected, and measured for (A,
E) VEGF, (B, F) BMP2, (C, G) interleukin 10, and (D, H) interleukin 6. Data shown are the mean ± standard error
(SE) of six independent samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano.
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differentiation.23,61,140–142,144,145,167–170 In the present study, Ti metal was treated to exhibit either
a hydrophilic or hydrophobic nanostructured surface in order to distinguish between the effects
these parameters have on osteogenic responses of MSCs and NHOst cells. Using a
hydrophobic, non-nanostructured surface (SLA) as a control, cells at two different stages in the
osteoblast lineage were grown separately to confluence on the modified surfaces. Subsequent
examination of mRNA expression and protein production showed that a hydrophilic
nanostructured surface facilitated the greatest increase in osteogenic markers. Interestingly, our
data suggest that a hydrophobic nanostructured surface may stunt or delay the osteogenic
capacity of MSC and NHOst cells compared to a hydrophobic non-nanostructured surface.
Although many other cell types are involved in osseointegration and the subsequent
remodeling of peri-implant bone, MSCs and NHOst cells are critical for the process of bone
mineralization. We used commercially available MSCs and NHOst cells from single donors,
which limits the scope of our results since it does not consider variability inherent to the human
population, or the health of the donors themselves. Despite these limitations, our results indicate
that the positive osteogenic effects nanostructures have on MSC and NHOst cells are dependent
on the inclusion of hydrophilicity.
Scanning electron microscopy confirmed the presence or absence of nanostructures on the
modified Ti surfaces. In accordance with previous studies, sand blasting and acid etching
techniques generated submicron scale roughness but did not induce nanostructure
formation.52,63 Instead, nanostructure formation was dependent upon the reorganization of the
oxide layer facilitated by the aqueous NaCl solution. Consistent with this idea, nanostructures
with a similar size were present on SLAnano and modSLA but not SLA. The exact process of
nanostructure formation is unknown; however, many studies have fabricated nanostructures on
metallic surfaces using a variety of methods involving changes in temperature, pressure, and
chemical treatments. The modification process used in this study also provided a consistent
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Figure 13. Effects of surface nanoscale features and energy on BMP mRNA levels of MSCs and NHOst cells.
MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, or modSLA grown to confluence. At
confluence, cells were incubated in fresh media for 12 h, collected, and measured mRNA levels of BMP4, BMP7,
BMPR1A, and NOG. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano.
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micro-roughness among SLA, SLAnano, and modSLA, allowing for an accurate separation
between the effects of the nanostructures and the surface hydrophilicity.
The hydrophilicity of the surfaces was validated using x-ray photoelectron spectroscopy and
contact angle measurements. The XPS spectra revealed that the thin Ti oxide layer consists
mainly of TiO2. Additionally, the presence of C(1s) is indicative of aliphatic carbons due to the
adsorption of carbon-containing molecules from the air.71 Exposure to air increased the value of
the peak corresponding to the presence of C(1s) carbon which was detected on SLA and
SLAnano surfaces similar to previous studies.52,71 Immediate storage in saline without any
exposure to air was an effective method for preventing organic impurity deposition resulting in a
very low C(1s) peak on the surface of modSLA. 52,71,184 Consistent with the XPS results, contact
angle measurements demonstrated SLA and SLAnano to be hydrophobic and modSLA to be
super-hydrophilic.
Cytoskeleton staining revealed that SLA, SLAnano, and modSLA surfaces were able to
support a normal osteoblastic morphology as demonstrated by the clear, branched morphology
adopted by MSCs185 and NHOst cells.186 Cytoskeleton organization of the cell is essential for
focal adhesion, stress fiber formation, and spreading, and is dependent on the spatial distribution
of both micro- and nanostructured topographies. 164,187 Cell morphology influences gene
expression,188 and MSC differentiation relies in part on extracellular mechanical cues inherent
to the underlying structure of the cytoskeleton. 185 It has been shown previously that MSC
adipogenesis is preceded by round cell morphology while MSC osteoblastogenesis is preceded
by a branched cell morphology when cultured on titanium substrates. 185 The branched
morphology displayed by MSCs undergoing osteoblastogenesis is like that observed in mature
osteoblasts grown on titanium substrates.186 Moreover, the production and expression of
osteoblastic markers further support enhanced osteoblastogenesis on the SLA, SLAnano, and
modSLA.
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Figure 14. Effects of surface nanoscale features and energy on integrin mRNA levels of MSCs and NHOst cells.
MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, or modSLA grown to confluence. At
confluence, cells were incubated in fresh media for 12 h, collected, and measured mRNA levels of ITGα1, ITGα2,
ITGα5, and ITGβ1. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano.
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A decrease in DNA compared to TCPS was accompanied by an increase of osteoblastic
markers of differentiation and maturation on SLA, SLAnano, and modSLA for both cell types.
Previous studies have shown that MSCs and NHOst cells grown on microstructured Ti surfaces
produce an osteogenic environment facilitating their differentiation and maturation with the
highest being produced on modSLA followed by SLA.70,158 These include the early marker of
osteoblastic differentiation, alkaline phosphatase specific activity; the late marker of osteoblastic
differentiation, osteocalcin; the osteoclast inhibitory factor, osteoprotegerin; the angiogenic
factor, VEGF; and the osteogenic factor, BMP2. Additionally, modified surfaces had the ability
to mitigate the inflammatory response compared to TCPS as indicated by the increased
production of the anti-inflammatory cytokine interleukin 10 (IL10) and the decreased production
of the pro-inflammatory cytokine interleukin 6 (IL6) in accordance with previous reports.158
Interestingly, the inflammatory response was highest on SLAnano among modified surfaces.
Additionally, MSC osteocalcin, VEGF, BMP2, and NHOst alkaline phosphatase specific activity,
osteoprotegerin, and BMP2 on SLAnano were lowest among modified surfaces. Although each
modification was able to support a healthy osteoblastic phenotype, it was frequently observed
that SLAnano had a comparatively diminished capacity to enhance production of osteoblastic
markers.
MSC and NHOst gene expression was less upregulated by SLAnano compared to SLA and
modSLA. In general, for both cell types, the expression of BMPs (BMP4, BMP7), receptors
(BMPR1A), and antagonists (NOG) was highest on modSLA followed by SLA as seen
previously.61,71,158 Additionally, both cell types primarily expressed α5β1 subunits when grown
on TCPS but shifted to the production of α1β1 and α2β1 subunits when grown on rough titanium
substrates. A further increase was observed for α2β1 subunits on hydrophilic and
nanostructured substrates as previously described.161–163 However, removal of the hydrophilicity
while retaining nanostructures resulted in fluctuations in osteoblastic gene expression. MSC
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expression of BMP4, its receptor BMPR1A,189 and its specific antagonist NOG159,190 decreased
on SLAnano suggesting a lessened capacity to stimulate an osteogenic environment by
nanostructures in the absence of hydrophilicity. SLAnano also altered the expression of BMP
complexes in NHOst cells. NOG expression was increased compared to SLA without a similar
increase in BMP4; furthermore, BMPR1A expression was highest on SLAnano.
Alterations in the balance of BMPs, their receptors, and antagonist results in altered bone
remodeling, a potential outcome indicated by the in vitro gene expression modulated by
SLAnano. Integrins are also important for both cell attachment and maintenance of the
osteoblastic phenotype, and an altered expression of integrin subunits was observed on
SLAnano. Although pro-osteoblastic integrin subunits increased on SLAnano, α1 and β1 were
decreased compared to SLA. Moreover, an increase of the non-osteoblastic subunit α5 was
observed for both MSCs and NHOst cells cultured on SLAnano with its expression being greater
than TCPS. Together, the expression of BMP and integrin complexes suggests that the bone
remodeling process is somewhat diminished on a hydrophobic and nanostructured surface.
However, this is capable of being recovered with the addition of surface hydrophilicity.
Previous studies analyzing the biological response to a hydrophobic and nanostructured
surface determined favorable effects of nanostructures on osteoblastic differentiation and
maturation. This contrasts with other studies comparing SLA to a hydrophobic, nanostructured
surface.191 Using thermally nanomodified hydrophobic Ti (NMSLA) and Ti-6Al-4V alloy surfaces,
it was shown that the osteoblastic differentiation of MG63 cells was enhanced compared to a
microrough and hydrophobic SLA. Interestingly, human MSC response to the NMSLA
modification suggested that differentiation was suppressed by the superposition of
nanostructures.191 In these studies, nanostructures were classified as submicron, reporting a
size range from 40 to 200 nm, while the nanostructure size range produced on surfaces used in
this study was between 10 and 11 nm. It is possible that osteoblastic differentiation and
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maturation can be altered by varying the size and shape of the nanostructures, an idea
previously suggested.164
Our results may be partially explained by a recent study investigating the influence of
nanostructures and hydrophilic Ti substrates on fibrinogen and fibronectin protein adsorption
and the degree of blood coagulation. 192 It was shown that a hydrophilic and nanostructured
surface led to the highest protein adsorption levels and the most pronounced degree of blood
coagulation whereas the effects of a hydrophobic nanostructured surface on these outcomes
were weak.192 This suggests that the effects the surface parameters have on early protein
adsorption may dictate the rate of MSC osteoblastic differentiation or NHOst maturation. The
effect of the nanostructures can be recovered and improved through the addition of the
hydrophilicity providing the optimum conditions of osteoblastic differentiation and maturation.

Conclusions
Clinical grade Ti was successfully modified to fabricate microrough surfaces exhibiting
hydrophobic or hydrophilic nanostructured surfaces. Although modified surfaces were able to
support osteoblastic morphology in MSCs, indicated by staining of the cytoskeleton, production
and expression of markers of osteoblastic differentiation and maturation suggest that an average
nanostructure size of approximately 11 nm may delay the process of osteoblastogenesis. The
effect of the nanostructures can be recovered with the addition of hydrophilicity. In order to
promote enhanced osteoblastic differentiation of MSCs and maturation of NHOst cells, a
nanostructured Ti surface will be dependent on an increased surface hydrophilicity.
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Chapter 5. Regulation of Osteoclasts by Osteoblast
Lineage Cells Depends on Titanium Implant Surface
Properties
Abstract
A critical stage during osseointegration of a titanium (Ti) implant is primary bone remodeling,
which involves cross talk among osteoclast precursors, osteoclasts, mesenchymal stem cells
(MSCs), and osteoblasts. This phase couples the processes of bone formation and resorption.
During remodeling, osteoclasts produce factors capable of regulating MSC migration and
osteogenesis. Furthermore, they degrade primary bone, creating a foundation with a specific
chemistry, stiffness, and morphology for osteoblasts to synthesize and calcify their matrix. MSCs
and osteoblasts receiving cues from the implant surface produce factors capable of regulating
osteoclasts in order to promote net new bone formation. The purpose of this study was to
determine the effects Ti implant surfaces have on bone remodeling. Human MSCs and normal
human osteoblasts (NHOsts) were cultured separately on 15mm grade 2 smooth PT,
hydrophobic-microrough SLA, hydrophilic-microrough Ti (mSLA) (Institut Straumann AG, Basel,
Switzerland), or tissue culture polystyrene (TCPS). After 7d, conditioned media from surface
cultures were used to treat human osteoclasts for 2d. Activity was measured by fluorescence of
released collagen followed by mRNA quantification. This study demonstrates that MSC and
NHOst cultures can suppress osteoclast activity in a surface dependent manner and osteoclast
mRNA levels are selectively regulated by surface treatments. The substrate-dependent
regulatory effect was mitigated when MSCs were silenced for integrin subunits and when
conditioned media were denatured. These results indicate that MSCs and NHOsts regulate at
least two aspects of remodeling: reduced fusion of new osteoclasts and reduced activity of
existing osteoclasts.
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Introduction
Osseointegration is a complex cascade of biological events responsible for providing a direct
structural and functional connection between the surface of a load-bearing implant and living
bone. Greater bone apposition to implant materials results in functional stability, reducing the
risk of failure while maintaining implant longevity. In addition to various intrinsic factors that
enhance or inhibit osseointegration, the implant surface directly contacts the biological tissues
and influences the outcome.
Titanium (Ti) and its alloys are choice materials for both dental and orthopaedic implants
because of their ability to form a passive oxide layer bestowing high biocompatibility and
corrosion resistance.121 Because of its stability in biological systems, Ti has been used
extensively to investigate the process of osseous wound healing and osseointegration. Our
previous studies have identified

several important surface characteristics including

microroughness, hydrophilicity, and chemistry that stimulate osteogenesis, resulting in
enhanced osseointegration. When grown on Ti surfaces that are microstructured and
hydrophilic, mesenchymal stem cells (MSCs) and osteoblasts (OBs) produce factors that create
an osteogenic environment by stimulating osteoblastic differentiation in progenitor cells distal to
the implant; promoting vasculogenesis; reducing inflammation; and regulating osteoclastic
resorption to achieve net new bone formation.61,70,71,80,161,193
Much of the research regarding osseointegration revolves around bone-forming OBs and
MSCs due in part to the necessity to achieve net new bone formation. Materials that do not
promote osteogenesis, such as polymers like polyether-ether-ketone, result in a fibrous
connective tissue interface.194 Although implant materials should actively promote bone
formation, long-term stability requires solutions that not only result in net new primary bone
formation but also provide continued osteogenic signals to maintain healthy bone remodeling.
Bone-resorbing osteoclasts (OCs) are present during peri-implant healing, significantly
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influencing implant outcomes by playing an important role during the initial and late phases of
osseointegration.195 Bone is continuously remodeled through a finely balanced equilibrium of
cell mediated extracellular matrix (ECM) degradation and formation. Bone remodeling is a
versatile and ubiquitous process providing the mechanism for adaptation to mechanical stress,
repair of micro-damage, and replacement of primary bone during osseointegration of implanted
materials.32 Because it can occur in separate areas asynchronously, locally generated regulatory
factors and environmental cues ensure the appropriate balance among OCs, OBs, and their
precursors. Although it seems counterintuitive, implant materials for dental and orthopaedic
applications should not inhibit OC-mediated bone resorption to promote net new bone formation,
but instead promote a healthy communication among these cells to achieve osseointegration
and maintain its longevity.
Achieving implant stability is critical for successful osseointegration; however, insertion of a
dental or orthopaedic implant influences the nature of bone healing.196 Immediately after
insertion, implant stability depends on the initial mechanical interlock with the surrounding bone.
Unless primary fixation is achieved via new bone formation between the implant surface and the
existing bone bed, micromotion of the implant and localized inflammation may occur, frequently
ending with osteolysis and implant failure. In addition, the trauma of implant placement ruptures
blood vessels and releases growth factors and proteins,62,197 which provide the local
environment with a provisional ECM important for blood clot formation. 198 The adsorption of
these early proteins is dependent upon the surface topography with superior anchorage
occurring on micro-roughened implant surfaces compared to smooth surfaces.199,200 Moreover,
this protein layer serves as a scaffold for the migration of MSCs to the implant surface. 201,202
Surface design that facilitates this contact osteogenesis has been shown to control the
fundamental processes that drive the osteoblastic differentiation of MSCs. 22,203 A cell-rich
immature bone (woven bone) is seen in the provisional connective tissue that surrounds newly
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formed blood vessels.204 Woven bone forms in direct contact with the surface of the Ti implant
and continues to form over 2 weeks.205 Although OCs are present in the peri-implant tissues as
early as 1 week following implantation, it is not until after formation of the woven bone that OC
activity in relation to osseointegration begins.195 This marks the beginning of the progressive
removal of woven bone, creating space for new lamellar bone formation and replacing passive
primary stability with active secondary fixation through biological bonding.206
Modifications to the implant surface topography, chemistry, and hydrophilicity are employed
as a means of controlling bone–implant interactions and shortening the time of bone fixation.
Furthermore, it is known that the communication among OCs, MSCs, and OBs is coupled to
provide control of bone mass and healing. Commitment of OC precursors to mature OCs is
dependent on production of RANKL (receptor activator of the NFκB ligand) 207 and its physiologic
inhibitor OPG (osteoprotegerin) 208 by OBs and MSCs. Implant surface microstructure and
hydrophilicity facilitate increased production of OPG by MSCs and OBs, leading to increased
bone formation. In this regard, much attention has been given to the anabolic aspects of
osseointegration. In contrast, there is little information regarding the OC-mediated catabolic
processes associated with bone remodeling. It remains unclear as to whether implant surface
topography can affect the process of osteoclastogenesis or OC function. A thorough
understanding of healing, repair, modeling, and remodeling of bone is critical for the
establishment and maintenance of osseointegration of dental and orthopaedic implants. Given
that the process of bone adaptation and maturation are critical features for the long-term success
of osseointegration, continued attention to the molecular processes underlying these events may
create new biological design criteria for implant surface design. This insight is critical to optimize
an implant surface capable of simultaneously enhancing peri-implant osteogenesis while also
positively influencing the later stages of osseointegration. Therefore, the objective of this study
was to determine the effects microrough and hydrophilic Ti surfaces have on a novel in vitro
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model of bone remodeling by studying their distal influence on OC formation and activity and the
mechanisms responsible for the influence.

Materials and Methods
Ti disk preparation
Grade 2 Ti disks, 15mm in diameter and 1mm in thickness, were provided by Institut
Straumann AG (Basel, Switzerland). Disks were degreased in acetone and processed for 30s in
in a 55°C 2% ammonium fluoride/2% hydrofluoric acid/10% nitric acid solution to produce
pretreatment Ti disks (PT). SLA substrates were prepared by subjecting PT substrates to sand
blasting (250 – 500μm corundum) and acid etching (HCl/H 2SO4). Disks were cleaned in HNO3,
rinsed in deionized water, air dried, and packed in aluminum foil. mSLA substrates were
produced using the same sandblasting and acid etching procedure as used for SLA, but
subsequent steps took place under nitrogen gas to prevent exposure to air. mSLA disks were
rinsed and stored in 0.9% NaCl solution. The methods used to characterize the surface
microroughness, contact angle, and carbon contamination of the surfaces (PT [S A=0.59µm;
θCA=93.6°; %C=31], SLA [SA=3.58µm; θCA=120.9°; %C=35], mSLA [SA=3.64µm; θCA=0°;
%C=17]) have been reported previously.209 All disks were γ-irradiated prior to use.
OC Cell Culture
Human OC precursors (OCPs; Lonza Biosciences, Walkersville, MD) were cultured on a
human type I collagen coated, 96-well OsteoLyse™ Assay Kit (Lonza Biosciences). OCPs were
differentiated into mature OCs using osteoclast precursor growth medium (OCGM, Lonza
Biosciences) supplemented with 33ng/ml macrophage colony stimulating factor (M-CSF, Lonza
Biosciences) and 66ng/ml receptor activator of nuclear factor kappa-B ligand (RANKL, Lonza
Biosciences). OCPs were also cultured in OCGM supplemented with 33ng/ml M-CSF without
RANKL for use as a negative control.
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Establishment of Osteoclast Phenotype and Treatment Period
In order to establish the OC phenotype and treatment period, OCPs were harvested at 3d,
7d, 9d, and 14d and subjected to the following assays.
OC Activity
OC activity was measured by the release of the europium conjugated human type I collagen
coated on the bottom of the OsteoLyse™ Assay Kit at each time point. 200μl of a fluorophore
releasing reagent (Lonza Biosciences) was placed in each well of a 96-well black, clear-bottom
assay plate (Corning Inc., Corning, NY). 10μl of cell culture supernatant was transferred to each
well of the assay plate containing the fluorophore releasing reagent. Fluorescence of each well
of the assay plate was measured with an excitation wavelength of 340nm and an emission
wavelength of 615nm over a 400μs period after an initial delay of 400μs.
Gene Expression
To quantify mRNA, cells were plated as described above. At each time point, mRNA was
isolated from cells using a TRIzol ® (Invitrogen, Carlsbad, California) extraction method. RNA
was quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA)
and then reverse transcribed into 250 ng/µL cDNA. Real-time PCR was performed using a
fluorescent dye (Power SYBR Green, Applied Biosystems, Foster City, CA) to quantify starting
mRNA levels using gene specific primers (Table 3). Levels of mRNA are normalized to GAPDH.
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Scanning Electron Microscopy (SEM) Imaging
OCs were qualitatively evaluated using SEM (Hitachi FE-SEM Su-70, Tokyo, Japan) at
each time point. In addition, the collagen coating of the OsteoLyse™ Assay Kit was assessed
before and after OC treatment. For assessment of the collagen coating, OCs were trypsinized
for 5min. All samples were then fixed in 4% paraformaldehyde for 15min after three rinses in 1x
PBS. Samples were then dehydrated stepwise in increasing ethanol concentrations of 15%,
30%, and 45% for two hours, followed by 60%, 75%, 90% and 100% (x3) for at least 1 hour. The
samples were then critically dried using a 1:1 exchange of 100% ethanol and
hexamethyldisilazane (HMDS, Sigma-Aldrich, St. Louis, MO) for 30min in a chemical safety
hood, then twice with 100% HMDS for 30min. Sample wells were trimmed to allow even sputter
coating, then dried in a desiccator for 24hrs prior to platinum sputter coating. Samples were
imaged with 56μA ion current, 5kV accelerating voltage and 8mm working distance.
Representative images were selected from 18 images per well and n=4 per group.
Tartrate-Resistant Acid Phosphatase (TRAP) Staining
OCs were stained for tartrate-resistant acid phosphatase (TRAP) and were analyzed using
light microscopy. OC groups (n=4) were prepared based on a modified manufacture’s protocol
(Sigma-Aldrich). Briefly, OCs were rinsed three times with 1x PBS, fixed in a fixative solution
comprising of 25mL citrate solution, 65mL acetone, and 8mL of 37% formaldehyde for 15min.
Followed by 3 rinses in deionized water. Staining solution consisting of 45mL of deionized water
at 37°C, 1mL diazotized Fast Garnet GBC solution, 0.5mL Naphthol AS-BI Phosphate Solution,
2mL Acetate solution, and 1mL Tartrate solution was prepared and 200μL of staining solution
was added to each well and allowed to incubate for 1hr at 37°C. Samples were counterstained
with 200μL hematoxylin solution for 2min and rinsed in deionized water prior to imaging with a
Carl Zeiss Primo Vert™ Inverted Microscope (Zeiss, Oberkochen, Germany). Representative
images were selected from 18 images per well and n=4 per group.
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MSC and NHOst Cell Culture
Human MSCs (Lonza Biosciences) were cultured in MSC growth medium (MSCGM; Lonza
Biosciences). Normal human osteoblasts (NHOsts, Lonza Biosciences) were cultured using
Dulbecco’s modified Eagle medium (DMEM, CellGro ®; Mediatech, Inc., VA) supplemented with
10% fetal bovine serum (FBS, Life Technologies, Carlsbad, CA) and 1% penicillin-streptomycin
(Life Technologies). MSCs and NHOsts were separately cultured on tissue culture polystyrene
(TCPS), PT, SLA, or mSLA at a density of 10,000 cells/cm2 at 37°C in 5% CO2 and 100%
humidity. Media were changed 24h after plating and every 48h thereafter for 7d. At 7d, cells
were incubated with fresh media for 24h, which was used for subsequent experiments.
Indirect Effects of MSC/NHOst Conditioned Media on OCs
MSCs, NHOsts, and OCPs were separately cultured as described previously. After culture
for each cell type, 200μl media from MSCs or NHOsts were transferred to wells of the
OsteoLyse™ Assay Kit containing differentiated OCs. In order to control for the initial
concentrations of M-CSF and RANKL used to differentiate the OCs, an additional group of
differentiated OCs was incubated with 200μl of MSC or NHOst media supplemented with
33ng/ml M-CSF and 66ng/ml RANKL. For each experiment, positive (differentiated OCs
receiving OCGM supplemented with 33ng/ml M-CSF and 66ng/ml RANKL) and negative
(undifferentiated OCPs receiving OCGM supplemented with 33ng/ml M-CSF) controls were
used. Differentiated OCs were treated for 2d, followed by quantification of activity and gene
expression.
Cell Presence and Conditioned Media Effects on OCs
In order to determine whether the observed indirect effects of conditioned media were
dependent on the presence of cells, MSCs were cultured on TCPS or mSLA and compared to
conditioned media collected from TCPS and mSLA without seeded cells. Both the cellular and
acellular TCPS and mSLA were incubated and received media changes in the exact same
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manner for 7d followed by treatment with MSCGM for 24hr. After treatment, conditioned media
were supplemented with 33ng/mL M-CSF and 66ng/mL RANKL and used treat differentiated
OCS for 2d. Positive and negative controls were also used.
Proteins and Conditioned Media Effects on OCs
Whether proteins were the primary factor for the observed effects of conditioned media on
OCs was determined by two methods of denaturation: 1) proteinase K or 2) heat. For proteinase
K denaturation, MSCs were cultured on either TCPS or mSLA as described previously. After
treatment with MSCGM, conditioned media were collected and treated with 200μg/ml proteinase
K (Sigma-Aldrich) for 1h at 37°C. Proteinase K activity was then neutralized with 5mM Pefabloc®
SC (Sigma-Aldrich) for 2h at 37°C. For heat treatment, conditioned media were placed in an
80°C water bath for 2h. Heat treated media were then cooled to room temperature by placing
samples on ice for 10 min. Denatured conditioned media were then supplemented with 33ng/mL
M-CSF and 66ng/mL RANKL prior to treating differentiated OCs for 2d using positive and
negative controls.
ITGA2 and ITGB1 Silencing
MISSION® shRNA lentiviral transduction particles (Sigma-Aldrich) were used to silence
human MSCs for either ITGA2 (SHCLNV-NM_002203) or ITGB1 (SHCLNV-NM_002211). MSCs
were plated at 20,000 cells/cm2 and cultured overnight at 37°C in 5% CO2 and 100% humidity.
Particles were added to the cells at a multiplicity of infection of 2 in culture media supplemented
with 8μg/ml hexadimethrine bromide for 18h. Transduced cells were selected using MSCGM
supplemented with 0.5 μg/ml of puromycin. Silencing of ITGB1 and ITGA2 were confirmed using
real-time qPCR and maintained over the period of culture (data not shown). A 70% reduction in
mRNA levels compared to the wild-type control was considered the minimum acceptable
decrease.
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Effects of ITGA2 and ITGB1 Silencing on Indirect Effects of MSC Conditioned Media
To determine if signaling via the α2 or β1 integrin subunit was required for the indirect effects
of conditioned media on OCs, wild type (WT) and silenced MSCs were cultured on TCPS or
mSLA for 7d in MSCGM followed by a 24hr treatment with MSCGM. Conditioned media were
supplemented with 33ng/ml M-CSF and 66ng/mL RANKL and used treat differentiated OCS for
2d. Positive and negative controls were also used.
Paracrine Effects of OPG and TGFβ1 in Conditioned Media
The contribution of osteoprotegerin (OPG) and transforming growth factor β1 (TGFβ1), two
known regulators of OC activity and function, to the indirect effects of conditioned media on OCs
were also evaluated. Conditioned media were collected from cultures of MSCs on TCPS or
mSLA as previously described. Conditioned media were supplemented with either 2μg/ml or
0.5μg/ml anti-TGFβ1 type II receptor antibody (R&D Systems, Minneapolis, MN); 1μg/ml or
0.1μg/ml soluble type II receptor (R&D Systems); or 2μg/ml or 0.5μg/ml anti-OPG antibody (R&D
Systems, Minneapolis, MN). All conditioned media were then supplemented with 33ng/ml MCSF and 66ng/mL RANKL and used treat differentiated OCs for 2d. Positive controls
supplemented with each treatment were also used.
Statistical Analysis
Data from surface characterization experiments and in vitro assays are presented as the
mean ± standard error (SE) per variable (n=6). A one–way analysis of variance was performed
with a two-tailed Tukey correction and α = 0.05. All statistical analyses were performed using
JMP statistical software.

Results
Initial studies established the OC phenotype and treatment period (Fig.15). Activity of OCs
is shown as differentiated OCs (OCPs receiving M-CSF and RANKL) per undifferentiated OCs
(OCPs receiving M-CSF) within the same time point. A significant increase in OC activity was
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observed at each time point (Fig.15A). Gene expression data are shown by indicating the source
of the media (OCGM) and the presence (+) or absence (-) of RANKL. No difference in OCP CA2
mRNA was detected at 3d, 7d, and 9d (Fig.15B). At 14d, CA2 mRNA increased to levels
comparable to 3d OC cultures. CA2 mRNA further increased in OCs 7d post-culture then
decreased at 14d. Similar CTSK expression was observed among OCPs and 3d OC cultures

Figure 15. Establishment of OC phenotype and treatment period. OCPs were differentiated with M-CSF (negative
control) or M-CSF and RANKL (positive control) on an OsteoLyse Kit. After 3d, 7d, 9d, and 14d OC activity was
measured by absorbance following the addition of 10μl of media to 200μl of a fluorophore releasing agent.
Afterwards, mRNA was isolated from OCs and CA2, CTSK, CSTB, ITGAV, ITGB3, and OCSTAMP were
measured. Data shown are the mean ± standard error (SE) of six independent samples. Groups not sharing a
letter are statistically significant at an α=0.05.
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(Fig.15C). CTSK expression in 7d OCs was highest and subsequently decreased at 9d and 14d.
OCP expression of CSTB (Fig.15D), ITGAV (Fig.15E), ITGB3 (Fig.15F), and OCSTAMP
(Fig.15G) was lower compared to OCs. CSTB and ITGAV expression increased to similar levels
on 7d, 9d, and 14d OCP cultures compared to 3d. No differences were detected in OCP ITGB3
and OCSTAMP expression. For OCs, similar levels of CSTB, ITGAV, and ITGB3 mRNA were
detected at 3d and 14d cultures; however, CSTB was highest in 9d OC cultures while ITGAV
and ITGB3 were highest in 7d OC cultures. Peak OCSTAMP expression was observed in 3d
OC cultures. OCSTAMP expression declined at 7d and further decreased to similar levels at 9d
and 14d.

Figure 16. Qualitative assessment of OCs. TRAP staining (Left) and SEM imaging (Right) of OCs at each harvest
point. OCPs cultured with M-CSF and without RANKL serve as negative controls while OCPs cultured with MCSF and RANKL serve as positive controls.
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Qualitative assessment of the OC phenotype at each time point is shown in Figure 16. As
early as three days, RANKL supplemented OCPs began to aggregate and fuse into
multinucleated OCs as indicated by TRAP stain. At 7d, increased TRAP stain multi-nucleation
as well as ruffled border formation in SEM images was seen. This phenotype continued to
develop through 9d. The 9d RANKL negative cultures had larger cells attributed to the actions
of M-CSF; however, they lacked the magnitude of surface area, TRAP stain intensity, and multinucleation compared to OCs. Interestingly, TRAP stain intensity and multi-nucleated cell density
decreased in the 14d RANKL positive cells while both increased in the 14d RANKL negative
cells suggesting that the phenotypic integrity of OCPs and OCs was lost by 14d. Although the
collagen coating is slightly altered by trypsin, differentiated OCs degrade much of the collagen
coating by 9d of culture and only a few fragments of protein are left by 14d.
Figure 17 shows the indirect effects microstructured Ti substrates have on OC activity via
MSCs (Fig.17A, B) and NHOsts (Fig.17C, D) after treatment for 2d. The sources of the
treatment media (OCGM or MSCs/NHOsts cultured on TCPS or PT, SLA, or mSLA disks) are
shown below each group. Furthermore, indications of whether treatment media were
supplemented with (+) or without (-) RANKL are shown below each group. For each cell type,
the OC activity was highest in the positive control and lowest in the negative control. Compared
to the positive control, OC activity was reduced following treatment with media collected from
cultures of MSCs (Fig.17A) and NHOsts (Fig.17C) grown on TCPS and microstructured Ti.
Similar effects were seen when media collected from MSCs and NHOsts were supplemented
with RANKL and M-CSF (Fig.17B, D respectively). OC activity was reduced to comparable
levels in groups treated with media collected from MSCs and NHOsts cultured on TCPS and PT
with or without RANKL and M-CSF supplementation. A further reduction in OC activity was
observed after treatment with media from SLA cultured MSCs followed by mSLA cultured MSCs.
Supplementing MSC treatment media with RANKL and M-CSF abrogated this effect. OCs
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Figure 17. The indirect effects of Ti surface cultured osteoblast lineage cell conditioned media on osteoclast
activity. OCPs were differentiated on an OsteoLyse Kit with M-CSF and RANKL. MSCs and NHOsts were
separately cultured on TCPS, PT, SLA, or mSLA. After 7d, MSC and NHOst media were collected, supplemented
with or without M-CSF and RANKL, and used to treat OCs, leaving a negative (OCPs + M-CSF) and positive
(OCPs + M-CSF + RANKL) control. After treatment for 2d, 10μl of media was placed into 200μl of a fluorophore
releasing agent and absorbance measured. Data shown are the mean ± standard error (SE) of six independent
samples. Groups not sharing a letter are statistically significant at an α=0.05.

treated with media collected from SLA and mSLA cultured NHOsts were not sensitive to the
effects of RANKL and M-CSF supplementation observed with MSC treatment.
Data regarding gene expression following treatment with MSC and NHOst conditioned media
(CM) supplemented with M-CSF and RANKL are shown in Figure 18. For all genes, expression
was higher in the positive control compared to the negative control. MSC-CM treatment reduced
OC CA2 (Fig.18A) and CSTB (Fig.18B) expression compared to the positive control. CA2
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expression further decreased when OCs were treated with SLA and mSLA MSC-CM. CSTB
expression decreased after MSC-CM treatment and continued to decrease in a surface
dependent manner with no differences detected between SLA and mSLA MSC-CM. OCSTAMP
(Fig.18C) was reduced to similar levels for all MSC-CM treatments. CTSK (Fig.18D) mRNA
levels decreased when treated with mSLA MSC-CM. Although not different from the positive
control, OC CTSK expression decreased when treated with SLA MSC-CM compared to TCPS
and PT MSC-CM. No differences in OC ITGAV (Fig.18E) expression were detected between
the positive control and OCs treated with SLA and mSLA MSC-CM; however, OCs treated with
TCPS and PT MSC-CM had significantly higher ITGAV expression compared to the positive
control and mSLA MSC-CM. OC ITGB3 expression (Fig.18F) increased compared to the
positive control following treatment.
Treatment with NHOst-CM reduced CA2 (Fig.18G) expression to similar levels. OC CSTB
(Fig.18H) mRNA levels decreased when treated with TCPS and PT NHOst-CM and further
decreased when treated with SLA and mSLA NHOst-CM. OCSTAMP (Fig.18I) mRNA levels
were reduced in OCs to similar levels; however, OCs treated with TCPS NHOst-CM had
significantly higher OCSTAMP mRNA levels compared to those treated with mSLA NHOst-CM.
CTSK (Fig.18J) expression was reduced in OCs treated with TCPS, PT, and SLA NHOst-CM
and further reduced in OCs treated with mSLA NHOst-CM. No differences in ITGAV (Fig.18K)
expression were detected in OCs treated with NHOst-CM compared to the positive control.
However, mSLA NHOst-CM reduced ITGAV expression compared to other treatments. ITGB3
(Fig.18L) mRNA levels were highest in OCs treated with TCPS and PT NHOst-CM. ITGB3
mRNA remained unchanged compared to the positive control in OCs treated with SLA and mSLA
NHOst-CM.
For experiments to determine the mechanisms responsible for the indirect regulation of OCs,
a simplified model was used that included only MSCs cultured on either TCPS or mSLA. Figure
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Figure 18. The indirect effects of Ti surface cultured osteoblast lineage cell conditioned media on osteoclast gene
expression. OCPs were differentiated on an OsteoLyse Kit with M-CSF and RANKL. MSCs and NHOsts were
cultured on TCPS, PT, SLA, or mSLA. After 7d, MSC and NHOst media were collected, supplemented with MCSF and RANKL, and used to treat OCs, leaving a negative (OCPs + M-CSF) and positive (OCPs + M-CSF +
RANKL) control. After treatment for 2d, OCs were harvested and mRNA levels of CA2, CSTB, OCSTAMP, CTSK,
ITGAV, and ITGB3 quantified. Data shown are the mean ± standard error (SE) of six independent samples.
Groups not sharing a letter are statistically significant at α=0.05.

19A demonstrates that the observed inhibitory effect is dependent on the presence of cells
conditioning the media prior to treatment, although there is an equal inhibitory effect on OCs due
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to treatment with acellular MSCGM. ITGA2 silenced MSCs (Fig.19B) and ITGB1 silenced MSCS
(Fig.19C) decreased OC activity compared to the positive control. shITGA2 MSCs cultured on
TCPS decreased OC activity compared to WT. The decrease in OC activity by mSLA MSC-CM
was attenuated by silencing ITGA2. Similar results were observed for shITGB1 MSCs; however,
no difference in OC activity was detected between TCPS WT MSC-CM and TCPS shITB1 MSCCM. In order to determine whether the inhibitory effect was due to proteins, two methods of
protein denaturation were employed. Treatments subjected to proteinase K digestion (Fig.19D)
decreased OC activity to levels comparable to the negative control regardless of the initial
surface. Interestingly, heat denaturation of proteins (Fig.19E) increased OC activity compared
to the intact protein treatments, although the activity was significantly lower than the positive
control.
The addition of an antibody against TGFβ type 2 receptor (Fig.20A) or soluble TGFβ type 2
receptor (Fig.20B) decreased OC activity when added to TCPS MSC-CM to levels like mSLA
MSC-CM. OC activity was unchanged when these factors were added to mSLA MSC-CM.
Furthermore, no effects on OC activity were detected when an antibody against osteoprotegerin
was added to either TCPS or mSLA MSC-CM, although the activity was significantly lower in
mSLA MSC-CM compared to TCPS MSC-CM (Fig.20C). In all instances, addition of either
antibody or soluble protein had no effect on the positive control.

Discussion
Implant design that promotes both early bone formation while maintaining healthy cellular
signaling throughout the remaining stages of osseointegration will achieve long-term implant
stability. It is now understood that surface properties modulate immune cell function and factors
produced by macrophages influence osteogenesis.209,210 Others have shown that osteocytes
make direct contact with the implant surface, suggesting their importance in maintaining healthy
bone remodeling as well as the longevity of implant osseointegration. 211,212 However, no studies
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Figure 19. The indirect effects of conditioned media are mediated through integrin signaling and dependent on
cells and proteins. (A) MSCs were cultured on TCPS or mSLA and compared to their acellular counterparts.
TCPS and mSLA containing no cells were incubated with MSCGM and received media changes identical to
MSC cultured TCPS or mSLA. MSCs silenced for either ITGA2 (B) or ITGB1 (C) were cultured on TCPS or
mSLA and compared to their WT controls. Conditioned media were subjected to protein denaturation via
proteinase K (D) or heat (E) and compared to non-denatured controls. After 7d, conditioned media were
collected, supplemented with M-CSF and RANKL, and used to treat OCs, leaving a negative (OCPs + M-CSF)
and positive (OCPs + M-CSF + RANKL) control. After treatment for 2d, 10μl of media was placed into 200μl of
a fluorophore releasing agent and absorbance measured. Data shown are the mean ± standard error (SE) of
six independent samples. Groups not sharing a letter are statistically significant at α=0.05.
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Figure 20. The influence of TGF-β1 and Osteoprotegerin on the indirect effects of
conditioned media. MSCs were cultured on TCPS or mSLA for 7d. Conditioned media
was collected and supplemented with M-CSF and RANKL as well as either (A) anti-TGFβ type 2 receptor antibody, (B) soluble TGF-β type 2 receptor, or (C) anti-osteoprotegerin
antibody. Conditioned media was then used to treat OCs, leaving a negative (OCPs + MCSF) and positive (OCPs + M-CSF + RANKL) control. After treatment for 2d, 10μl of
media was placed into 200μl of a fluorophore releasing agent and absorbance measured.
Data shown are the mean ± standard error (SE) of six independent samples. Groups not
sharing a letter are statistically significant at α=0.05.

osseointegration. A novel in vitro model of bone remodeling was developed and used to assess
the influence commercially available Ti implant surfaces have on osteoclastogenesis and OC
activity. CM collected from MSCs and NHOsts cultured on smooth, microrough, and/or
hydrophilic Ti surfaces decreased OC activity with NHOst cultures having a more robust effect.
Gene expression was selectively regulated rather than completely shut down suggesting that
the OCs have the capacity to return once the regulatory stimulus favors bone resorption.
The OsteoLyse™ assay kit is a cell culture plate coated with europium-conjugated human
type I collagen used in experiments of OC differentiation and activity. 213–215 OC resorptive activity
is directly proportional to the release of Eu-labeled collagen fragments. Although type I collagen
is the most abundant protein in bone, the assay lacks the complexity of native bone, including
the presence of bone mineral. Furthermore, ITGAV and ITGB3 complex binding can occur on
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multiple bone matrix proteins not present in the assay substrate. Shifting to bone or dentine may
alter the expression patterns observed in the present study and may be necessary to confirm
our results. Lastly, the assay does not allow cell culture beyond 14d as indicated by the
phenotypic changes in both the OCPs and OCs. This could be due to the complete resorption
of the collagen coating leading to cell death or foreign body giant cell (FBGC) fusion. Because
OCs and OCPs are from the hematopoietic lineage, 216 they are sensitive to many chemokines
including interleukin 4 (IL-4). IL-4 is the driving factor for FBGC fusion and is produced by OCs
and OCPs.217,218 As a result, the chosen period of our model permits only 9d of total OC culture.
Despite these limitations, our model proved to be a practical in vitro tool for studying bone
remodeling. Our results confirm countless observations that MSCs and NHOsts release factors
capable of limiting the degree and extent to which OCs resorb bone. However, for the first time
we have shown that the attenuating effect is enhanced when cultured on microstructured and/or
hydrophilic Ti surfaces. CM were supplemented with RANKL and M-CSF to ensure that their
abrupt removal was not the cause of the decreased OC activity. The observed effect went largely
unchanged, although differences were detected between SLA and mSLA MSC-CM without
supplementation. Despite this observation, our results suggest that surface microroughness may
play a larger role in mitigating OCs than hydrophilicity. Furthermore, these observed effects are
not due to the influence Ti surfaces have on cell attachment, proliferation, or death. Previously
we have shown that cell proliferation is reduced on Ti surfaces compared to TCPS, but
osteogenic differentiation is increased. 61,71,93 Although, SLA and mSLA have the fewest number
of cells attached, CM from these surface cultures resulted in the greatest decrease in OC activity.
Differential gene expression in osteoclasts following treatment with CM suggests that
pathways in OCs are selectively targeted. The fusion marker, OCSTAMP, was markedly reduced
in OCs following treatment with CM from both cell types suggesting that a portion of the
regulatory influence acts to prevent OC fusion. In order to initiate resorption, mature OCs attach
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to the mineralized bone matrix, forming a sealing zone. Their initial attachment and subsequent
activation are mediated by integrins, specifically, the osteopontin/vitronectin receptor, αVβ3.219–
221

Attachment of αVβ3 induces signaling mechanisms that control cytoskeletal reorganization,

which is important for the spreading, motility, and sealing zone organization. 222–224 Interestingly,
expression of either subunit did not decrease, suggesting that this signaling complex maintains
its activity after treatment with MSC or NHOst CM. Following formation of the sealing zone by
αVβ3 signaling, the resorption lacuna beneath the OC forms where its membrane is folded
forming the ruffled border. The OC can release hydrogen ions through the ruffled border via
activity of carbonic anhydrase II (CA2), thereby reducing the pH and dissolving the mineralized
portion of the ECM. In humans, CA2 deficiency causes non-functional osteoclasts and
osteopetrosis.225 Its expression is induced through RANKL dependent pathways so its reduction
would reduce the ability of the osteoclast to maintain optimal pH gradients, thus decreasing
activity.226
In addition to regulating pH in the resorption lacunae, osteoclasts secrete enzymes like
lysosomal cysteine proteinases and matrix metalloproteinases are then secreted to degrade the
organic matrix.26,27 Cathepsin K (CTSK) is one of the main cysteine proteinases secreted into
the resorption lacuna.26,227 CTSK has been shown to degrade insoluble type I collagen, and
inhibition of its enzymatic activity in vitro and in vivo models prevents matrix degradation. 228,229
Osteoclasts are also rich in cystatin B (CSTB), a natural inhibitor of cysteine proteinases. A
balance between CTSK and CSTB is important for regulating cell survival as addition of CSTB
to osteoclasts protects them from experimentally induced apoptosis. 230 The decreased CTSK
and CSTB accompanying CM treatment suggests that organic matrix degradation is subsiding,
and OCs may be attempting to regulate their survival. Interestingly, NHOsts had a more robust
effect on CTSK expression compared to MSCs. In general, NHOsts produce higher quantities
of regulatory factors compared to MSCs, suggesting that regulation may be dependent on the
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cell type.
The potential regulatory difference between cell types was the impetus for choosing MSCs
to study mechanisms mediating OCs. In addition, we focused on the modulating effects of mSLA.
Microroughness was the more important surface feature in terms of reducing OC activity, but
our

previous

studies

indicated

that

mSLA

is

superior

at

facilitating

MSC

differentiation.53,70,71,93,158 MSCs are attachment dependent and interact with their underlying
substrate via integrins such as α2β1. Silencing of both the ITGA2 and ITGB1 subunits in MSCs
attenuated the inhibitory effect on OCs. Interestingly, TCPS shITGA2 MSC-CM decreased OC
activity suggesting a unique signaling through the α2 integrin subunit.
Proteins produced by MSCs cultured on Ti surfaces are crucial to the observed phenomena
in the present study. Although there is an inhibitory effect on OCs due to factors present in the
basal growth media, MSC-CM decreased OC activity, which further declined with mSLA MSCCM treatment. Heat denaturation of the CM mitigated the inhibition of OC activity. Interestingly,
proteinase K digestion inhibited OC activity more. Proteinase K cleaves peptide bonds adjacent
to the carboxylic group of aliphatic and aromatic amino acids. 231 If proteins have complicated
secondary, tertiary, and/or quaternary structures, proteinase K may be unable to access certain
amino acids preventing their complete degradation. This could lead to selective degradation and
exacerbate the effect if antagonistic proteins are denatured over agonistic proteins. Moreover,
susceptible proteins could be digested in a way that leaves the residual fragments active.
Alternatively, addition of proteinase K and its neutralizer may have diluted the CM preventing
OCs from receiving sufficient nutrients to stay healthy.
There is a myriad of signals capable of regulating OCs. One mechanism by which MSCs
control OCs is mediated by TGFβ1-dependent regulation of OPG production. 80 TGFβ1 enhances
the proliferation of MSCs and osteoblasts and stimulates ECM protein production like type I
collagen. Latent TGFβ1 and latent TGFβ binding protein are synthesized and stored in the ECM.
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Most of the TGFβ1 produced by OBs cultured on Ti is in latent form, and the amount incorporated
into the matrix is increased on rougher surfaces. 82 Once the bone remodeling phase of
osseointegration begins, OCs degrade the newly synthesized matrix releasing the stored, latent
TGFβ1 and convert it into active TGFβ1. Once activated, TGFβ1 regulates OCs, in part, by
regulating production of OPG. OPG serves as a decoy receptor for RANKL, which prevents
RANKL-RANK binding on the OCP surface inhibiting OC differentiation.83 A feedback
mechanism is in place that allows osteoblasts to produce soluble RANKL in order to deplete
excess OPG if the regulatory stimulus favors new osteoclast formation. Microrough Ti substrates
facilitate increased production of OPG by osteoblasts; however, levels of RANKL do not change.
Thus, the net effect is bone formation without bone resorption. Soluble TGFβ type 2 receptor
and anti-TGFβ type 2 receptor antibody will compete with endogenous TGFβ. Addition of these
factors to TCPS MSC-CM but not mSLA MSC-CM decreased OC activity, suggesting that TGFβ
signaling is an important regulatory protein produced by MSCs cultured on TCPS. However,
TGFβ was not a contributing factor to the regulation of OCs by surfaces. This could be due to
the overwhelming presence of other factors. Furthermore, the addition of anti-OPG antibody to
both the TCPS and mSLA MSC-CM did not mitigate the decreased OC activity confirming the
importance of OPG as a regulator of OC fusion rather than a regulator of OC activity.

Conclusions
We have shown that microstructured Ti surfaces indirectly regulate OC activity and gene
expression. After surface recognition by integrins, MSC and NHOst protein production is
modulated and responsible for the decreased activity of existing OCs and reduced fusion of new
OCs. In addition, OC gene expression is selectively regulate suggesting more than one pathway
of control may be involved. Of the proteins responsible, TGFβ and OPG do not contribute to the
surface dependent regulation in vitro.
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Chapter 6. Bisphosphonates Inhibit Surface Mediated
Osteogenesis
Abstract
Bisphosphonates target osteoclasts, slowing bone resorption and providing rationale to
support osseointegration. However, bisphosphonates may negatively affect osteoblasts,
impairing peri-implant bone formation. The goal of this study was to assess the effects
bisphosphonates have on surface mediated osteogenesis of osteoblasts. MG63 cells were
cultured on 15mm grade 2 titanium disks: smooth PT, hydrophobic-microrough SLA, or
hydrophilic-microrough mSLA (Institut Straumann AG, Basel, Switzerland). Tissue culture
polystyrene (TCPS) was used as a control. At confluence, cells were treated with 0M, 10 -8M, 107

M, and 10-6M of alendronate, zoledronate, or ibandronate for 24h. Sprague Dawley rats were

also treated with 1μg/kg/day ibandronate or phosphate buffered saline control for 5wk. Calvarial
osteoblasts (rOBs) were isolated, characterized, and cultured on surfaces. Osteogenic markers
in the media were quantified using ELISAs. Bisphosphonate treatment reduced osteocalcin,
osteoprotegerin, osteopontin, BMP2, PGE2, TGFβ1, IL10, and VEGF in MG63 cells. The effect
was more robust on rough surfaces, and higher concentrations of bisphosphonates stunted
production to TCPS/PT levels. Ibandronate conditioned rOBs produced less osteogenic markers
similar to direct bisphosphonate treatment. These results suggest bisphosphonate exposure
jeopardizes the pro-osteogenic response osteoblasts have to microstructured surfaces. Their
effects persist in vivo and negatively condition osteoblast response in vitro. Clinically,
bisphosphonates could compromise osseointegration.

Introduction
Bisphosphonates (BPs) are synthetic compounds characterized by two C–P bonds sharing
a carbon atom (P–C–P), making them chemically stable analogues of pyrophosphates (P–O–
P). Substitution of oxygen with carbon makes BPs completely resistant to enzymatic hydrolysis
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while maintaining their affinity for bone mineral.232 Differences in side chain moieties at the R 1
and R2 positions of the P–C–P bond explain the wide variance in the physiochemical properties
and physiological effects among BPs. 232 Substitutions of a hydroxyl and a nitrogen containing
group have proven to greatly increase affinity and adherence to the hydroxyapatite surface as
well as their anti-resorptive potency. As a result, the molecular mechanisms of action and tissue
distribution of these aminobisphosphonates are restricted to the skeleton making them widely
used to treat diseases of calcium metabolism.233 These anti-resorptive effects have also led to
their use to positively influence osseointegration of titanium (Ti) dental and orthopaedic implants.
The primary mechanism by which BPs prevent bone loss is through actions on bone
resorbing osteoclasts. BPs preferentially bind to exposed bone mineral at surfaces undergoing
resorption where they are then internalized by osteoclasts, disrupting their resorptive ability. 234
While these actions on osteoclasts are well known, their effects on other bone cells like
osteocytes, osteoblasts, and mesenchymal stem cells (MSCs) are less understood. Low
concentrations of BPs were shown to prevent apoptosis of osteocytes and osteoblasts.235 This
effect is mediated by hexameric connexion-43 hemichannels, calcium influx, and activation of
the extracellular signal-regulated kinases, suggesting that intracellular uptake is not required. 236
BPs were also shown to stimulate the proliferation of osteoblasts and their progenitors as well
as enhance alkaline phosphatase activity, mineral formation, and expression of bone
morphogenetic protein (BMP)-2, collagenase-3, osteocalcin, and osteoclast inhibitory factors. 237
Other studies, however, have reported adverse effects of BP treatment. Calcium
deposition,238 collagen production,239 mineralized bone nodule formation,240 and response to
parathyroid hormone (PTH)241 are impaired by BPs. Furthermore, BPs can impede
angiogenesis,242 cause microfracture accumulation,243 and are associated with osteonecrosis of
the jaw (ONJ),244 all of which can be detrimental to the formation of healthy bone tissue
especially during implant osseointegration. Much controversy as to the efficacy of BP therapy
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on implant osseointegration stems from these contrasting observations.
Despite these discrepancies, current research does reveal that BPs modulate osteoblast
biosynthesis; however, the current knowledge has been limited to osteoblasts cultured on tissue
culture polystyrene (TCPS). Osteoblast differentiation and maturation are very different when
cultured on implant surfaces compared to TCPS.70,71 Surface microtopography and hydrophilicity
enhance the production of osteoblast markers in MG63 osteoblast-like cells,245 primary human
osteoblasts and MSCs,22 and fetal rat calvarial cells,246 without supplements typically used to
induce osteoblast differentiation. The increased osteogenic potential of these implant surfaces
in vitro correlates with a more rapid and sufficient osseointegration in preclinical and clinical
studies. It is unknown whether BPs affect the surface mediated osteogenesis of osteoblasts, but
other osteotropic agents such as 1α,25-dihydroxy vitamin D3 (1α,25(OH)2D3)247 and 17βestradiol75 are known to modulate the cellular response and work synergistically with implant
surface characteristics.
As the population of patients receiving BPs continues to grow, it is imperative to determine
these effects as they could directly influence the ability of implants to osseointegrate and
maintain their longevity clinically. Unravelling these molecular mechanisms may help expand the
utility of BPs, ensure their overall safety, and limit their contraindications. The goal of this study
was to test the hypothesis that clinically used, nitrogen-containing bisphosphonates
(alendronate, zoledronate, and ibandronate) modulate the pro-osteogenic response osteoblasts
have to implant surface roughness and hydrophilicity.

Materials and Methods
MG63 Cell Culture
Human MG63 cells (ATCC, Manassas, VA) were separately cultured on tissue culture
polystyrene (TCPS) or 15mm diameter, 1mm thick, grade 2 Ti disks modified as described
previously

to

be

smooth/hydrophobic

(PT),

microrough/hydrophobic

(SLA),

or
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microrough/hydrophilic (mSLA). Disks were provided as a gift from Institut Straumann AG
(Basel, Switzerland). Cells were seeded at a density of 10,000 cells/cm2 and incubated at 37°C
in an atmosphere of 5% CO2 and 100% humidity using Dulbecco’s modified Eagle medium
(DMEM; Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (FBS; Life
Technologies, Carlsbad, CA) + 1% penicillin-streptomycin (Life Technologies). Media were
changed 24h after plating and every 48h thereafter until cells reached confluence on TCPS.
Biological Response
Confluent cultures were incubated with fresh media supplemented with either 0M, 10-8M, 10M, or 10-6M alendronate (C4H12NNaO7P2•3H2O; Merck Sharp & Dohme, Kenilworth, NJ),

7

zoledronate

(C5H10N2O7P2•H2O;

Novartis

AG,

Basel,

Switzerland)

or

ibandronate

(C9H22NNaO7P2•H2O; AuroMedics, East Windsor, NJ) for 24h. Radioimmunoassay kits were
used to measure intact osteocalcin (Biomedical Technologies, Stoughton, MA) and
prostaglandin E2 (PGE2; Perkin Elmer, Wellesley, MA) levels in alendronate and zoledronate
treated cultures. Active transforming growth factor β1 (TGFβ1) was measured prior to
acidification of the conditioned media, using an ELISA kit specific for human TGFβ1 (Promega
Corp., Madison, WI). Total TGFβ1 was measured after acidifying the media and latent TGFβ1
was defined as total TGFβ1 minus active TGFβ1. For ibandronate treated MG63 cultures,
ELISAs were used to measure levels of intact osteocalcin (Alfa Aesar, Haverhill, MA),
human/mouse/rat BMP2 (PeproTech, Rocky Hill, NJ), osteopontin (R&D Systems, Minneapolis,
MN), interleukin 6 (IL6; R&D Systems), and interleukin 10 (IL10; R&D Systems) following
manufacturer’s instructions. ELISAs for osteoprotegerin (R&D Systems) and vascular
endothelial growth factor VEGF-A (VEGF-A; R&D Systems) were used for all MG63 cultures.
Experiments treating MG63 cells with either alendronate or zoledronate were normalized to cell
number, while ibandronate treated cultures were normalized to DNA content.
Cell number or DNA content was determined in all cultures 24h after BP treatment. For cell
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number, cells were released from the surfaces by two sequential incubations in 0.25% trypsin
for 10min at 37°C. Released cells were counted using an automatic Z1 Coulter Cell Particle
Counter (Beckman Coulter, Fullerton, CA). Cell lysates were then collected by centrifuging the
cells after counting. For DNA content, cell monolayers were washed twice with 0.2ml phosphatebuffered saline (PBS), lysed in 0.05% Triton X-100, and homogenized by sonication at 40A using
a Vibra-Cell ultrasonicator (Sonics & Materials Inc., Newtown, CT). DNA content in the cell lysate
was measured with PicoGreen (Promega, Madison, WI) using a Synergy H1 Hybrid Reader
fluorescence detector (BioTek, Winooski, VT) at an excitation of 485nm and emission of 538nm.
Alkaline phosphatase specific activity [orthophosphoric monoester phosphohydrolase, alkaline;
E.C. 3.1.3.1] was assayed in cell lysates by measuring the conversion of p-nitrophenylphosphate
to p-nitrophenol at pH 10.25 and a temperature of 37°C. Absorbance was measured at 405nm.
Activity was normalized to total protein content in the cell lysates as determined by a
bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA).
Rat Calvarial Osteoblast Isolation and Biological Response
All subsequent experiments were carried out under an Institutional Animal Care and Use
Committee approved protocol at Virginia Commonwealth University (protocol AD10000675) and
reported according to ARRIVE guidelines. All animals were treated humanely per the guidelines
outlined in the Guide for the Care and Use of Laboratory Animals by the National Institutes of
Health. CD Sprague Dawley rats were single-housed in an individually ventilated, solid-bottomed
polysulfone cage and kept at a temperature of 17-28ºC with a humidity of 40-70% and a 12/12
h light/dark cycle. All rats were given ad libitum access to standard pellet and water and received
fresh food daily.
Six, 9mo old, virgin, female CD Sprague Dawley rats (Charles River Laboratories,
Wilmington, MA) were injected subcutaneously with 25μg/kg ibandronate (n=3) or PBS (n=3) on
day 0 and on day 25. Rats were euthanized 5wk after the first injection (day 35), so each animal
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received a total of two injections of ibandronate or PBS. After euthanasia via CO2 inhalation, the
heads were cleaned with 70% ethanol and betadine solution and the frontal and parietal bones
excised. Connective tissue was then removed, and the remaining bone was minced into pieces
approximately 1mm x 1mm. Explants from each animal in the same group were pooled together
into a 100mm x 20mm Petri dish with DMEM + 10% FBS + 1% penicillin-streptomycin. Petri
dishes were incubated at 37°C in an atmosphere of 5% CO2 and 100% humidity until cells
reached confluence. Cells were passaged and explants were placed into a new Petri dish. This
process was repeated until migration of osteoblasts from the explants stopped.
The osteoblastic phenotype of primary rat osteoblasts (rOBs) was confirmed by treating
confluent cultures of rOBs with either 0M or 10-8M 1α,25(OH)2D3 (Enzo Biochem, Farmingdale,
NY) for 24h. Conditioned media were measured for intact rat osteocalcin (Alfa Aesar) and
alkaline phosphatase specific activity was quantified in cell lysates. Verified rOBs (passage<4)
were cultured on modified Ti substrates as described for the MG63 cells (Section 2.2). At
confluence, cells were incubated with fresh DMEM for 24h. Responses were assessed using
ELISAs measuring osteocalcin, rat/mouse osteopontin (R&D Systems), mouse osteoprotegerin
(R&D Systems), human/mouse/rat BMP2 (PeproTech), mouse receptor activator of nuclear
kappa-B ligand (RANKL; R&D Systems), and rat VEGF-A (R&D Systems). Alkaline phosphatase
specific activity was measured in cell lysates and normalized to total protein content.
Immunoassays were normalized to DNA content.
Statistical Analysis
Data are presented as the mean ± standard error (SE) of n=6 cultures per variable. All
experiments were repeated at least three times to ensure validity of the results. Data shown in
the figures are from representative experiments. A t-test was used was used to determine
significant differences for experiments assessing the osteoblastic phenotype of rOBs. A two-way
analysis of variance (ANOVA) was used to model the mean production of biological variables by
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MG63 cells or rOBs cultured on four different surfaces (TCPS, PT, SLA, mSLA) and treated with
four different BP concentrations (0M, 10-8M, 10-7M, 10-6M). The model included main effects for
surface and BP concentration, as well as a surface by BP concentration interaction. If a
significant interaction was identified between variables, mean differences between the levels of
surface were compared at specific levels of BP concentration (and vice versa). If no significant
interaction was present, mean differences were compared separately within each variable. A
two-tailed Tukey correction was used to adjust for multiple comparisons to maintain an
experiment-wise error rate (α) of 0.05. All statistical analyses were performed using JMP
statistical software (SAS Institute Inc., Cary, North Carolina).

Results
MG63 Cell Response
Alendronate
Control (0M) MG63 cultures had reduced cell numbers (Fig.21A) on Ti surfaces compared
to TCPS and further reduced on SLA and mSLA compared to PT. When treated with
alendronate, cell number remained similar on PT and TCPS but was reduced on SLA except
when treated with 10-6M alendronate. mSLA cultures had reduced cell numbers similar to SLA.
Within each surface cell number increased when treated with 10 -6M alendronate compared to
10-8M. 10-6M treated PT and SLA cultures saw increased cell numbers compared to other
concentrations. Alkaline phosphatase specific activity (Fig.21B) was reduced on all surfaces.
Treatment with 10-6M alendronate increased activity compared to no treatment for TCPS, PT,
and SLA cultures. Osteocalcin levels (Fig.21C) significantly increased on mSLA compared to
PT and TCPS. Treatment with 10-6M alendronate decreased osteocalcin levels within surface
cultures compared to non-treated controls for mSLA. On other surfaces, the decrease was
significant to the 10-8M treatment. Osteoprotegerin (Fig.21D) and latent TGFβ1 (Fig.21E) levels
increased on SLA and mSLA cultures compared to TCPS and PT cultures. 10 -6M alendronate
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treatment

decreased

osteoprotegerin

MG63

production

on

all

surfaces and decreased latent TGFβ1
levels in SLA and mSLA cultures.
PGE2 (Fig.21F) levels were increased
on SLA and mSLA compared to TCPS
and PT across all concentrations.
TCPS,

SLA,

and

mSLA

cultures

treated with 10-6M alendronate had
significant

reductions

in

VEGF

(Fig.21G) production compared to
untreated controls.
Zoledronate
Cell number (Fig.22A) significantly
decreased on SLA compared to PT
and TCPS and further decreased on
mSLA for untreated MG63 cultures.
Treatment

with

10-7M

zoledronate

resulted in increased cell numbers
compared to non-treated controls on
each surface. These numbers were

Figure 21. Effects of alendronate treatment on MG63 cells cultured
on microstructured and hydrophilic Ti substrates. MG63 cells were
cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells
were treated with 0M (control), 10-8M, 10-7M, or 10-6M alendronate
for 24h. After 24h, cells were counted (A) and alkaline phosphatase (B)
specific activity was quantified in lysates. Media were assayed for
osteocalcin (C), osteoprotegerin (D), latent TGFβ1 (E), PGE2 (F), and
VEGF (G). Data shown are the mean ± standard error (SE) of six
independent samples. Letters denote significance among alendronate
treatments within the same substrate culture. Groups not sharing a
letter are statistically significant at α=0.05. Symbols denote significance
among surface cultures within the same alendronate treatment. *p <
0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA.

similar to 10-6M treatment for SLA and mSLA cultures. Few differences were detected with
alkaline phosphatase specific activity (Fig.22B); however, none of these differences were due
to treatment with zoledronate. Surface topography significantly increased osteocalcin levels
(Fig.22C) while treatment with zoledronate decreased its production to similar levels across all
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surfaces. Osteoprotegerin (Fig.22D)
production was similar to osteocalcin,
although

mSLA

production

after

treatment remained higher compared
to

PT

and

TCPS.

Furthermore,

treatment decreased production on all
surfaces compared to non-treated
controls.

Increased

latent

TGFβ1

(Fig.22E) levels were detected in
mSLA cultures. Treatment with high
concentrations

of

zoledronate

decreased latent TGFβ1 production
compared to non-treated controls or
lower concentrations. PGE2 (Fig.22F)
and VEGF (Fig.22G) increased in a
surface dependent manner. Treatment
with

10-7M

or

10-6M

zoledronate

reduced the production of PGE2 in SLA
and mSLA cultures and the production
of VEGF in PT and mSLA cultures.
VEGF was reduced in SLA cultures

Figure 22. Effects of zoledronate treatment on MG63 cells cultured
on microstructured and hydrophilic Ti substrates. MG63 cells were
cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells
were treated with 0M (control), 10-8M, 10-7M, or 10-6M zoledronate for
24h. After 24h, cells were counted (A) and alkaline phosphatase
specific activity (B) was quantified in lysates. Media were assayed for
osteocalcin (C), osteoprotegerin (D), latent TGFβ1 (E), PGE2 (F), and
VEGF (G). Data shown are the mean ± standard error (SE) of six
independent samples. Letters denote significance among zoledronate
treatments within the same substrate culture. Groups not sharing a
letter are statistically significant at α=0.05. Symbols denote significance
among surface cultures within the same zoledronate treatment. *p <
0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA.

when treated with 10-6M zoledronate.
Ibandronate
Compared to TCPS, DNA content (Fig.23A) was reduced on all surfaces. A further reduction
was observed on SLA and mSLA compared to PT. Treatment with ibandronate increased the
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DNA content within surface cultures.
Alkaline phosphatase specific activity
(Fig.23B) was reduced in response to
surface topography. Treatment with 107

M or 10-6M ibandronate reduced

activity further on Ti substrates while
10-6M ibandronate treatment reduced
the activity on TPCS. Production of
osteocalcin (Fig.23C), osteoprotegerin
(Fig.23D),
osteopontin

BMP2
(Fig.23F),

(Fig.23E),
and

VEGF

(Fig.23G) were significantly increased
on SLA compared to TCPS and PT and
mSLA compared to TCPS, PT, and
SLA. MG63s cultured on TCPS or Ti
substrates produced less osteocalcin,
BMP2, osteopontin, and VEGF when
treated

with

Osteoprotegerin

ibandronate.
production

was

reduced in SLA cultures when treated
with

ibandronate;

however,

mSLA

Figure 23. Effects of ibandronate treatment on MG63 cells cultured
on microstructured and hydrophilic Ti substrates. MG63 cells were
cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells
were treated with 0M (control), 10-8M, 10-7M, or 10-6M ibandronate
for 24h. After 24h, cell lysates were assayed for DNA content (A) and
alkaline phosphatase specific activity (B). Media were assayed for
osteocalcin (C), osteoprotegerin (D), BMP2 (E), osteopontin (F), and
VEGF (G). Data shown are the mean ± standard error (SE) of six
independent samples. Letters denote significance among ibandronate
treatments within the same substrate culture. Groups not sharing a
letter are statistically significant at α=0.05. Symbols denote significance
among surface cultures within the same ibandronate treatment. *p <
0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA.

cultures were not sensitive to the 10 -8M concentration. Ti substrates facilitated the decreased
production of IL6 (Fig.24A) and the increased production of IL10 (Fig.24B). Treatment with
ibandronate decreased production of IL6 in TCPS and PT cultures while stimulating production
in SLA and mSLA at 10-6M and 10-7M/10-6M concentrations respectively. Ibandronate treatment
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decreased production of IL10 in all cultures.

Figure 24. Effects of ibandronate treatment on MG63 cell inflammatory response cultured on microstructured and
hydrophilic Ti substrates. MG63 cells were cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells were
treated with 0M (control), 10-8M, 10-7M, or 10-6M ibandronate for 24h. After 24h, media were collected and assayed for IL6
(A) and IL10 (B). Data shown are the mean ± standard error (SE) of six independent samples. Letters denote significance
among ibandronate treatments within the same substrate culture. Groups not sharing a letter are statistically significant at
α=0.05. Symbols denote significance among surface cultures within the same treatment. *p < 0.05 vs. TCPS; #p < 0.05 vs.
PT; $p < 0.05 vs. SLA.

Rat Calvarial Osteoblast Response
Addition of 10-8M 1α,25(OH)2D3 to confluent cultures of rOBs increased osteocalcin and
alkaline phosphatase specific activity, confirming their successful isolation and expansion. DNA
content of rOBs (Fig.25A) was reduced on Ti surfaces compared to TCPS for both treatment
groups. When cultured on the same surface, ibandronate rOBs had decreased DNA content
compared to PBS rOBs. Similarly, decreased levels of alkaline phosphatase specific activity
(Fig.25B) were observed on Ti surfaces with the lowest levels occurring on SLA and mSLA for
both groups of osteoblasts. Ibandronate treatment decreased alkaline phosphatase specific
activity in rOBs cultured on TCPS and PT compared to PBS rOBs. Osteocalcin production
(Fig.25C) was increased in a surface dependent manner (mSLA>SLA>PT>TCPS) for all rOBs;
however, ibandronate rOBs had decreased productions when cultured on SLA and mSLA
compared to PBS rOBs. Osteoprotegerin levels (Fig.25D) decreased on Ti surfaces compared
to TCPS while ibandronate treatment was able to stimulate its production compared to PBS.
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Production

of

BMP2

osteopontin

(Fig.25E),

(Fig.25F),

VEGF

(Fig.25G), and RANKL (Fig.25H) was
increased in rOBs cultured on Ti
surfaces compared to TCPS. When
cultured

on

ibandronate

the

same

rOBs

had

surface,
decreased

production compared to PBS rOBs.

Discussion
Bisphosphonates are commonly
used to treat metabolic bone disorders
due to their high affinity for bone and
their antiresorptive effects via actions
on osteoclasts. Because BPs slow the
rate and severity of bone resorption, it
is reasonable to assume that they
could

significantly

osseointegration

of

orthopaedic

implants,

during

bone

the

impact

the

dental

and

particularly

modeling

and

remodeling phases. This suggests that
BPs could affect bone formation as well
as bone resorption. The results of the

Figure 25. Response of calvarial osteoblasts isolated from aged rats
treated with ibandronate to microstructured and hydrophilic Ti
substrates. Six 9-month-old, female, virgin, CD Sprague-Dawley rats
were treated with either 25μg/kg ibandronate (n=3) or PBS (n=3) on
day 0 and again on day 25. Rats were euthanized on day 35. Calvarial
osteoblasts were isolated and cultured separately on TCPS, PT, SLA,
or mSLA in DMEM. At confluence, cells were treated with fresh DMEM
for 24h. After 24h, media were collected, and cell lysates were assayed
for DNA content (A) and alkaline phosphatase specific activity (B).
Media were assayed for osteocalcin (C), osteoprotegerin (D), BMP2
(E), osteopontin (F), VEGF (G), and RANKL (H). All osteoblasts used
were of passage 3 or less. Data shown are the mean ± standard error
(SE) of six independent samples. Letters denote significance between
ibandronate and PBS (control) treatments within the same substrate
culture. Groups not sharing a letter are statistically significant at
α=0.05. Symbols denote significance among surface cultures within the
treatment. *p < 0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA.

present study confirm that osteoblasts respond to nitrogen-containing BPs and demonstrate that
implant surface properties modulate their response.
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The physicochemical and biological profile of clinically available BPs are dose-dependent
and vary with the chemistry of the compound making it difficult to extrapolate findings from one
BP to another with respect to its actions. Differences in pharmacokinetics, pharmacodynamics,
affinity to bone, cell permeability, and intracellular protein binding between mechanistically
similar BPs contribute significantly to their potency. For these reasons, the response of MG63
cells to three different nitrogen-containing BPs at three different concentrations was assessed
to determine whether the observed effects were similar. This study shows for the first time that
the surface mediated osteogenesis of MG63 cells and rOBs is impaired by BP treatment. These
results support previous observations in our lab 75,84,93,247,248 and others249,250 showing that the
response of cells to osteotropic agents is surface-dependent. The observed effects were dose
dependent and were more robust in SLA and mSLA cultures compared to PT and TCPS cultures,
indicating that BPs could affect cells differently depending on their specific state of differentiation
and/or maturation.
Typically, microrough and/or hydrophilic SLA and mSLA cultures of osteoblasts exhibit a
more differentiated and mature phenotype compared to smooth PT and TCPS cultures. 82 Late
stage modulators of differentiation and mineralization, osteocalcin, BMP2, and osteopontin, as
well as the angiogenic factor, VEGF, were increased on microstructured surfaces while the early
differentiation marker, alkaline phosphatase specific activity was decreased. Moreover,
osteoblasts on microstructured substrates produce factors that favor osteogenesis over
osteoclastic resorption by producing increased TGFβ1 and osteoprotegerin, which inhibit
osteoclast activation.80 The effects of alendronate, zoledronate, or ibandronate on confluent
cultures of MG63 cells are consistent with studies showing that BPs enhance the proliferation of
osteoblasts,251,252 as indicated by the increased cell number or DNA content. BP treatment was
also able to reduce production of VEGF suggesting impeded angiogenesis as described
previously.242 However, our results are inconsistent with studies describing their ability to
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increase production of osteogenic markers.237 With the exception of alkaline phosphatase
specific activity, BP treatment decreased all pro-osteogenic markers as well as the antiinflammatory cytokine IL10. Many of the markers measured in this study were more susceptible
to BP treatment in SLA and mSLA cultures compared to TCPS and PT cultures, and, for IL6
production, had opposite effects between TCPS/PT and SLA/mSLA cultures. These results
along with findings suggesting BPs both increase 253 and decrease254 IL6 production by
osteoblast-like cells, indicate that BPs could affect cells differently depending on the specific
state of differentiation and/or maturation.
The inconsistencies among studies could also be influenced by the alternate pathways
through which Ti surface topography facilitates osteogenesis compared to TCPS. On TCPS,
osteoblastic differentiation occurs through the canonical Wnt3A pathway while also primarily
expressing the α5β1 integrin complex.70,161 Surface mediated differentiation occurs through the
calcium-dependent Wnt5A pathway and shift to the production of α1β1 and α2β1 integrin
complexes.70,161 In addition, this occurs with media supplements typically used to induce
osteoblastic differentiation. Very few studies have investigated the effects BPs have on surface
mediated differentiation and maturation of osteoblasts, and many are concerned with the effects
BP coated Ti substrates have on osteogenesis. 255 rOBs isolated from 1d old Sprague Dawley
rats saw no changes in osteoblastic markers when cultured on Ti substrates coated with
immobilized pamidronate.256 Another study reported positive osteogenic effects of Ti surfaces
coated with immobilized alendronate on human osteoblasts and MSCs. 257 However, the
chemical process used to coat the substrates could easily distort the already highly variable
chemical effects of the BPs. Many of these studies also used osteogenic media to induce
differentiation.257,258 Since the differentiation of cells driven by surface topography and
osteogenic media are divergent,71 BPs could alter downstream signalling mechanisms
differently.

Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 104

Osseointegration in Metabolically Compromised Conditions • Spring 2019

Differences in BP chemistries were also evident when comparing their biological effects.
Alendronate was most inhibitory at the highest concentration, 10 -6M, and occasionally elicited
pro-osteogenic effects at the lowest concentrations by increasing osteocalcin and PGE 2 on
certain surfaces. Zoledronate was effective at all concentrations; however, its effects were
mostly limited to the more differentiated SLA and mSLA cultures. Ibandronate had the greatest
impact on the production of osteogenic factors on all surface cultures as well as at all
concentrations. Interestingly, each BP had a different effect on alkaline phosphatase specific
activity as it was increased by alendronate, not affected by zoledronate, and impaired by
ibandronate. Despite these differences, high concentrations of each BP were able to reduce the
osteogenic potential of SLA and mSLA to similar levels as TCPS and PT. This has significant
clinical implications suggesting BP usage impairs the osteoblast response to microstructured
surfaces and potentially slowing the rate of osseointegration.
Because the effects of BPs have shown to be dependent on cell type, we obtained primary
cell cultures from a clinically relevant animal model in order to verify our findings. Moreover, we
were interested in whether the effects of BP treatment in vivo could persist well after
administration. Relatively lower-affinity BPs have demonstrated extended bone mineral density
maintenance for up to a year despite a resolution of turnover markers with that time frame. This
indicates that the primary determinant of the antiresorptive potency for bisphosphonates is more
likely to be the biochemical and cellular effects of BPs on bone cells, as illustrated by correlations
between potency for effects at the molecular/cellular level and antiresorptive potency in animal
models.259 9-month old female rats were used in the present study because they closely match
the age when human patients would likely begin receiving BPs as a first line therapy for
metabolic bone disorders.260
Ibandronate was selected for the animal study out of the three tested BPs since it has an
average inhibitory potency compared to other nitrogen containing BPs. 259 Ibandronate
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conditioned rOBs displayed decreased markers of osteogenesis compared to PBS conditioned
rOBs. Unlike MG63 cells, however, BP treatment decreased osteoprotegerin production and
increased RANKL production on microstructured surfaces. Previously, it was shown that the
osteoblast-specific production of osteoprotegerin decreases while RANKL increases with age in
humans261 and rodents.79 Perhaps the maturation of aged osteoblasts facilitated by
microstructured Ti surfaces accelerates this senescent-like phenotype. Additionally, BPs have
been shown to increase serum osteoprotegerin in vivo, which correlates with increased bone
mineral density.262 It is unknown if the increased osteoprotegerin reflects a direct effect of BPs
on osteoblasts or an indirect effect by altering osteoclastogenesis and thereby altering the
catabolism of osteoprotegerin. Regardless, our data suggest that the effects of BP treatment
persists well after administration in vivo, and negatively influences the ability of osteoblasts
isolated from BP-treated animals to undergo osteogenesis on microstructured surfaces in vitro.
The present study is not without its limitations. First, the correlation between BP potency in
vitro and in vivo is rather poor, which may be due to the lack of consideration of the relative
affinity of BPs for bone when establishing in vitro models. Moreover, there is little information on
the concentrations that osteoblasts, osteocytes, or osteoclasts are exposed to in vivo, so our
experiment was designed to mimic clinical treatment. 233,263–265 Treatment method, dose, and
frequency were determined based on findings that total amount, not frequency, of ibandronate
injections is important for drug efficacy and the optimal dose was 1.0μg/kg.263–265 Subcutaneous
injection was chosen instead of oral administration to ensure total dosage delivery to each rat.
25 days was chosen to mimic monthly injections used clinically while also minimizing distress
arising from frequent injections. It should be noted that 1.0μg/kg of ibandronate is approximately
83.5 M, which is roughly 8 times higher than the highest concentration used for in vitro
experiments.
Perhaps the most important limitation to our study is that the main cell type investigated was
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the MG63 cell line, which are immature osteoblast-like cells originally isolated from a male
human osteosarcoma and most recipients of BPs are post-menopausal females. BPs have been
frequently demonstrated to elicit antitumor effects including inhibition of proliferation and
induction of apoptosis in human myeloma cells 266,267 and osteosarcoma cells268,269 in vitro. The
exact mechanisms for the observed antitumor effects are unclear, although studies suggest BPs
may act by decreasing certain tumor-stimulating cytokines like TGFβ1270 or by decreasing
angiogenic factors like VEGF.271,272 Production of both latent TGFβ1 and VEGF were inhibited
by BPs when MG63 cells were cultured on SLA and mSLA surfaces but not in TCPS or PT
cultures. Although ibandronate inhibited VEGF production in TCPS and PT cultures at all
concentrations, alendronate inhibited production of VEGF on TCPS at 10-6M compared to no
treatment, while zoledronate inhibited production of latent TGFβ1 in TCPS cultures and VEGF
on PT cultures compared to no treatment. Moreover, certain concentrations of BPs favored
proliferation over apoptosis as indicated by cell number and DNA content. In general, much
higher concentrations (>10μM) of BPs than what was used for the present experiments are
needed to affect tumor cell proliferation and survival.273,274 Furthermore, confirmation of the
effects in primary rOBs also serves to eliminate any possible tumor specific effects.

Conclusions
We have shown that MG63 cells and rOBs are sensitive to surface roughness and
hydrophilicity and their response to nitrogen containing BPs is modified by this topography. Since
BP treatment was more robust in cells cultured on rough and/or hydrophilic surfaces compared
to smooth substrates, this effect may be dependent on cell maturation state, as well as donor
sex and age. These results suggest that bisphosphonate exposure may jeopardized the proosteogenic response osteoblasts have to microstructured surfaces. Their effects persist in vivo
and condition osteoblasts to negatively influence their in vitro response. Clinically,
bisphosphonates could compromise peri-implant bone formation slowing the rate and quality of
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implant osseointegration. Although our results were observed in both MG63 cells and rOBs,
confirmation of our findings in vivo need to be conducted.
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Chapter 7. Ibandronate Treatment Before and After
Implant Insertion Impairs Osseointegration in Aged
Rats with Ovariectomy Induced Osteoporosis
Abstract
Excessive decreases in bone volume (BV) and bone mineral density (BMD) can lead to
osteoporosis, potentially hindering implant osseointegration. Bisphosphonates are commonly
used to combat osteoporosis by slowing osteoclast-mediated resorption; however, functional
osteoclasts are integral to bone remodeling and, thus, implant osseointegration, potentially
contraindicating bisphosphonate use during implantation. To optimize the use of implant
technologies in patients with compromised bone structure and metabolism, we need a more
complete understanding of the biological response to surface design. The goal of this study was
to assess the effects of osteoporosis and bisphosphonates on osseointegration of titanium (Ti)
implants with microstructured surfaces, which have been shown to support osteoblast
differentiation in vitro and rapid osseointegration in vivo. Forty, 8-month-old, virgin, female CD
Sprague Dawley rats underwent ovariectomy (OVX) or sham (SHOVX) surgery. After 5 weeks,
animals were injected subcutaneously with either the bisphosphonate (BIS), Ibandronate
(25μg/kg), or phosphate-buffered saline (PBS) every 25 days. 1 week after the initial injection,
Ø2.5mm x 3.5mm microrough (SLA; grit-blasted/acid etched) implants were placed
transcortically in the distal metaphysis of each femur resulting in four groups: 1) SHOVX+PBS;
2) SHOVX+BIS; 3) OVX+PBS; and 4) OVX+BIS. After 28d, qualitative properties of the bone
and implant osseointegration were assessed using micro-computed tomography (microCT),
calcified histomorphometry (Van Gieson’s stain), and removal torque testing. microCT revealed
decreased bone volume in OVX rats, which was slowed by bisphosphonate treatment. Reduced
bone-to-implant contact (BIC) was evident in OVX+PBS compared to SHOVX+PBS. Although
BV/TV was increased in OVX+BIS compared to OVX+PBS, bisphosphonate treatment had no
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effect on BIC. Removal torque testing revealed a higher maximum torque, torsional stiffness,
and torsional energy in SHOVX compared to OVX with no effects due to bisphosphonate
treatment. Our results show that osseointegration is decreased in osteoporotic animals.
Ibandronate halts the progression of osteoporosis but does not enhance osseointegration.

Introduction
Sufficient bone volume (BV) and bone mineral density (BMD) are two of the most important
patient factors for predicting the long-term success of dental and orthopaedic implant
osseointegration, which is defined as the direct anchorage of an implant to mature bone tissue
without the growth of fibrous tissue.275–277 These factors significantly diminish with age and their
reduction is exacerbated by certain factors including postmenopausal estrogen deficiency.
Osteoporosis is also characterized by excessive decreases in BMD and BV as a result of
increased rates of bone turnover. An estimated 53.6 million U.S. adults over the age of 50 were
affected by osteoporosis or osteopenia in 2010.4 By 2030, its prevalence is projected to increase
to 71.4 million people.4 Furthermore, 80% of those affected by osteoporosis were
postmenopausal women.4 Although data on the outcomes of dental and orthopaedic implants in
osteoporotic patients are very limited, the compromised qualitative properties of the bone,
strength, and healing associated with osteoporosis suggest these patients experience lower
rates of implant success.
Healthy osseointegration is critically dependent on bone remodeling, which involves the
reciprocal communication among osteoblasts, osteoclasts, mesenchymal stem cells (MSCs),
and osteoclast precursors (OCPs).195,196,278 During remodeling, osteoclasts resorb a volume of
bone leaving behind a foundation with a specific chemistry,55 stiffness,153 and morphology206 for
osteoblasts to synthesize and calcify their matrix. Osteoclasts produce factors (both independent
and as a byproduct of matrix resorption) capable of regulating MSC and osteoblast migration
and their subsequent osteogenesis.32 In turn, MSCs and osteoblasts release factors capable of
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limiting the degree and extent to which osteoclasts resorb bone. Any defects in the coupling of
bone resorption to bone formation has not only been implicated in impaired healing and
osseointegration but also the onset and progression of osteoporosis. Although age-related
mechanisms contributing to osteoporosis may originate from accelerated bone resorption or
impaired bone formation,279 these processes are not independent.
Bisphosphonates are commonly used to combat osteoporosis by targeting osteoclasts,
slowing the rate and severity of bone resorption. These events translate to decreased bone
turnover and increased BV and BMD.280 Bisphosphonates have also been reported to exert
anabolic effects on osteoblasts in vitro by stimulating proliferation236,237, preventing
apoptosis,235,281 and enhancing production of alkaline phosphatase, bone morphogenetic protein
(BMP)-2, type-I collagen, and osteocalcin,237,282–284 The positive effects bisphosphonates have
on osteoblasts has provided some rationale for their use to enhance osseointegration. Other
studies, however, have reported impaired mineralized bone nodule formation 238,240 and
responses to parathyroid hormone (PTH) with bisphosphonates.241,285–288 Furthermore,
bisphosphonates can impede angiogenesis 242,289,290 and are associated with osteonecrosis of
the jaw (ONJ) at high doses,244,291 both of which can be detrimental to peri-implant bone
formation and osseointegration. Moreover, functional osteoclasts are integral to healthy bone
remodeling. Therapeutic interventions targeting either half of this process will inevitably affect its
counterpart, contraindicating the use of bisphosphonates when bone remodeling is of the utmost
importance like implant osseointegration.
Considering the growing number of osteoporotic patients292 and high rate of bisphosphonate
prescriptions,293 the success of implant outcomes and osseointegration in this demographic has
turned into a significant dental and orthopaedic challenge. To optimize the use of implant
technologies in patients with compromised bone structure and metabolism, a more complete
understanding of the biological response to surface design and the impact of bisphosphonate
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treatments on osseointegration are needed. The goal of this study was to assess the effects
post-menopausal osteoporosis and bisphosphonate treatment have on the osseointegration of
clinically used microstructured titanium (Ti) implants.

Materials and Methods
This study was conducted under approval of the Institutional Animal Care and Use
Committee at Virginia Commonwealth University. All experiments were carried out in
accordance with approved procedures and reported according to ARRIVE guidelines. All
animals were treated humanely per the guidelines outlined in the Guide for the Care and Use of
Laboratory Animals by the National Institutes of Health. Animals were single-housed in an
individually ventilated, solid-bottomed polysulfone cage and kept at a temperature of 17-28ºC
with a humidity of 40-70% and a 12/12 h light/dark cycle.
Implant Preparation
Ti implants were designed to fit a rat femur and provided by Institut Straumann AG (Basel,
Switzerland). 3.5mm long implants with a 2.5mm outer diameter and a 0.8mm pitch were initially
machined from a rod of grade 4 Ti. They were then processed for 30s in a 55°C 2% ammonium
fluoride/2% hydrofluoric acid/10% nitric acid solution. Implants were sand-blasted with large grit
particulate (250 – 500 µm corundum) followed by acid etching in a boiling mixture of HCl and
H2SO4 to generate implant with a surface similar to the clinically used SLA implant. 52 Implants
were cleaned in HNO3, rinsed in ultrapure water, packed in aluminum foil, and γ-irradiated before
use.
Implant Characterization
Scanning Electron Microscopy (SEM)
Scanning electron microscopy (SEM; Hitachi SU-70 FE-SEM, Hitachi, Tokyo, Japan) was
used to qualitatively evaluate implant surface structure and roughness. Six images at varying
magnifications were captured on 3 implants per surface modification using 5 kV accelerating
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voltage for a total of 18 images.
Laser Confocal Microscopy
Laser confocal microscopy (LCM, Zeiss LSM 710, Zeiss, Oberkochen, Germany) was used
to quantitatively evaluate surface micro-roughness. Measurements on each implant (n=3) were
taken over an area of 106.2µm x 106.2µm with a 20x objective and a scanning pitch of 50nm. A
Gaussian high-pass filter with a cutoff wavelength of 100µm was used when calculating average
surface roughness (Sa) over three scans per implant (total n=9).
X-Ray Photoelectron Spectroscopy (XPS)
Chemical composition of the samples (n=3) was obtained from the sample surfaces by XPS
(Thermo K-Alpha XPS, Thermo Fisher Scientific, Waltham, MA, USA). Spectra were collected
using a 500µm spot size, using an XR5 gun and Al Kα x-ray source at 15kV. Scans were taken
with a 20ms dwell time and 1eV step size. Three different locations on each sample (total n=9)
were analyzed.
Animals and Surgical Procedures
A schematic detailing the timing of surgical procedures and treatments is shown in Figure
26. All surgical procedures were performed at the same session under isoflurane inhalation
anesthesia. 40, 8-month-old, skeletally mature, virgin, female CD Sprague-Dawley rats (Charles
River Laboratories, Wilmington, MA) underwent ovariectomy (OVX; n=20) or sham OVX
(SHOVX; n=20) surgery. The OVX and SHOVX surgeries were performed by Charles River
Laboratories. Development of the osteoporotic phenotype occurred over the next 5 weeks.
Bisphosphonate Treatment
Animals received two bisphosphonate injections. The first injection was at 5wk post-OVX;
animals received subcutaneous injections of either the bisphosphonate (BIS), ibandronate
(AuroMedics Pharma LLC, Dayton, NJ, USA) (25μg/kg), or phosphate buffered saline (PBS)
resulting in four groups: 1) SHOVX + PBS (n=10 animals); 2) SHOVX + BIS (n=10 animals); 3)
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Figure 26. Schematic of the Experimental Procedures. 40, 8-month old, skeletally mature, virgin, female CD SpragueDawley rats underwent ovariectomy (OVX; n=20) or sham OVX (SHOVX; n=20) surgery. After 5 weeks, animals were injected
with either ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion
of a Ti SLA implant 1 week later. Implants were allowed to osseointegrate for 28d.

OVX + PBS (n=10 animals); 4) OVX + BIS (n=10 animals). One week after the first injection, the
implants were placed (described below). Animals received a second injection of ibandronate or
PBS 25 days after the first injection; thus, animals had bisphosphonate treatment before and
after the placement of the implants. Treatment method, dose, and frequency were based on
previous reports detailing that total amount, not frequency, of ibandronate injections is important
for drug efficacy with an optimal dose of 1.0μg/kg/day.294 A subcutaneous injection was chosen
over oral administration to ensure total dosage delivery to each rat. 25 days was chosen to mimic
monthly injections used clinically while also minimizing distress arising from frequent injections.
This timing has also been successfully employed previously.295
Transcortical Implant Surgeries
One week after the first injections, SLA modified implants were placed transcortically into the
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distal metaphysis of both femurs. Animals were anesthetized with 5% isoflurane gas inhalation.
The hind limbs were prepared by shaving and cleaning using ethanol and chlorohexidine.
Anesthesia was maintained at 4% isoflurane in O 2 gas inhalation for the duration of the surgical
procedure. Cleaned, anesthetized animals were placed in a supine position and covered with a
sterile surgical drape. An 8mm incision was made over the medial side of the right knee.
Overlying muscle was separated, and the distal femur was exposed using blunt dissection to a
point immediately above the articular capsule. A high-speed dental hand-piece was used to
create a progressively larger pilot hole in the distal femur using a series of increasing diameter
drill bits (Ø1.0mm, Ø1.6mm, Ø2.0mm, and Ø2.2mm) with a 3.5mm drill stop. Ti SLA implants
were then screwed into place by hand using a custom-made driver. Following implant placement,
custom-made stainless-steel cover screws were placed on the end of the implant to prevent
bone from growing into the internal threading of the implant. The periosteum and muscle were
reapposed and sutured in place using resorbable sutures and the skin was closed with 9mm
wound clips. These steps were then repeated for the left femur. Animals recovered from
anesthesia on a water-circulating warming pad and were injected subcutaneously with 1mg/kg
buprenorphine SR LAB. All animals had access to water ad libitum for the duration of the study;
however, food access was regulated.
Diet and Pair Feeding
The diet of ovariectomized animals is a potential source of at least two confounding variables.
The first is the tendency of rats to have increased appetites following OVX. This can lead to
excessive weight gain potentially altering the mechanical loading on the implant thus affecting
the osseointegration.296 In order to eliminate weight gain as a confounding variable, the animals
in this study were pair fed. Each week SHOVX+PBS animals had their food intake monitored by
calculating the difference in available food weight in a 24-hour period. The average difference
across the four SHOVX+PBS animals was given to each animal in the three remaining groups
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daily. The success of the pair feeding regimen was verified by weekly weighing of all animals for
the duration of the study.
The content of the food can also confound the results studies involving ovariectomized
animals. Many rodent feeds are made from products known to contain phytoestrogens.
Phytoestrogens are structurally similar with 17β-estradiol causing them to have estrogenic
and/or anti-estrogenic effects potentially preventing bone loss.297 Because the dietary estrogenic
activity is a concern, all animals were given a phytoestrogen-free diet (Advanced Protocol
Verified Casein Diet 10 IF, LabDiet, St. Louis, MO, USA).
Tissue Analysis
Transcortical implants were allowed to osseointegrate for 28d, after which rats were
euthanized via CO2 inhalation. The hind limbs from each animal were isolated for removal torque
testing (n=5 animals/group) or micro-computed tomography (microCT) and histological analysis
(n=5 animals/group). Each limb was treated as a separate sample providing an effective sample
size of 10 per group for both the removal torque testing and microCT/histological analysis.
MicroCT
MicroCT (SkyScan 1173, Bruker, Kontich, Belgium) was used to assess the osteoporotic
phenotype in the femoral head as well as evaluate peri-implant bone growth and bone-to-implant
contact (BIC) in the distal femur. Femurs used for microCT were stored and fixed in 10% neutral
buffered formalin for at least 24hr prior to imaging. The femoral heads of fixed samples were
scanned at a resolution of 1120x1120 pixels (image pixel size of 12.94µm) over 360° using a
1.0mm aluminum filter, 85kV voltage, 94μA current, and 270ms exposure time. 5 x-ray
projections were acquired every 0.2° and averaged. A standard Feldkamp reconstruction was
done using NRecon Software (Bruker) with a beam hardening correction of 20% and a Gaussian
smoothing kernel of 0. To calibrate for cortical tissue mineral density and trabecular bone mineral
density, 4mm epoxy resin rods containing concentrations of 0.25 and 0.75gcm-3 calcium
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hydroxyapatite (CaHA). Cortical and trabecular bone were isolated, and densities determined
separately using CTAn analysis software (Bruker). Total porosity and trabecular number were
also quantified from the isolated trabecular bone.
The distal femoral metaphysis was scanned at a resolution of 1120x1120 pixels (image pixel
size of 13.66µm) over 360° using a 0.25mm brass filter, 120kV voltage, 66μA current, and 420ms
exposure time. 5 x-ray projections were acquired every 0.2° and averaged. After reconstruction,
a uniform volume of interest (VOI) was isolated. The VOI began at the base of the implant and
extended 3mm towards its apex to eliminate any variability arising from the implant not being
exactly at bone level for every sample. The VOI was shrink-wrapped, dilated 2 pixels around the
implant, and subtracted from the original VOI. The remaining bone and implant were thresholded
and quantified as the total bone volume (BV) and then normalized to the total uniform VOI (TV)
to get bone volume over total volume (BV/TV). The BIC was calculated using a separate BV that
encompassed only the bone in direct contact with the implant. The same VOI was dilated 10
pixels around the implant, rethresholded, further dilated by 3 pixels, and subtracted from the
original VOI. After eroding the remaining VOI by 3 pixels, the remaining BV was normalized to
the implant volume.
Histology
Following imaging with microCT, samples were placed in fresh 10% neutral buffered
formalin and sent to be commercially processed for calcified histological staining (Histion,
Everett, WA, USA). Femurs were embedded in methyl methacrylate, sectioned longitudinally
relative to the implant and transaxially relative to the femur (transcortical), and stained with
Stevenel’s blue and van Gieson. Sections were imaged using bright field light microscopy with
an AxioCam MRc5 camera and Axio Observer Z1 and analyzed using ZEN 2012 Blue Edition
software (Zeiss). Histomorphometry was then used to evaluate peri-implant bone growth and
BIC.
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New peri-implant bone growth was quantified within a uniform rectangular region of interest
(ROI) for all samples that was 3.56mm in width by 3.0mm in length with an area of 10.7mm 2.
The ROI was drawn 0.3mm beneath the distal portion of the implant and centered. The area of
all bone within the ROI was then quantified (BV) and normalized to the area of the ROI (TV).
The area of bone contained within the ROI divided by the area of the ROI was defined as the
histological BV/TV. In addition, the perimeter of the implant contained within both the trabecular
region and the cortical region of the bone was measured. The trabecular BIC and cortical BIC
were determined by dividing the length of bone in direct contact with the implant by the trabecular
and cortical perimeter length respectively. The total BIC was calculated by summing both lengths
of contact and dividing by the total perimeter of the implant.
Removal Torque
Removal torque testing was performed on fresh, non-fixed samples using an ElectroForce
3200 Series III test instrument (TA Instruments, New Castle, DE, USA). Because of their
asymmetrical shape, femurs were mounted in 1cm diameter flexible polyurethane tubing to
ensure no movement of the femur during analysis (Fig.31A). The tubing was cut into 5cm
segments and halved longitudinally to provide access to the transcortical implant. Femurs were
secured to the tubing with polyurethane adhesive and allowed to cure overnight at 4°C prior to
testing. The transcortical implant in each hind limb was then fit to a custom-made driver and
aligned to the testing machine axis to ensure no initial torque was present on the implant (0Nm).
A clamp was then carefully tightened, securing each sample in place with no initial compressive
load present on the implant (0Nm). A 0Nm compressive load was critical to guarantee no axial
mismatch between the implant and the testing apparatus, which could greatly alter our results.
Torque was then applied to each sample with a rotational speed of 0.1°s -1 with an axial
displacement of 0.8mm/360° to ensure no compressive load was applied to the sample during
the duration of each test. Torque vs. degree graphs were generated for each sample and fit to
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a bilinear model in order to distinguish the toe-region from the linear region using an open-source
least squares spline modeling package (SLM - Shape Language Modeling version 1.14) for
MATLAB (MathWorks, Natick, MA, USA). The linear region of each graph was then evaluated
for the maximum torque, torsional energy (area below linear region), and torsional stiffness
(slope of linear region).
Osteoblast Response In Vitro
To further assess the effects of bisphosphonate treatment, following euthanasia, calvarial
osteoblasts were isolated from the frontal and parietal bones of rats in each of the four
experimental groups. After removal of the periosteum and soft tissue, bone fragments were
digested for 15min at 37°C with 0.25% trypsin-EDTA (Life Technologies, Carlsbad, CA). Bones
were minced into pieces approximately 1mm x 1mm and placed into a 100mm x 20mm Petri
dish with Dulbecco’s modified Eagle medium (DMEM; Mediatech, Manassas, VA) + 10% fetal
bovine serum (FBS) + 1% penicillin-streptomycin (Life Technologies). At confluence, cells were
subpassaged and cultured as above. The osteoblast phenotype of each of the four groups of
isolated cells was confirmed by measuring alkaline phosphatase specific activity and osteocalcin
production after treatment of confluent cultures with either 0M or 10 -8M 1α,25-dihydroxy vitamin
D3 (1α,25(OH)2D3; Enzo Biochem, Farmingdale, NY) for 24hrs on tissue culture polystyrene
(TCPS).
Validated rat osteoblasts (rOBs) from each experimental group were cultured on TCPS or
15mm Ti SLA disks. Disks were prepared from Ti sheets but subjected to the same sand-blasting
and acid etching procedure as described above. Cells were plated at a density of 10,000
cells/cm2 and incubated at 37°C in an atmosphere of 5% CO 2 and 100% humidity. Media were
changed 24h after plating and every 48h thereafter for 7d. At 7d, cells were incubated with fresh
DMEM for 24h. Media were collected and immunoassays were used to measure levels of intact
rat osteocalcin (Alfa Aesar, Haverhill, MA) rat/mouse osteopontin (R&D Systems, Minneapolis,
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MN), mouse osteoprotegerin (R&D Systems), human/mouse/rat BMP2 (PeproTech), mouse
receptor activator of nuclear kappa-B ligand (RANKL; R&D Systems), and rat vascular
endothelial growth factor-A (VEGF; R&D Systems).
After collection of media, cell monolayers were washed twice with 0.2ml PBS, lysed in 0.05%
Triton X-100, and homogenized by sonication at 40 amplitude using a Vibra-Cell ultrasonicator
(Sonics & Materials Inc., Newtown, CT). DNA content in the cell layer lysate was measured with
PicoGreen (Promega, Madison, WI) using a Synergy H1 Hybrid Reader fluorescence detector
(BioTek, Winooski, VT) at an excitation of 485 nm and emission of 538 nm. Alkaline phosphatase
specific activity [orthophosphoric monoester phosphohydrolase, alkaline; E.C. 3.1.3.1] was
assayed by measuring the conversion of p-nitrophenylphosphate to p-nitrophenol at pH 10.25
and temperature of 37°C. Absorbance was measured at 405nm. Activity was normalized to total
protein content in the cell lysates as determined by bicinchoninic acid protein assay kit (Thermo
Fisher Scientific, Waltham, MA). Immunoassay data were normalized to DNA content.
Statistical Analysis
Based on previous studies,193,296 in order to detect a 30% mean difference with 20% variance
and a type I error rate of 0.05, a two-tailed one-way ANOVA power analysis determined a sample
size of 10 per group is necessary to maintain 80% power. In order to ensure that differences in
mechanical loading would not affect the results, identical implants were placed in the right and
left hind limbs. In addition, animals received the same systemic treatment (e.g. OVX/SHOVX or
ibandronate/PBS), which prevents any potential carry-over effects between legs. Since both legs
were treated identically, it is safe to assume that movement or loading in one limb will not affect
the movement or loading experienced by the other limb. The design of our study permits the
assumption that implants from individual limbs can be treated as independent data points rather
than dependent. Data are presented as the mean ± standard error (SE) for each analysis. All
cell culture experiments had a sample size of six (n=6) and repeated at least three times to
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ensure validity of the results. Data shown in the figures are from representative experiments. A
one–way analysis of variance with a two-tailed Tukey correction was performed to adjust for
multiple comparisons to maintain an experiment-wise error rate (α) of 0.05. All statistical
analyses were performed using JMP statistical software (SAS Institute, Cary, NC, USA).

Results
Transcortical Implant
Characterization
Qualitative images of
the transcortical Ti SLA
implants as well as the
cover screw are shown in
Figure

27.

morphology

Gross
of

stainless-steel

the
cover

screw and Ti SLA implant
can be seen in Figure
27A

and

Figure

27B

respectively. SEM images
of the transcortical Ti SLA

Figure 27. Qualitative Characterization of Ti SLA Implants. Photographs showing the
dimensions of the stainless-steel cover screw (A) and Ti SLA implant (B). The space
between each mark represents 1mm. Surface morphology was assessed using
scanning electron microscopy (C – D).

implants (Fig.27C – F) reveal the rough surface induced by the sand-blasting and acid etching
procedure, resulting in a combination of microscale and submicron-scale surface features.
These complex features were also strewn with unmodified areas characterized by flat and
smooth sections. Together the sand-blasting and acid etching procedure led to an average
surface roughness (Sa) of 3.91 ± 0.09 µm as measured by confocal microscopy (Table 4). XPS
survey spectra (Table 4) displayed titanium (Ti), oxygen (O), and carbon (C) as the main atomic
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components of the SLA implant.

Evaluation of Pair Feeding and Osteoporotic Phenotype
Animals from the four groups maintained similar weights and levels of activity throughout the
duration of the study. Select week results from the overall ANOVA F-test (Week 1: F3,36 = 1.5, p
= 0.2376; Week 4: F3,36 = 1.1, p = 0.3467; Week 8: F3,36 = 0.6, p = 0.6041; Week 10: F3,36 = 0.2,
p = 0.8946) indicate a successful pair feeding regimen.
MicroCT was used to evaluate the osteoporotic phenotype of the femoral head with
representative images shown in Figure 28A – D. The cortical tissue mineral density (Fig.28E)
was not affected by the OVX nor treatment with ibandronate. However, the trabecular bone
mineral density (Fig.28F) was significantly reduced in OVX animals compared to SHOVX
animals. Treatment with ibandronate mitigated the loss of the trabecular bone mineral density.
Total porosity (Fig.28G) was increased in OVX animals receiving PBS compared to SHOVX
animals. OVX animals receiving ibandronate had a total porosity similar to both SHOVX animals
and OVX animals receiving ibandronate. Trabecular number (Fig.28H) decreased in OVX
animals receiving PBS compared to the other groups.
MicroCT
3D reconstructions of microCT scans (Fig.29A – D) showed peri-implant bone formation in
all animal groups. Furthermore, the transcortical implants did not contact the growth plate
eliminating any potential influence on the bone formation in our defined VOI. The BV/TV
(Fig.29E) decreased in OVX animals compared to SHOVX, and the severity of the reduction
was lessened in OVX animals receiving ibandronate. Osseointegration was achieved in all
animal groups as well. BIC values (Fig.29F) obtained through microCT analysis were reduced
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in OVX animals compared to SHOVX animals after 4 weeks. Ibandronate treatment of both
SHOVX and OVX animals did not influence BIC values.

Figure 28. Characterization of the Ovariectomy Induced Osteoporotic Phenotype. 8-month-old, female, virgin, CD Sprague
Dawley rats underwent sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with
either ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a
Ti SLA implant 1 week later. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Femoral heads
of the animals were analyzed with 3D microCT reconstructions (A – D). Cortical tissue mineral density (E), trabecular bone
mineral density (F), total porosity (G), and trabecular number (H) were quantified from the microCT reconstructions. Data
shown are the mean ± standard error (SE) of ten samples. Groups not sharing a letter are statistically significant at an α=0.05.
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Figure 29. MicroCT Assessment of Implant Osseointegration. 8-month-old, female, virgin, CD Sprague Dawley rats underwent
sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with either ibandronate (BIS)
or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a Ti SLA implant 1 week
later. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the animals were
analyzed with 3D microCT reconstructions (A – D). Bone volume over total volume (BV/TV; E) and bone-to-implant contact
(BIC; F) were quantified from the microCT reconstructions. Data shown are the mean ± standard error (SE) of ten (n=10)
independent samples. Groups not sharing a letter are statistically significant at an α=0.05.
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Histology
Histological sections of transcortical implants from each animal group (Fig.30A – D)
confirmed the results seen from the microCT analysis. More trabecular bone can be seen in the
SHOVX groups (Fig.30A, B) compared to the OVX groups (Fig.30C, D). Quantification of the
total bone area with a fixed region of interest (Fig.30E) was significantly higher in SHOVX
animals compared to OVX animals. Administration of ibandronate mitigated some of the loss in
OVX animals. BIC (Fig.30F) was higher in SHOVX compared to OVX animals and were not
influenced by ibandronate treatment.

Figure 30. Histological Assessment of Implant Osseointegration. 8-month-old, female, virgin, CD Sprague Dawley rats
underwent sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with either
ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a Ti SLA
implant 1 week later. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the
animals were embedded in methyl methacrylate, sectioned longitudinally relative to the implant and transaxially relative to the
femur (transcortical), and stained with Stevenel’s blue and van Gieson (A – D). Bone volume over total volume (BV/TV; E)
and bone-to-implant contact (BIC; F) were quantified using histomorphometrics. Data shown are the mean ± standard error
(SE) of six ten (n=10) independent samples. Groups not sharing a letter are statistically significant at an α=0.05.
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Mechanical Testing
Isolated femurs were secured in polyurethane tubing and aligned to the machine axis in a
custom-fabricated sample holder to ensure no movement was created during the test (Fig.31A).
Representative torque vs. degree graphs for each group (Fig.31B – E) display the bilinear model
(red) fit to the experimental data (blue). The end of each curve identifies failure, and no
secondary peaks were observed for any sample. The middle vertical dashed line (black)

Figure 31. Removal Torque Assessment of Implant Osseointegration. 8-month-old, female, virgin, CD Sprague Dawley rats
underwent sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with either
ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a Ti SLA
implant 1 week later. After 28d of osseointegration, femurs were isolated, and analyses were performed on fresh, non-fixed
samples as outlined (A). Torque vs. degree graphs were generated for each sample and fit to a bilinear model in order to
distinguish the toe-region from the linear region (B – E). The linear region of each graph was then evaluated for the maximum
torque (F), torsional energy (G), and torsional stiffness (H). Data shown are the mean ± standard error (SE) of ten (n=10)
independent samples. Groups not sharing a letter are statistically significant at an α=0.05.
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separates the toe region (left section) and the linear region (right section) as determined by the
least squares spline modeling package in MATLAB. The maximum torque (Fig.31F) and
torsional energy (Fig.31G) was greatest in SHOVX animals and significantly reduced in OVX
animals. Ibandronate treatment had no effect on either parameter. Torsional stiffness (Fig.31H)
was greatest in SHOVX animals treated with PBS and lowest in OVX animals treated with PBS.
SHOVX+BIS and OVX+BIS animal torsional stiffness values were not different from either
SHOVX+PBS or OVX+PBS.
In Vitro Response of Calvarial Osteoblasts
1α,25(OH)2D3 stimulated osteocalcin production and alkaline phosphatase specific activity in
confluent cultures of rOBs from all four experimental groups, confirming their successful isolation
and expansion. DNA content (Fig.32A) and alkaline phosphatase specific activity (Fig.32B) in
cultures grown on SLA were lower than in cultures grown on TCPS. DNA content was higher in
cultures of osteoblasts isolated from ibandronate treated animals grown on TCPS compared to
the other treatment groups. Among SLA cultures, DNA content was highest in SHAM+BIS
osteoblasts. Ibandronate treatment decreased alkaline phosphatase specific activity among
TCPS cultures, but no effect was observed in SLA cultures. SLA increased osteoblast
osteocalcin (Fig.32C) production in all groups except SHAM+BIS, which remained like TCPS
cultures. Furthermore, OVX+BIS osteoblasts had decreased osteocalcin production compared
to OVX+PBS osteoblasts. Osteoprotegerin (Fig.32D) levels decreased in SLA cultures
compared to TCPS. Osteoblasts isolated from OVX animals had decreased osteoprotegerin
levels in TCPS cultures, although ibandronate treatment did stimulate its production. Production
of BMP2 (Fig.32E), osteopontin (Fig.32F), VEGF (Fig.32G), and RANKL (Fig.32H) was
increased on SLA compared to TCPS with the highest levels of BMP2, osteopontin, and RANKL
occurring in OVX+PBS osteoblasts. The highest levels of VEGF were observed in SHAM+PBS
osteoblasts. Ibandronate treatment led to decreased productions of these proteins in SLA
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cultures compared to their respective PBS controls with SHAM+BIS osteoblasts producing
amounts of osteopontin and VEGF to levels similar to those observed in TCPS cultures.

Figure 32. In Vitro Response of Primary Calvarial Osteoblasts. Calvarial osteoblasts were isolated from each of the
four groups of animals and cultured separately on either TCPS or SLA in DMEM. After 7d, cells were treated with fresh
DMEM for 24h. After 24h, media were collected, and cell lysates were assayed for DNA content (A) and alkaline
phosphatase specific activity (B). Media were assayed for osteocalcin (C), osteoprotegerin (D), BMP2 (E), osteopontin
(F), VEGF (G), and RANKL (H). Data shown are the mean ± standard error (SE) of six (n=6) independent samples.
Groups not sharing a letter are statistically significant at α=0.05.
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Discussion
Osseointegration involves a complex cascade of biological events, ultimately leading to the
structural and functional connection between mature, lamellar bone and the inserted implant. 277
The cellular miscommunication associated with osteoporosis leads to excessive bone resorption
and impaired bone remodeling, which challenges successful osseointegration and implant
outcomes. Although bisphosphonates are known to increase BV and BMD by mitigating the
resorptive damage caused by overactive osteoclasts, their continued disruption of bone
remodeling may contribute to greater risks of compromised implant osseointegration. In order to
improve osseointegration and long-term stability of implants in osteoporotic patients, we sought
to determine the effects ibandronate treatment has on the osseointegration of microrough Ti
implants in an aged, OVX-induced osteoporotic rat model.
In the present study, microCT analyses, calcified histomorphometrics, and removal torque
testing revealed decreased osseointegration in ovariectomized animals compared to SHAM
operated controls. Moreover, ibandronate treatment did not affect BIC and removal torque
values, although it was able to halt the progression of the osteoporotic phenotype as observed
through increased BV/TV in ovariectomized animals. The physiological consequences of
osteoporosis are known to alter cellular communication leading to lower qualitative properties of
the bone and impaired healing.298 It is clear from this study and others that the estrogen deficient
osteoporotic phenotype negatively impacts implant osseointegration. 299–302 Previous studies,
however, have lauded the use of bisphosphonates to reverse the negative effects of
osteoporosis on implant osseointegration. 303–309 On the other hand, BIC and removal torque
values were either unaffected308,310 or decreased311 by bisphosphonate therapy in healthy
animals. Despite the inhibitory effect bisphosphonates have on bone remodeling, the precise
mechanism of action is not fully understood, which has led to many studies with variations in
experimental methods. Selection of the appropriate animal model, development of the
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osteoporotic phenotype, timing of both the bisphosphonate treatment and implant insertion as
well as the route of bisphosphonate administration and location of implant placement are
important factors. Conflicting results between these studies and ours can be largely explained
through these differences. It should also be noted that the femoral implant model is not an exact
replica of bone turnover in the oral cavity, which could limit the translation of our results to clinical
outcomes for patients receiving dental implants rather than orthopaedic implants.
An ovariectomized rat is a well-characterized model that closely mimics postmenopausal
osteoporosis in humans. Basic multicellular unit-based endocortical and cancellous bone
remodeling occurs in both rats and humans.312,313 Estrogen deficiency in both humans and rats
leads to an increased presence of osteoclasts on the endocortical bone surface causing
cancellous and endocortical bone loss by altering the balance between bone formation and bone
resorption.314–316 In contrast, there is increased bone formation at the periosteal surface. 314,317
As a result of the opposing changes in radial growth and endocortical remodeling, cortical bone
volume generally remains unchanged in ovariectomized rats, similar to what was observed in
this study. However, trabecular bone turnover is known to be elevated in ovariectomized
rats,318,319 which explains the increased total porosity as well as the decreased trabecular
number in PBS treated ovariectomized rats.
Evidence also suggests that both the age of the animal during OVX and implant insertion
could significantly influence the results. While rats reach skeletal maturity around 3 months, their
growth rate changes continuously for the first 6 months of life.320 In some instances, bone
elongation in rats may persist up to their first 8 months. 320 OVX of growing rats results in
cancellous osteopenia due to increased resorption of growth plate calcified cartilage. 315 The
amount of primary spongiosa that serves as a template for future bone apposition is
subsequently decreased.315 As bone growth slows with age, the contribution of altered
endochondral ossification to the skeletal effects of OVX diminishes, and the contribution of
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altered bone remodeling increases and eventually becomes the predominant mechanism for the
alteration of cancellous bone mass.
Further methodological complications arise when bone remodeling targeting therapies and
implant osseointegration are introduced to the ovariectomized rat model. Many previous reports
using this model to investigate implant osseointegration and bisphosphonate therapy perform
the OVX surgery in rats under the age of 6 months. 303–309 In spite of not approximating the
relative timing of the onset of menopause in humans, it is difficult to attribute the impaired
osseointegration to altered bone remodeling. A few of these studies do refer to the
ovariectomized

skeletal

phenotype

as

estrogen-deficient

osteoporosis

rather

than

postmenopausal; however, no attempt was made to control for the number of phytoestrogens
present in the animal diet, potentially altering the results. Another study using ovariectomized 6
– 9 month old retired breeders found that osseointegration of implants was enhanced by
bisphosphonate therapy.321 The multiple pregnancies and lactations incurred by the retired
breeders has been shown to result in osteopenia. 322 Compared to age-matched virgins, OVX of
retired breeders results in less bone loss and more variable indices of bone mass and
turnover.322
Regardless of the age at OVX, the osteoporotic phenotype needs sufficient time to develop
as the combination of rat age and skeletal site used influence the resulting temporal pattern of
bone loss.323 Studies treating animals with bisphosphonates 306 or inserting implants305 on the
same day as the OVX surgery do not fully capture the impact the physiological changes the
osteoporotic phenotype has on implant osseointegration. Furthermore, studies treating animals
with bisphosphonates either on the same day of the implant surgery or immediately after are not
appropriate models to study the effects postmenopausal osteoporosis have on the
osseointegration of implants. Clinically, patients diagnosed with osteoporosis will not remain
untreated until after a surgical intervention.
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The effects of bisphosphonates have also been shown to be dose-dependent and vary with
the chemistry of the compound being tested. Daily and weekly treatment regimens are available
for many of these bisphosphonates, but it is predicted that novel and simplified regimens with
bisphosphonates given at intervals between doses of longer than 1 week will be more convenient
for patients and improve adherence to therapy. Ibandronate has the potential to be effective
when administered less frequently than once weekly. Preclinical studies using OVX rats found
that the lowest dose of ibandronate that completely prevented bone loss was 1 µg/kg/day.
Although the bone turnover in skeletally mature rats is approximately 3 – 5 times higher
compared to humans, it decreases with age and OVX.316,324 Considering the age at OVX (8
months), the bone turnover of the rats used in this study closely reflects that of adult human
bone. In addition, intermittent and continuous dosing of ibandronate produced similar results, so
administration of 25 µg/kg/25 days was selected to mimic monthly injections patients would
receive clinically as well as minimizing animal distress. 325
3.5mm long and 2.5mm wide, grade 4, Ti implants were custom made for this study. This
design allowed for a transcortical insertion, which more closely mimics clinical procedures as
opposed to intramedullary canal insertion commonly performed on mice. The SLA surface
modification is clinically used, and no studies have investigated this topography in response to
either OVX induced osteoporosis and/or ibandronate treatment. Furthermore, this is the first
reported use of these transcortical implants custom-made to fit rat femurs. Scanning electron
microscopy, laser confocal microscopy, and x-ray photoelectron spectroscopy revealed a
surface morphology, average surface roughness, and surface composition similar to what has
been previously reported for implants processed in the same manner. 209,210,326
Primary calvarial osteoblasts were obtained from the osteoporotic animals and were used to
evaluate potential phenotypic and/or proliferative changes. rOBs were cultured on 15mm
diameter and 1mm thick Ti disks that were processed to have the same surface microstructural
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features as those seen on the implants used in vivo. Both OVX and ibandronate treatment were
able to condition rOBs in vivo to alter their response in vitro. Typically, cells cultured on rough
surfaces display attributes of more differentiated and mature osteoblasts with decreased
proliferative capacity and cell number than those on TCPS. 327 While this was true for all groups,
rOBs isolated from untreated OVX animals had higher productions of osteogenic markers
compared to SHOVX, while bisphosphonate treatment decreased osteogenic and angiogenic
markers compared to PBS treated cells. This suggests that the altered bone remodeling in OVX
animals may be reinvigorated with implant surface properties, and bisphosphonate exposure
may jeopardize the pro-osteogenic response osteoblasts have to microstructured surfaces.
Furthermore, components of the osteoprotegerin/RANKL/RANK system, a critical pathway for
the regulation of bone remodeling, were affected differently. In this study, rOBs displayed a
decreased production of osteoprotegerin and an increased production of RANKL compared to
TCPS. Previous studies have shown that aging in humans

261,328

and rodents78,79 leads to

increased RANKL and decreased osteoprotegerin production by osteoblasts, which could be
exacerbated by the enhanced maturation that Ti surfaces facilitate in osteoblasts. Interestingly,
ibandronate treatment facilitated an increased osteoprotegerin and decreased RANKL
productions indicating bisphosphonate treatment can influence and condition a shift from bone
resorption to bone formation at the cellular level. Bisphosphonates have been shown to increase
serum osteoprotegerin levels and that increases of osteoprotegerin correlate with increases in
BMD.262 It is unclear if the increased osteoprotegerin reflects a direct effect of bisphosphonates
on osteoblasts or an indirect effect by altering osteoclastogenesis and thereby altering the
catabolism of osteoprotegerin.

Conclusions
In conclusion, our results show that osseointegration is decreased in osteoporotic animals.
Clinically relevant doses of ibandronate were able to halt the progression of the osteoporotic
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phenotype. However, these doses were unable to enhance the osseointegration of microrough
titanium implants. These in vivo results were supported by in vitro studies examining the
biological response of primary rat osteoblasts to SLA disks.
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Chapter 8. Titanium Implant Surface Properties
Enhance Osseointegration in Aged Osteoporotic
Rats without Pharmacologic Intervention
Abstract
Successful osseointegration involves resorption of primary bone and its replacement with
mature bone. Osteoporosis compromises bone remodeling, increasing rates of implant failure.
Anti-osteocatabolic drugs can treat osteoporosis but continue to suppress bone remodeling,
contraindicating their use during osseointegration. This study determined whether implant
surfaces that promote osseointegration in normal rats can promote osseointegration in
osteoporotic rats without pharmacologic intervention. Virgin female 8-month-old CD Sprague
Dawley

rats

(N=25)

were

ovariectomized.

At

6

weeks,

microstructured/non-

nanostructured/hydrophobic (SLA), microstructured/nanostructured/hydrophobic (SLAnano), or
microstructured/nanostructured/hydrophilic (mSLA) Ti implants (Ø2.5mm x 3.5mm; Institut
Straumann AG, Basel, Switzerland) were placed in the distal metaphysis of each femur. At 28
days,

bone

quality

and

implant

osseointegration

were

assessed

using

microCT,

histomorphometrics, and removal torque values (RTVs). Calvarial osteoblasts were isolated and
cultured on Ø15mm SLA, SLAnano, or mSLA discs for 7 days. mSLA promoted increased boneto-implant contact and RTVs in vivo and facilitated increased osteoblastic marker production in
vitro compared to SLA and SLAnano, suggesting that osseointegration occurs in osteoporotic
animals, and implant surface properties improve its rate. When appropriate microstructure is
present, hydrophilicity has a greater influence than nanostructures. These results provide critical
insight for developing implants with improved osseointegration in patients with metabolic
disorders of bone remodeling.

Introduction
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Osteoporosis is a systemic disease characterized by the microarchitectural deterioration of
bone tissue leading to low bone mass and strength. It is one of the most common metabolic
diseases and has become a significant topic of public health around the world as many countries
begin to encounter the morbidities of an aging population. In 2010, the number of U.S. adults
with osteoporosis or low bone mass (osteopenia) was estimated to be 53.6 million, representing
54% of the U.S. population over the age of 50 years.4 Moreover, osteoporosis is more prevalent
in postmenopausal women, affecting over 80% of the total estimated U.S. population with
osteoporosis.4 The prevalence of the disease will continue to increase as the number of people
aged 60 or older is expected to grow to nearly 2 billion by 2050.329 The comorbidities of
edentulism and fracture risk with osteoporosis are driving the necessity to develop more
permanent, predictable, and complication-free dental and orthopaedic implants for this
demographic.330
Osseointegration is important for determining the success of dental and orthopaedic implant
outcomes as it results in the direct structural and functional connection between the surface of
a load-bearing implant and living bone.196 This complex biological process involves the modeling
of primary bone followed by its subsequent remodeling into mature bone, which is achieved
through a locally regulated communication between bone resorbing osteoclasts and bone
forming osteoblasts.196 The communication between osteoclasts and osteoblasts is also
important for maintaining bone homeostasis, and any defects in the coupling of bone resorption
to formation can lead to osteoporosis.331 Evidence suggests age-related osteoporosis develops
from a combination of accelerated bone loss owing to excessive resorption and impaired bone
formation during remodeling.331 Metabolic disorders like osteoporosis could jeopardize the bone
healing process and thus the predictability of implant osseointegration.332
Multiple cellular mechanisms that contribute to the dysfunctional coupling in osteoporosis
have been identified. During osteoporosis development, the proliferation and recruitment of
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mesenchymal stem cells (MSCs) to the site of resorption is hindered.333–336 MSCs also exhibit a
reduced capacity to differentiate into osteoblasts and an increased capacity to differentiate into
adipocytes.337–339 This shift from osteoblastogenesis to adipogenesis has been shown to
contribute to the development of osteoporosis by reducing bone formation and increasing
marrow fat accumulation.340,341 Those MSCs that do differentiate into mature osteoblasts suffer
from a decreased life-span as well as an impaired bone-forming capacity with alterations in
collagen stability, alignment, and composition.342–346
Osteoporotic bone cells also have a decreased capacity to regulate osteoclasts as evident
by their decreased production of transforming growth factor β1 (TGFβ1) and osteoprotegerin
(OPG) and increased production of receptor activator of nuclear kappa-B ligand (RANKL).77–
79,262

These cells also produce many cytokines that have been implicated as stimulators of

osteoclastic activity including interleukin 1 (IL-1), tumor necrosis factor α (TNFα), interleukin 6
(IL-6), prostaglandin E2 (PGE2), and interleukin 11 (IL-11).77,347,348 In many respects,
osteoporosis can be viewed as a breakdown of healthy cellular communication, a breakdown
that can be locally reinvigorated using implants with optimized surface parameters.
Implant surface characteristics have proven important for determining successful dental
implant outcomes. The positive influence of surface topography on implant osseointegration,
achieved through grit-blasting and acid-etching, has been a topic of investigation for several
decades.29,349,350 Today, microrough surfaces dominate the market as they have been shown to
achieve faster bone integration, a higher percentage of bone to implant contact (BIC), and a
higher resistance to shear, as determined by removal torque values (RTVs), when compared to
smooth implant surfaces.35 Surface nanoroughness142 and hydrophilicity55 have also been
shown to be beneficial, particularly when the surface is microstructured. These features provide
a surface structure much more analogous to natural bone, thereby influencing the adsorbed
protein type, quantity, and conformation as well as downstream control of cellular adhesion,
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proliferation, and differentiation. Moreover, when grown on these substrates, cells produce
factors that regulate osteoclasts to achieve net new bone formation. It was recently shown that
MSCs and osteoblasts grown on microstructured surfaces can regulate osteoclast activity and
gene expression to different degrees depending on the properties of the substrate surface.326
This suggests that small variations in surface properties alone can drastically regulate the fusion
of new osteoclasts and the activity of existing osteoclasts.
Much of the research in the field of implantology has been limited to healthy animals and
patients. Variations in surface micro/nanoroughness, hydrophilicity, and chemistry may prove
important when trying to achieve implant osseointegration in compromised patients. To optimize
the use of implant technologies in patients with compromised bone structure and metabolism, a
more complete understanding of surface design on osseointegration is needed. The goal of the
present study was to determine whether changes in surface micro-/nanostructure and
hydrophilicity are sufficient to promote osseointegration in an aged rat with untreated
osteoporosis induced by ovariectomy.

Materials and Methods
Implant Preparation
2.5mm diameter, 3.5mm long, 0.8mm pitch, Ti implants were provided by Institut Straumann
AG (Basel, Switzerland). Implants were machined from a rod of grade 4 Ti degreased in acetone
and processed for 30s in a 55°C 2% ammonium fluoride/2% hydrofluoric acid/10% nitric acid
solution. Implants were then blasted with 250 – 500µm corundum and boiled in a mixture of HCl
and H2SO4. This process was performed in air to generate sandblasted large grit acid etched
(SLA) implants. A version of this procedure was performed under nitrogen with subsequent
storage in 0.9% saline to generate modified SLA (mSLA) implants. A subset of mSLA implants
were aged in saline for 1 month, removed from solution, rinsed in ultrapure water, and
repackaged in Al foil to generate SLAnano implants. All implants were γ-irradiated before use.
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Implant Characterization
Scanning Electron Microscopy
Scanning electron microscopy (SEM; Hitachi SU-70 FE-SEM, Hitachi, Tokyo, Japan) was
used to qualitatively evaluate implant surface structure and roughness. Six images at varying
magnifications were captured on implants (n=3) implants per surface modification using 5kV
accelerating voltage for a total of 18 images.
Laser Confocal Microscopy
Laser confocal microscopy (LCM, Zeiss LSM 710, Zeiss, Oberkochen, Germany) was used
to quantitatively evaluate surface micro-roughness. Measurements on each implant (n=3) were
taken over an area of 106.2µm x 106.2µm with a 20x objective and a scanning pitch of 50nm. A
Gaussian high-pass filter with a cutoff wavelength of 100µm was used when calculating average
surface roughness (Sa) over three scans per implant (total n=9).
X-Ray Photoelectron Spectroscopy (XPS)
Chemical composition of the samples (n=3) was obtained from the sample surfaces by XRay Photoelectron Spectroscopy (XPS, Thermo K-Alpha XPS, Thermo Fisher Scientific,
Waltham, MA, USA). Spectra were collected using a 500µm spot size, using an XR5 gun and Al
Kα x-ray source at 15kV. Scans were taken with a 20ms dwell time and 1eV step size. Three
different locations on each sample (total n=9) were analyzed.
Animals and Surgical Procedures
This study was conducted under approval of the Institutional Animal Care and Use
Committee at Virginia Commonwealth University. All experiments were carried out in
accordance with approved procedures and reported according to ARRIVE guidelines. All
animals were treated humanely per the guidelines outlined in the Guide for the Care and Use of
Laboratory Animals by the National Institutes of Health. Animals were single-housed in an
individually ventilated, solid-bottomed polysulfone cage and kept at a temperature of 17-28ºC
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with a humidity of 40-70% and a 12/12 h light/dark cycle.
A schematic detailing the timing of surgical procedures is shown in Figure 33. Ovariectomy
(OVX) surgery was performed on 25, 8-month-old, virgin, female CD Sprague-Dawley rats
(Charles River Laboratories, Wilmington, MA). The OVX induced osteoporotic phenotype
developed over the next 6 weeks. All animals had access to water ad libitum for the duration of
the study; however, OVX animals were pair fed a phytoestrogen-free diet (Advanced Protocol
Verified Casein Diet 10 IF, LabDiet, St. Louis, MO, USA) to age matched sham OVX controls.
The success of the pair feeding regimen was verified by weekly weighing of all animals for the
duration of the study, as described previously.85
Once the phenotype developed, SLA (n=10 animals), mSLA (n=10 animals), or SLAnano
(n=5 animals) implants were inserted transaxially into the distal metaphyses of each femur under
anesthesia. Animals were anesthetized with 5% isoflurane gas inhalation and maintained at 4%
isoflurane in O2 gas inhalation for the duration of the surgical procedure. The hind limbs were
prepared by shaving and cleaning using ethanol and chlorohexidine. For each hind leg, an 8mm
incision was made over the medial side of the knee and the distal metaphysis was exposed
using blunt dissection. A dental handpiece was used to create a 2.2mm diameter and 3.5mm
deep hole. Implants were inserted and hand-tightened using a custom-made driver. A stainlesssteel cover screw was placed on the end of each implant to prevent bone from growing into the

Figure 33. Schematic of the Experimental Procedures. 25, 8-month old, skeletally mature, virgin, female CD Sprague-Dawley
rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion of either a nonnanostructured/hydrophobic SLA, a nanostructured/hydrophobic SLAnano, or a nanostructured/hydrophilic modSLA was
inserted into the distal metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to euthanasia.
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internal threading of the implant. The periosteum and muscle were reapposed and sutured in
place using resorbable sutures and the skin was closed with 9mm wound clips. Animals
recovered from anesthesia on a water-circulating warming pad and injected subcutaneously with
1mg/kg buprenorphine SR LAB.
28d after the implant surgery rats were euthanized via CO 2 inhalation. The hind limbs from
each animal were isolated and prepped for analysis by micro-computed tomography (microCT)
and histological analysis (n=5 animals/group). A separate cohort of animals receiving either SLA
or mSLA implants were used for remsoval torque testing (n=5 animals/group). Each limb was
treated as a separate sample providing an effective sample size of 10 per implant group for both
the removal torque testing and microCT/histological analysis.
Tissue Analysis
MicroCT
MicroCT (SkyScan 1173, Bruker, Kontich, Belgium) was used to assess the peri-implant
bone growth and bone-to-implant contact (BIC). Femurs used for microCT were stored and fixed
in 10% neutral buffered formalin for at least 24hr prior to imaging. The distal femoral metaphysis
was scanned at a resolution of 1120x1120 pixels (image pixel size of 13.66 µm) over 360°using
a 0.25mm brass filter, scanning energies of120kV and 66μA, 420ms exposure time, and 5 x-ray
projections acquired every 0.2° and averaged. Using NRecon Software (Bruker), reconstruction
of the scanned images was performed using a standard feldkamp algorithm with a beam
hardening correction of 20% and a Gaussian smoothing kernel of 0. After reconstruction,
samples were analyzed using CTAn version 1.16.4.1 (Bruker). Bone volume over total volume
(BV/TV) was calculated by isolating a uniform volume of interest (VOI) for all samples which
contained the distal 3mm of implant and surrounding bone. 3mm was chosen to eliminate any
variability arising from the implant not being exactly at bone level for every sample. The implant
was then thresholded, the VOI was shrink-wrapped and dilated 2 pixels around the implant and
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subtracted from the original VOI. The remaining bone in the VOI was then thresholded and
quantified yielding total bone volume (BV) and normalized to the total uniform volume of interest
(TV). Bone-to-implant contact (BIC), which quantifies only the bone in direct contact with the
implant, was quantified by isolating the distal 3mm of the implant. The implant was thresholded
and shrink-wrapped, and the VOI was dilated 10 pixels around the implant and saved as a new
volume of interest. In the new VOI, the implant was thresholded, dilated 3 pixels, and subtracted
from the VOI. The remaining VOI was then eroded 3 pixels. The remaining bone in the final VOI
was thus only in direct contact with the implant (BV) and was normalized to the volume of the
implant (TV).
Histology
Following imaging with microCT, samples were placed in fresh 10% neutral buffered formalin
and sent to be commercially processed for calcified histological staining (Histion, Everett, WA,
USA). Femurs were embedded in methyl methacrylate, sectioned longitudinally relative to the
implant and transaxially relative to the femur, and stained with Stevenel’s blue and van Gieson.
Sections were imaged using bright field light microscopy with an AxioCam MRc5 camera and
Axio Observer Z1 and analyzed using ZEN 2012 Blue Edition software (Zeiss).
New peri-implant bone growth was quantified within a uniform rectangular region of interest
(ROI) for all samples that was 3.5mm in width by 3.0mm in length for a total of 10.7mm2. The
ROI was centered on each implant and began 0.3mm beneath its base. The area of all bone
within the ROI was quantified yielding BV and normalized to the area of the ROI yielding TV.
The area of bone contained within the ROI divided by the area of the ROI was defined as the
histological BV/TV. In addition, the perimeter of the implant contained within both the trabecular
region and the cortical region of the bone was measured. The trabecular BIC and cortical BIC
were determined by dividing the length of bone in direct contact with the implant by the trabecular
and cortical perimeter length respectively. The total BIC was calculated by summing both lengths
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of contact and dividing by the total perimeter of the implant.
Removal Torque
Removal torque testing was performed on fresh, non-fixed samples using an ElectroForce
3200 Series III test instrument (TA Instruments, New Castle, DE, USA). Because of their
asymmetrical shape, femurs were mounted in 1cm diameter flexible polyurethane plastic tubing
to ensure no movement of the femur during analysis (Fig. 5A). The tubing was cut into 5cm
segments and halved longitudinally to provide access to the implant. Femurs were secured with
polyurethane adhesive and allowed to dry overnight prior to testing. The implant on the samples
were then fit to a custom-made driver and aligned to the testing machine axis to ensure no initial
torque was present on the implant (0Ncm). Torque was then applied to the implants with a
rotational speed of 0.1°s-1 with an axial displacement of 0.8mm/360° to ensure no compressive
load was applied to the sample. Torque vs. degree graphs were generated for each sample and
fit to a bilinear model in order to distinguish the toe-region from the linear region using an opensource least squares spline modeling package (SLM - Shape Language Modeling version 1.14)
for MATLAB (MathWorks, Natick, MA, USA). The linear region of each graph was then evaluated
for the maximum torque, torsional energy (area below linear region), and torsional stiffness
(slope of linear region).
Osteoblast Isolation and Biological Response in Vitro
Calvarial osteoblasts were also isolated from the frontal and parietal bones of euthanized
rats using an explant technique. After removal of the periosteum and soft tissue, bones were
digested for 15min at 37°C with 0.25% trypsin-EDTA (Life Technologies, Carlsbad, CA). Bones
were minced into pieces approximately 1mm x 1mm and placed into a 100mm x 20mm Petri
dish with Dulbecco’s modified Eagle medium (DMEM; Mediatech, Manassas, VA) + 10% fetal
bovine serum (FBS) + 1% penicillin-streptomycin (Life Technologies). At confluence, cells were
subpassaged and cultured as above. In order to ensure 1α,25-dihydroxy vitamin D3
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(1α,25(OH)2D3; Enzo Biochem, Farmingdale, NY). The osteoblastic phenotype of each of the
four groups of isolated cells was confirmed by measuring alkaline phosphatase specific activity
and osteocalcin production after treatment of confluent cultures with either 0M or 10-8M
1α,25(OH)2D3 for 24hrs (Supplementary Fig. 1) on tissue culture polystyrene (TCPS).
Validated rat osteoblasts (rOBs; passage < 4) were separately cultured on TCPS or 15mm
Ti SLA, SLAnano or mSLA discs. Discs were prepared from Ti sheets but subjected to the same
implant sand-blasting and acid etching procedure as described above. Fabrication of these discs
has been described previously.22 Cells were plated at a density of 10,000 cells/cm2 and
incubated at 37°C in an atmosphere of 5% CO 2 and 100% humidity. Media were changed 24h
after plating and every 48h thereafter for 7d. At 7d, cells were incubated with fresh DMEM for
24h. Media were collected and immunoassays were used to measure levels of intact rat
osteocalcin (Alfa Aesar, Haverhill, MA) rat/mouse osteopontin (R&D Systems, Minneapolis, MN),
mouse osteoprotegerin (R&D Systems), human/mouse/rat BMP2 (PeproTech), mouse receptor
activator of nuclear kappa-B ligand (RANKL; R&D Systems), and rat vascular endothelial growth
factor (VEGF; R&D Systems).
After collection of media, cell monolayers were washed twice with 0.2ml PBS, lysed in 0.05%
Triton X-100, and homogenized by sonication at 40 amplitude using a Vibra-Cell ultrasonicator
(Sonics & Materials Inc., Newtown, CT). DNA content in the cell lysate was measured with
PicoGreen (Promega, Madison, WI) using a Synergy H1 Hybrid Reader fluorescence detector
(BioTek, Winooski, VT) at an excitation of 485 nm and emission of 538 nm. Alkaline phosphatase
specific activity [orthophosphoric monoester phosphohydrolase, alkaline; E.C. 3.1.3.1] was
assayed in cell lysates by measuring the conversion of p-nitrophenylphosphate to p-nitrophenol
at pH 10.25 and temperature of 37°C. Absorbance was measured at 405nm. Activity was
normalized to total protein content in the cell lysates as determined by bicinchoninic acid protein
assay kit (Thermo Fisher Scientific, Waltham, MA). Immunoassay data were normalized to DNA
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content.
Statistical Analysis
Based on previous studies,193,296 in order to detect a 30% mean difference with 20% variance
and a type I error rate of 0.05, a two-tailed one-way ANOVA power analysis determined a sample
size of 10 per group is necessary to maintain 80% power. In order to ensure that differences in
mechanical loading would not affect the results, identical implants were placed in the right and
left hind limbs. Since both legs were treated identically, it is safe to assume that movement or
loading in one limb will not affect the movement or loading experienced by the other limb. The
design of our study permits the assumption that implants from individual limbs can be treated as
independent data points rather than dependent. Data are presented as the mean ± standard
error (SE) for each analysis. All cell culture experiments had a sample size of six (n=6) and
repeated at least three times to ensure validity of the results. Data shown in the figures are from
representative experiments. Except for the removal torque experiment, a one–way analysis of
variance was performed with a two-tailed Tukey correction to adjust for multiple comparisons. A
t-test was used for the removal torque experiment. P values of <0.05 were considered significant
for all statistical analyses and were performed using JMP statistical software (SAS Institute,
Cary, NC, USA).

Results
Implant Characterization
Qualitative SEM images (Fig.34A – I) revealed that the sandblasting and acid etching
procedure maintained the overall threaded macrostructure of the implants (Fig.34A – C) while
creating similar microtopographies (Fig.34D – F). At a higher magnification (Fig.34G – I), the
presence of nanostructures was observed on SLAnano (Fig.34H) and mSLA (Fig.34I) implants.
Nanostructures were absent from SLA implants (Fig.34G). Confocal microscopy confirmed the
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Figure 34. Material Characterization of Implants. SLA, SLAnano, and mSLA substrates were examined by scanning
electron microscopy (SEM) at 35x (A – C), 20Kx (D – F) and 100Kx (G – I). Surface roughness (Sa) was assessed using laser
confocal microscopy measured using a 106.2µm x 106.2µm scan size (J). Surface chemical composition was assessed using
X-Ray Photoelectron Spectroscopy (XPS) with spectra of O, Ti, and C shown (K).

similarities in microtopographies, revealing no differences among the implants’ mean surface
roughness (Fig.34J). XPS (Fig.34K) showed carbon (C), oxygen (O), and titanium (Ti) to be the
main atomic components of the SLA, SLAnano, and modSLA implants. No differences in
chemical composition was detected between SLA and SLAnano. Compared to mSLA, both SLA
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Figure 35. MicroCT Assessment of Implant Osseointegration. 8-month old, skeletally mature, virgin, female CD SpragueDawley rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion of either
a non-nanostructured/hydrophobic SLA, a nanostructured/hydrophobic SLAnano, or a nanostructured/hydrophilic modSLA
was inserted into the distal metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to euthanasia.
After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the animals were analyzed
with 3D microCT reconstructions (A – C). Bone volume over total volume (BV/TV; D) and bone-to-implant contact (BIC; E)
were quantified from the microCT reconstructions. Data shown are the mean ± standard error (SE) of ten independent
samples. Groups not sharing a letter are statistically significant at an α=0.05.

and SLAnano had increased carbon content and decreased oxygen content. Similar titanium
content was detected among all three implant surfaces.
MicroCT and Histology
3D reconstructions of microCT scans (Fig.35A – C) show the implant placement in the distal
metaphysis of the femurs. The implants did not contact the growth plate eliminating any potential
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Figure 36. Histological Assessment of Implant Osseointegration. 8-month old, skeletally mature, virgin, female CD
Sprague-Dawley rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion
of either a non-nanostructured/hydrophobic SLA, a nanostructured/hydrophobic SLAnano, or a nanostructured/hydrophilic
modSLA was inserted into the distal metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to
euthanasia. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the animals were
embedded in methyl methacrylate, sectioned longitudinally relative to the implant and transaxially relative to the femur, and
stained with Stevenel’s blue and van Gieson (A – C). Bone volume over total volume (BV/TV; D) and bone-to-implant contact
(BIC; E) were quantified using histomorphometrics. Data shown are the mean ± standard error (SE) of six independent
samples. Groups not sharing a letter are statistically significant at an α=0.05.

influence on the bone formation in our defined VOI. The BV/TV (Fig.35D) was unaffected by the
implant type. mSLA promoted increased BIC compared to SLA and SLAnano (Fig.35E).
Representative histological sections from each group are shown in Fig.36A – C. mSLA
promoted increased BV/TV (Fig.36D) and BIC (Fig.36E) compared to SLA and SLAnano.
Removal Torque
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Figure 37. Removal Torque Assessment of Implant Osseointegration. 8-month old, skeletally mature, virgin, female CD
Sprague-Dawley rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion
of either a non-nanostructured/hydrophobic SLA or a nanostructured/hydrophilic modSLA was inserted into the distal
metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to euthanasia. After 28d of osseointegration,
femurs were isolated and analyses were performed on fresh, non-fixed samples as outlined (A). Torque vs. degree graphs
were generated for each sample and fit to a bilinear model in order to distinguish the toe-region from the linear region (B, C).
The linear region of each graph was then evaluated for the maximum torque (D), torsional energy (E), and torsional stiffness
(F). Data shown are the mean ± standard error (SE) of ten independent samples. Groups not sharing a letter are statistically
significant at an α=0.05.

Since microCT and histomorphometrics revealed no differences between SLA and SLAnano,
removal torque testing was performed on animals receiving either SLA or mSLA. Isolated femurs
were secured in polyurethane tubing and aligned to the machine axis in a custom-fabricated
sample holder to ensure no movement was created during the test (Fig.37A). Representative
torque vs. degree graphs for SLA (Fig.37B) and mSLA (Fig.37C) display the bilinear model (red)
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Figure 38. Response of primary calvarial osteoblasts isolated from ovariectomized aged rats to microstructured and
hydrophilic Ti substrates. Calvarial osteoblasts were isolated and cultured separately on TCPS, SLA, SLAnano, or mSLA
in DMEM. After 7 days, cells were treated with fresh DMEM for 24h. After 24h, media were collected, and cell lysates were
assayed for DNA content (A) and alkaline phosphatase specific activity (B). Media were assayed for osteocalcin (C), BMP2
(D), VEGF (E), osteopontin (F), RANKL (G), and osteoprotegerin (H). The ratio of RANKL to osteoprotegerin is shown in (I).
All osteoblasts used were of passage 4 or less. Data shown are the mean ± standard error (SE) of six independent samples.
Groups not sharing a letter are statistically significant at α=0.05.

fit to the experimental data (blue). The middle vertical dashed line (black) separates the toe
region (left section) and the linear region (right section) as determined by the least squares spline
modeling package in MATLAB. The maximum torque (Fig.37D), torsional energy (Fig.37E), and
torsional stiffness (Fig.37F) were increased around mSLA implants compared to SLA.
In vitro Cell Response
Addition of 10-8M 1α,25(OH)2D3 to confluent cultures of rOBs increased osteocalcin and
alkaline phosphatase specific activity, confirming their successful isolation and expansion. DNA
content (Fig.38A) and alkaline phosphatase specific activity (Fig.38B) were decreased in SLA
cultures compared to TCPS. On microstructured surfaces, DNA content was further reduced in
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 150

Osseointegration in Metabolically Compromised Conditions • Spring 2019

mSLA cultures compared to SLAnano. No differences in alkaline phosphatase specific activity
were detected on microstructured surfaces. rOBs cultured on modified surfaces produced higher
quantities of osteocalcin (Fig.38C), BMP2 (Fig.38D), VEGF (Fig.38E), osteopontin (Fig.38F),
and RANKL (Fig.38G) compared to TCPS cultures. Except for osteopontin, mSLA facilitated the
greatest production of these factors while SLAnano stimulated the least. Although no differences
were detected between mSLA and SLA osteopontin, a greater production was found on mSLA
compared to SLAnano. No difference in RANKL production was detected between SLA and
SLAnano cultures. Osteoprotegerin production (Fig.38H) was decreased to similar levels on
modified surfaces compared to TCPS; however, the RANKL/OPG ratio (Fig.38I) was increased
with the highest levels detected on mSLA.

Discussion
The morbidities associated with an aging population have increased the need for
technologies that provide predictable implant osseointegration in dental and orthopaedic sites.
Osteoporosis is one such metabolic condition that occurs when excessive bone resorption is not
compensated by a concomitant increase in bone formation. The inability of osteoblasts to match
the accelerated osteoclastic bone resorption with new bone formation implies a defect in the
coupling process. The increased fracture rates351 and impaired healing352 associated with
osteoporosis have become a significant dental and orthopaedic challenge. Systemic
administration of drugs like bisphosphonates or osteoinductive agents like BMPs or parathyroid
hormone-related protein (PTHrp) can improve clinical implantation outcomes by increasing bone
volume (BV) and bone mineral density (BMD). However, these technologies can be expensive
and sometimes require long-term administration. Evidence also indicates their use may have
deleterious side effects including osteonecrosis of the jaw and are contraindicated for some
applications. Therefore, approaches that do not rely on pharmacologic interventions are needed.
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Much of the research regarding the pathophysiology of osteoporosis and mitigating its effects
have focused on regulating the hyperactivity of osteoclasts. Impairment of osteoclasts will also
cause an inhibitory effect on bone remodeling causing issues where bone turnover is of the
utmost importance, such as osseointegration of dental implants. Alternatively, few studies have
explored enhancing the osteoanabolic activity of osteoblasts and their progenitors, MSCs.
Because of their capacity to self-renew and differentiation into various cell types, treatment
strategies aimed at altering the differentiation direction of MSCs or augmenting normal
endogenous MSCs could be a potential method for osteoporosis therapy. Specifically, for
osteoporosis, this means targeting the altered differentiation potential of MSCs that favors
adipogenesis over osteoblastogenesis. Promoting osteoblastic differentiation is not only
important for promoting net new bone formation but also for the recruitment of other
osteoprogenitor cells via paracrine signaling to hasten the peri-implant healing process.
Although the goal of the present study was not concerned with systemic treatment of
osteoporosis, the idea of locally mitigating the effects of osteoporosis by targeting MSC and
osteoblast differentiation and maturation is pertinent to enhancing implant osseointegration in
osteoporotic patients.
In an approach that does not rely on pharmacologic interventions, we have shown that
exploitation of the physical surface properties of Ti implants can promote peri-implant bone
formation and osseointegration in a model of aged post-menopausal osteoporosis. Moreover,
mSLA, a hydrophilic and micro-/nano-structured surface, promoted enhanced osseointegration
compared to SLA, a hydrophobic and micro-structured surface, and SLAnano, a hydrophobic
micro-/nanostructured surface. Higher BIC values and RTVs were observed in animals receiving
mSLA implants. These values were similar to those found in non-compromised animals as
previously reported.85 Interestingly, increased BV/TV was observed around the mSLA implants
as determined by histomorphometrics. The unique mSLA surface is known to promote the
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production of factors by cells that act via autocrine/paracrine signaling to induce bone formation
locally and distal to the implant,61,80 which translates into enhanced contact and distal
osteogenesis in vivo.196 Future studies are needed to assess the extent to which mSLA can
promote peri-implant bone formation in osteoporotic animals as well as other compromised
conditions.
The processing technique used in this study allowed accurate separation between the effects
of the nanostructures and the surface hydrophilicity. The sand blasting and acid etching
procedure provided a consistent micro-roughness among SLA, SLAnano, and mSLA; however,
this process did not induce nanostructure formation. Instead, nanostructure formation was
dependent upon the reorganization of the oxide layer facilitated by the aqueous NaCl solution.
Similar sized nanostructures were present on SLAnano and mSLA but not SLA. The exact
process of nanostructure formation is unknown; however, many studies have fabricated
nanostructures on metallic surfaces using a variety of methods involving changes in
temperature, pressure, and chemical treatments. X-ray photoelectron spectroscopy (XPS)
revealed that aqueous NaCl storage also maintained increased surface oxygen content by
preventing carbon contamination on mSLA compared to SLA and SLAnano. Although SLAnano
was originally prepared and stored in the same manner as mSLA, removal from NaCl solution
was sufficient to reduce the oxygen levels and increase carbon levels to that of SLA. Due to the
shape of the implant itself, quantification of the hydrophilicity by contact angle was not possible.
However, the contact angle of the 15mm discs subjected to identical surface treatments has
been reported previously.22 Additionally, the XPS results revealed a surface composition similar
to what was reported on hydrophilic surfaces compared to hydrophobic surfaces.22 These results
also confirm our findings reported for the SLA implant confirming batch-to-batch fabrication
consistency.85
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The mechanisms responsible for the enhanced osseointegration observed in vivo can be
explained by much of our previous in vitro work. Estrogen is an osteoprotective hormone, and
its deficiency leads to an elevated rate of bone turnover culminating in osteoporosis in females
and, in some cases, older males. We showed that female osteoblasts are more sensitive to
treatment with 17β-estradiol (E2) when cultured on microstructured Ti.73,75,81 Sensitivity to E2
treatment was also shown to increase when these cells were cultured on SLA and mSLA
compared to TCPS or PT. Furthermore, E2 treatment induces the expression of Wnt5a and
Wnt11 signaling pathway components. On TCPS, MSC differentiation occurs through the
canonical Wnt3A pathway, causing an accumulation of β-catenin in the cytoplasm and its
translocation into the nucleus to serve as a transcriptional activator.67–69 Our studies have
demonstrated surface mediated MSC differentiation downregulates genes associated with the
Wnt3A pathway while upregulating genes of the Wnt11 73 and non-canonical calcium-dependent
Wnt5a pathway.70,71 These data suggest that surface design may be able to compensate for low
E2 typical of osteoporosis by stimulating MSC differentiation and osteoblast maturation.
Successful osseointegration not only requires net new bone formation but also involves
osteoclast-mediated bone remodeling. Therefore, implants designed for osteoporotic patients
should mitigate the effects of the altered communication among the cells responsible for bone
remodeling. In osteoporotic patients, MSCs and osteoblasts produce factors favoring
osteoclastogenesis unfettered by any regulatory feedback mechanisms. Increased levels of proinflammatory IL-6 and decreased levels of TGFβ1 are produced by bone cells isolated from
osteoporotic patients compared to healthy patients.77–79,262 Interestingly, both E2 treatment and
microstructured Ti substrates are known to inhibit IL-6 production while enhancing production of
TGFβ1 and OPG.75,80,81 It was also shown that conditioned media from MSC cultures grown on
microstructured Ti substrates for 7 days inhibit osteoclast activity and this is correlated with
surface-dependent production of osteoclast inhibitory factors.326 In addition to the high

Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 154

Osseointegration in Metabolically Compromised Conditions • Spring 2019

production of negative regulators of osteoclast activity, cells produce high levels of osteocalcin
and osteopontin.22,53 Osteocalcin has been shown to promote the chemotaxis, adhesion, and
spreading of osteoclasts86,87 while osteopontin plays a role in anchoring osteoclasts to the
mineralized bone matrix.88 The sequential production of these factors suggests microstructured
Ti facilitates the production of a cascade of factors by MSCs and osteoblasts to mediate
osteoclast recruitment while preventing their premature fusion and activity.
Many studies have suggested a favorable effect of a nanostructured surface on osteoblast
differentiation and maturation in vitro and new bone formation in vivo. No positive influence of
nanostructures on implant osseointegration in OVX-induced osteoporotic animals was observed
in this study. Moreover, the production of osteoblastic factors was impaired in primary
osteoblasts when cultured on the hydrophobic/nanostructured SLAnano surface in vitro, an
effect observed previously in healthy cells. Calvarial osteoblasts isolated from OVX animals
displayed decreased osteocalcin, VEGF, BMP2, and osteopontin when cultured on SLAnano.
The nanostructure size of the SLAnano surface was previously reported to be ~10nm22 whereas
studies that observed positive effects of nanostructures ranged from 40 – 200nm.51,142,191 This
suggests that osteoblastic differentiation and maturation can be altered by varying the size and
shape of the nanostructures. Moreover, the effect of the nanostructures can be recovered and
improved through the addition of the hydrophilicity providing the optimum conditions of
osteoblastic differentiation and maturation. Interestingly, rOBs on all surfaces displayed
decreased productions of OPG and increased productions of RANKL compared to TCPS.
Previous studies have shown that aging in humans and rodents leads to an increased
osteoblast-specific production of RANKL and decreased osteoprotegerin in osteoblasts,78,79
which could be exacerbated by the enhanced maturation that Ti surfaces facilitate in osteoblasts.

Conclusions
Clinical grade Ti was successfully modified to fabricate microrough surfaces exhibiting
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hydrophobic or hydrophilic nanostructured surfaces. Moreover, these surfaces were able to
osseointegrate in an aged rat model of OVX-induced osteoporosis without pharmacologic
intervention. Although modified surfaces were able to osseointegrate, a hydrophilic and micro/nano-structured mSLA surface had better osseointegration as indicated by higher percent BIC
and RTVs. These values are also like what was previously observed in healthy animals receiving
SLA implants. In vitro production of markers of osteoblastic differentiation and maturation were
also greatest on mSLA while a hydrophobic and micro-/nano-structured SLAnano surface
delayed the process of osteoblastogenesis. These results suggest that when the appropriate
microstructure is present, hydrophilicity may play a greater role in stimulating differentiation of
MSCs and osteoprogenitor cells and maturation of osteoblasts than nanostructures.
Furthermore, when presented with the optimal surface, similar degrees of osseointegration
between healthy and compromised patients can be achieved. Because of these differences
observed both in vitro and in vivo, modified implant surfaces can exert their control over the
altered bone remodeling and turnover observed in patients with osteoporosis to stimulate
functional osseointegration. This insight is critical to the development of implants that support
osseointegration in compromised patients.
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Chapter 9. Conclusions and Future Perspectives
This work has established that microstructured Ti and TiZr surfaces play significant roles in
the bone remodeling stage of osseointegration. We have shown that Ti and TiZr can be
successfully modified to enhance surface hydrophilicity, create microroughness, and induce
nanostructure formation. Although all modified surfaces were able to facilitate a healthy
osteoblastic phenotype in both MSCs and NHOsts, nanostructure size of ~11nm may delay the
process of osteoblastogenesis. However, the effect of these nanostructures can be recovered
with enhanced surface energy (hydrophilicity). This holds true when comparing the in vitro
response of these cells between Ti to TiZr. Both MSCs and NHOsts responded similarly to both
surfaces despite differences in bulk material and variations in surface nanostructure
morphology/density. While it is tempting to definitively conclude that surface hydrophilicity
overpowers any influence elicited by the surface chemistry (Ti vs. TiZr) or the surface
nanoroughness, we are unable due to missing controls. Future studies would benefit from
comparing hydrophobic/microrough Ti and TiZr as well as comparing hydrophilic/microrough
Ti/TiZr to hydrophilic/microrough/nanorough Ti/TiZr. equivalent.
We also showed that cellular response to surface roughness and hydrophilicity is modulated
by nitrogen containing BPs. BPs are commonly used to combat osteoporosis by targeting OCs,
slowing the rate and severity of bone resorption providing rationale for their use to enhance
osseointegration. Our results indicate their use may have deleterious effects on implant success
and patient safety contraindicating their use when implant osseointegration is the desired
outcome. Exposure to BPs jeopardizes the pro-osteogenic response osteoblasts have to
microstructured surfaces. Since BP treatment was more robust in cells cultured on rough and/or
hydrophilic surfaces compared to smooth substrates, this effect may be dependent on cell
maturation state, as well as donor sex and age. Moreover, their effects persist in vivo and
condition osteoblasts to negatively influence their in vitro response. Because of their persistent
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effects, clinicians may consider implementing a “drug holiday” for patients prescribed BPs,
especially those who need a dental and/or orthopaedic implant. Future studies should assess
the time it takes for primary osteoblasts to recover from the persistent effects of different BPs.
Clinically, BPs could compromise peri-implant bone formation slowing the rate and quality of
implant osseointegration. In order to assess the effects of BPs on osseointegration, an aged rat
model with ovariectomized induced osteoporosis was employed. Our results show that
osseointegration is decreased in osteoporotic animals compared to age-matched controls.
Clinically relevant doses of ibandronate were able to halt the progression of the osteoporotic
phenotype. These doses neither increased nor decreased implant osseointegration. However,
the in vitro response of isolated osteoblasts was impaired, especially in sham ovariectomized
animals. Interestingly, cells isolated from untreated ovariectomized animals responded more
favorably to microstructured surfaces when compared to cells isolated from healthy controls.
Whether implant surface properties alone were enough to stimulate peri-implant bone
formation and osseointegration was assessed using only untreated ovariectomized rats. Clinical
grade 4 Ti implants were successfully modified to fabricate microrough surfaces exhibiting
hydrophobic or hydrophilic nanostructured surfaces like the grade 2 Ti disks used for in vitro
studies. Each implant was able to osseointegrate in an aged rat model of OVX-induced
osteoporosis without pharmacologic intervention. Unlike what was seen in vitro, the hydrophobic
nanostructured implant surface did not impair osseointegration. Perhaps after 28d the influence
of ~11nm nanostructures cannot be observed and instead reserves its influence over the initial
stages. The aspect that was similar to what was observed in healthy MSC and NHOst cultures
was the superior influence a hydrophilic and micro-/nano-structured surface had over
osseointegration. In vitro production of osteoblastic markers from isolated primary cells were
perpetuated on this surface as well. These results support the hypothesis that hydrophilicity may
exert a greater influence compared to nanostructures. Whether or not it is greater than
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Figure 39. Eph/Ephrin and semaphorin system mRNAs in MSCs cultured on Ti surfaces. Groups not sharing a letter are
statistically different at α=0.05.

microroughness remains to be determined. Regardless, these results suggest that modified
implant surfaces exert their control over the altered bone remodeling and turnover observed in
patients with osteoporosis to stimulate functional osseointegration.
The question of what to do with this information now presents itself. Current research in the
field of dental and orthopaedic implantology tends to focus on the development of novel methods
of altering biomaterial surfaces and characterizing their effects on early stage osteogenesis.
While these approaches are well-intentioned, it is unlikely that development of an optimal surface
design capable of stimulating similar degrees of osseointegration between healthy and
osteoporotic patients will manifest itself in this way. Instead, research in the field of dental and
orthopaedic implantology should focus on knowledge gaps in bone biology and how implant
surface features alter the dynamics of wound healing. Thus, it is of great importance to determine
which factors regulate coupling and the influence dental implant surface features have on these
mechanisms.
By investigating the extent to which microstructured Ti surfaces modulate the dynamic
interplay of multiple cell types, we are innovating the redundancy of contemporary biomaterial
surface research. Using a newly developed system that exploits the OsteoLyse Assay Kit, we
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Figure 40. Effects of exogenous and endogenous Sema3A on MSCs cultured on microstructured Ti surfaces. Groups not
sharing a letter are statistically different α=0.05.

have shown that microstructured Ti surfaces indirectly regulate OC activity and gene expression
After surface recognition by integrins, MSC and NHOst protein production is modulated and
responsible for the decreased activity of existing OCs and reduced fusion of new OCs. In
addition, OC gene expression is selectively regulate suggesting more than one pathway of
control may be involved. Of the proteins responsible, the classic coupling mediators, TGFβ and
OPG, do not contribute to the surface dependent regulation in vitro. Efforts should now continue
exploring alternative mechanisms capable of regulating bone remodeling.
Two other systems have been identified as important regulators of bone remodeling: 1)
Eph/Ephrins and 2) Semaphorins. These two systems aid bone homeostasis and offer an
intriguing mechanism for a reciprocal communication of the cell types involved. We have
demonstrated that components of these signaling systems are modulated by microstructured Ti
surfaces (Fig.39). Our research shows mRNAs for EPHB2 and SEMA3A increase on modSLA.
Expression of the SEMA3A receptor, NRP1, is increased on SLA and modSLA. In contrast,
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Figure 41. Semaphorin system mRNAs in OCs treated for 2d with media collected from MSCs cultured on Ti surfaces.
Exogenous RANKL and M-CSF was added to control for initial quantity for OC differentiation. OCPs and untreated OCs were
used as a negative and positive control respectively. Groups not sharing a letter are statistically different α=0.05.

EPHB3, EFNB2, and SEMA3C expression in MSCs decreases in a surface-dependent manner.
Addition of exogenous SEMA3A to surface cultured MSCs stimulates their osteoblastic
differentiation while addition of a SEMA3A neutralizing antibody slows their osteoblastic
differentiation (Fig.41). Moreover, conditioned media from MSC cultures stimulates SEMA3C
expression in OCs and decreases expression of SEMA4D and PLXNA1 (Fig.41). SEMA4D
produced by OCs can bind to PLXNB1 on the OB surface to decrease bone formation. Currently,
SEMA3C has no known role in regulating bone homeostasis in TCPS culture. Our results
suggest that surface-dependent modulation of MSCs and their downstream modulation of
osteoclastic activity involve important, novel roles for semaphorin family proteins. Future
research should focus on expanding the role semaphorins play in modulating bone remodeling
in vitro as well as in vivo.
A thorough understanding of how cells interact with the physical features of their
environments has led to the development of implants that are both biocompatible and bioactive.
By targeting the surface of the substrate, major enhancements in the performance of dental and
orthopaedic implants have been achieved. Implant surface features are now designed to mimic
the inherent surface roughness, surface chemistry, and surface hydrophilicity of native bone.
Furthermore, methods to recreate the complex hierarchical features of an osteoclast resorption
pit are now widely used to induce combinations of macroscale, microscale, mesoscale, and
nanoscale topography. Thus, by mimicking the surface structure present on native bone tissue,
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contemporary dental and orthopaedic implants can be designed to achieve rapid and optimal
osseointegration. As research into these areas progresses, the future of implantology could see
patient-specific implant designs that modulate different pathways, promoting healthy bone
formation despite health issues the patient may present.
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